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to  fulfill  its various  tasks, which  range  from physical protection against exterior stress and 
maintaining homoeostasis to immune evasion. A major component of the bacterial cell wall is 
the peptidoglycan network (PGN). Built up by a carbohydrate backbone of repeating units of 
N‐acetylglucosamine  and N‐acetylmuramic  acid  linked  to  a  peptide  stem  containing  non‐




N‐acetylmuramoyl‐L‐alanine  amidases  cleave  the  amide  bond  between  the  carbohydrate 
backbone and the peptide stem and represent a class of PGN‐modulating enzymes that ensure 







with  its  substrate  component muramoyltetrapeptide. Close  investigation of  the molecular 
interactions between enzyme and substrate, along with the analyses of the apo‐structure and 
enzymatic  activity  assays,  elucidated  the  likely  reaction mechanism  as  well  as  substrate 
specificity. Since the  intact substrate,  including the scissile bond,  is present  in the complex 
structure, it moreover serves as a starting point for therapeutics against methicillin‐resistant 
Staphylococcus aureus. Further studies with AmiA‐cat in this regard involve a fragment‐based 







amidases,  AmiC2  drills  holes  into  the  septal  disk  that  separates  neighboring  cells,  thus 
generating a nanopore array used for nutrient exchange and communication. My cooperation 




activity and specificity of  this unusual amidase.  In particular,  I study  the separate and / or 
cooperative influence of the additional domains, AMIN‐A, AMIN‐B, and the proline‐rich linker 
of  the AmiC2 holo‐enzyme on  catalysis  and  specificity.  Furthermore,  in  cooperation,  I  am 
working  on  elucidating  the  exact  chemical  composition  of  Nostoc  PGN,  perhaps  even 
differences between nascent, septal, and mature PGN. The results will be essential to generate 








Die  Bakterienzellwand  ist  eine  hochdynamische  Struktur,  die  einem  ständigen  Wandel 
unterliegt, um ihre verschiedenen Aufgaben zu erfüllen. Diese reichen von physischem Schutz 
gegen  äußere  Belastungen  über  die  Aufrechterhaltung  der  Zellhomöostase  bis  zur 
Immunevasion. Ein Hauptbestandteil der bakteriellen Zellwand ist das Peptidoglycan (PGN). 
Es  ist aus einem Kohlenhydratgerüst mit abwechselnden Einheiten von N‐Acetylglucosamin 
und  N‐Acetylmuraminsäure  sowie  einem  Peptidstamm,  der  auch  nicht‐proteinogene 
Aminosäuren  beinhaltet,  aufgebaut.  PGN  ist  eine  netzartige  Struktur,  die  außerdem 
verschiedene  Proteine  und  weitere  Komponenten  der  Zellwand  verankert.  Je  nach 
Zusammensetzung  des  Peptidstammes  selbst  und  der  Art  der  Vernetzung  zwischen  den 
Peptidstämmen kann das PGN ein sehr dichtes Netz oder ein eher lockeres Geflecht sein. 
N‐Acetylmuramoyl‐L‐Alanin‐Amidasen  spalten  die  Amidbindung  zwischen  dem 
Kohlenhydratgerüst und dem Peptidstamm und stellen eine Klasse von PGN‐modulierenden 
Enzymen dar, die seine Plastizität sicherstellen. Die vorliegende Arbeit konzentriert sich auf 
diese  Enzymklasse  und  soll  zum  Verständnis  der  zugrunde  liegenden Mechanismen  jener 
enzymatischen Spaltung beitragen, die für die Plastizität von PGN verantwortlich  ist. Dieser 
Fragestellung  wurde  mit  Hilfe  biochemischer  und  zellbiologischer  Methoden  sowie  der 
Röntgenstrukturanalyse nachgegangen. 
Das  bi‐funktionelle  Major  Autolysin  AtlA  von  Staphylococcus  aureus  besteht  aus  einer 
Glucosaminidase und einer Amidase, welche posttranslational voneinander getrennt werden. 






Reaktionsmechanismus  sowie  die  Substratspezifität  des  Enzyms  geliefert.  Da  das  intakte 
Substrat einschließlich der zu spaltenden Bindung in der Komplexstruktur vorhanden ist, dient 












AmiC2  im  ausreifenden  Septum  lokalisiert,  und  ich  habe  die  Struktur  der  katalytischen 




Spezifität  dieser  ungewöhnlichen  Amidase  regelt.  Insbesondere  wird  momentan  der 
getrennte und / oder kooperative Einfluss der zusätzlichen Domänen des AmiC2‐Holoenzyms 
‐ AMIN‐A, AMIN‐B sowie Prolin‐reicher Linker ‐ auf die Katalyse und Spezifität von AmiC2‐cat 
erforscht.  Außerdem wird  die  genaue  chemische  Zusammensetzung  des  PGN  von Nostoc 
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Ferdinand  Cohn  defined  bacteriology  and  discovered  bacterial  endospores,  Louis  Pasteur 
invented the sterilization process (“pasteurization”) and developed attenuated vaccines, and 
Robert  Koch  established  methods  for  culturing  pure  microbial  cultures  and  linked 
microorganisms  to  infectious diseases  [1]. Therefore, most people associate bacteria with 
disease and see them as pathogens, however, this is only part of the truth. 
When cyanobacteria evolved  into oxygenic phototrophs 3.3 billion years ago,  they  started 
oxygenizing Earth and laid a basis for “higher” life [1, 2]. Respiration of oxygen provides more 
energy,  and  the  formation  of  the  ozone  layer  protects  land‐life  from UV  radiation  [2‐4]. 
Furthermore, according to the endosymbiotic theory, all eukaryotic cells harbor organelles of 
bacterial  origin  [5].  Bacteria  are  also  true  symbiotic  partners  for multicellular  organisms 
including humans [6]. Giving one example, the microbiome  in our gut helps with digestion, 
provides  vitamins  or  other  essential  compounds,  and  competes  with  pathogenic 





















are  Gram‐positive  bacteria  that  colonize  the  skin  or  mucous  membranes  of  the  upper 
respiratory  tract  [10,  11]. Most  members  of  this  facultatively  anaerobic  genus  produce 

















Staphylococcus  aureus  produces  the  carotenoid  pigments  staphyloxanthin  that  gave  it  its 
name  (Latin:  aureus,  for  "golden").  Staphyloxanthin  has  antioxidant  capabilities,  thereby 
enabling  S.  aureus  to  cope with  oxidative  stress  from  reactive  oxygen  species  (ROS)  and 
making it more resistant to neutrophil killing [14]. 
Although  harmless  to  healthy  individuals,  S.  aureus  can  cause  severe  infections  in 
immunocompromised individuals. Apart from the immune‐evading function, the biofilm also 
contributes  to  persistent  infections, which  ultimately  lead  to  complications  [15,  16].  The 
multilayered polysaccharide matrix [17] also contributes to pathogenicity. Still, the primary 
function is the protection from the host’s immune system [18]. 





coagulase,  but  also  hyaluronidase,  fibrinolysin,  lipase,  ribonuclease,  deoxyribonuclease, 
Protein A, Panton–Valentine  leukocidin  (PVL), or  toxic  shock  syndrome  toxin  I  [10]. These 
enzymes  facilitate  destruction  of  host  tissue  and  promote  the  spread  of  infection, while 
Protein A binds to immunoglobulins and helps to evade opsonization and phagocytosis. PVL 




(MGE)  that  make  up  15‐20  %  of  its  genome  and  carry  resistance‐genes,  host‐adaption 
mechanisms, or encode for toxins [22]. MGEs include staphylococcal cassette chromosomes 
(SCC), plasmids, transposons, or S. aureus pathogenicity  islands, and are mostly transferred 








use  them  to  defend  their  ecological  niche  against  adversaries. When  Alexander  Fleming 
discovered  penicillin  in  1929, mankind,  too,  started  to  utilize  those  compounds  to  treat 



















were  introduced,  the  bacteria  responded,  and  first  strains  of  methicillin‐resistant 
Staphylococcus aureus (MRSA) were discovered in the early 1960s [27‐29].  
MRSA strains are resistant to all β‐lactam antibiotics because of a special penicillin binding 




isolates  in  the  1960s  (…)  and  were  shown  to  have  acquired  staphylococcal  cassette 
chromosome  (SCCmec)  at  least  23  separate  times”  [32].  The  constant  and  high  selection 
pressure  in healthcare  facilities  from a broad variety of antibiotics  forces MRSA  strains  to 
adapt and evolve and,  consequently,  to acquire new antibiotic  resistances against  several 
classes of antibiotics  (e.g. gyrase or bacterial RNA polymerase  inhibitors and glycopeptide 
based antibiotics) [32‐34], posing a serious threat to human health [31]. This  is reflected  in 




Institut, reported case numbers  in Germany decreased  in the period of 2012 to 2014  from 
4,498 to 3,841 cases [36]. However, with an actual prevalence of around 10,000 annual MRSA 
infections, the numbers are still concerning [37]. Higher hygienic standards may play a role in 
decreasing  numbers  of  hospital‐acquired MRSA  (HA‐MRSA)  [38]  as  intensive  screening  of 
patients and staff as well as consequent treatment have kept the MRSA infection rate in the 
Netherlands  under  3%  [39].  Nevertheless,  community‐associated  MRSA  (CA‐MRSA)  and 
livestock‐associated  MRSA  (LA‐MRSA)  infections  have  been  increasing  and  spreading 










Cyanobacteria  set  the  basis  for  higher  life  on  earth  by  introducing  oxygen  into  the  
atmosphere  through  oxygenic  photosynthesis  [2‐4].  The  taxonomy  of  cyanobacteria  is 
controversial.  One  method  of  classification  is  the  division  into  five  groups  based  on  
different  characteristics  and  properties  that  allow  the  adaption  to  a  broad  variety  of  























persist  even  under  extreme  conditions  and  germinate  into  a  new  filament  in  a  better 
environment [52‐54] (Figure 3 A+C). Hormogonia are short gliding filaments that are formed 









At  low  levels of  fixed nitrogen, Nostoc  filaments  form heterocysts at  termini or along  the 
filament in a semi‐regular pattern (Figure 3 A+B and Figure 4). Differentiation into heterocysts 
is  irreversible and  linked  to  severe  changes  in order  to perform nitrogen  fixation  [54]. As 
oxygen  is  harmful  to  nitrogenase  and  inhibits  N2‐fixation,  heterocysts  form  a microoxic 
environment by  formation of a  special cell envelope on  top of  the cell wall  to prevent O2 
diffusion  into  the  cell.  They  are  also  no  longer  able  to  perform  oxygenic  photosynthesis 
because they lack photosystem II [41]. As a result, heterocysts need carbon sources for the 
production of ATP and, equally importantly, as electron donors to reduce nitrogen [41]. The 













[44,  58,  63]  (Figure  5  A).  It  was  shown  that  these  nanopores  are  essential  for  cell‐cell 
communication  and  that  N‐acetylmuramoyl‐L‐alanine  amidases  are  involved  in  their 





































the presence or absence of an outer membrane  (OM). A close‐up on  the cell wall shows  the  individual PGN pattern and





















complex.  Individual  bacteria  implement  a  variety  of  alterations,  modifications,  and 
substitutions in order to adapt their cell wall (Table 1). This is also reflected in the annotation 
of PGN‐subtypes like “A3α” for S. aureus or “A1γ” for e.g. E. coli, B. subtilis, and N. punctiforme 








incorporate  L‐Lys  instead  of mDAP  (Figure  7).  Another  alteration  is  the  exchange  of  the 
terminal  D‐Ala  with  D‐Ser  or  D‐lactate  (D‐Lac),  which  correlates  with  certain  antibiotic 
resistances. An overview on amino acid usage  is given  in Table 1 [72]. Furthermore, Gram‐
negative PGN  is usually directly  cross‐linked, while  a pentaglycine bridge, which  also may 
contain other amino acids, connects Gram‐positive peptide stems  [74, 76]. Other variables 
include  the  occasional  absence  of  unlinked,  terminal  D‐Ala  residues,  different  amidation 

























































almost every bond of PGN and were  in  the  focus of several  reviews  [79‐81]. The different 
enzyme classes, their tasks, and some respective representative examples are given below: 










































not  least,  it was  shown  that  they  are  also  important  for  intercellular  communication  and 
nutrient exchange in filamentous bacteria (AmiC2 N. punctiforme [43]).  











domains adopt globular, mixed  αβ‐folds. So  far,  little  is known about  the  remaining  three 
members  of  the  clan  (Amidase_5,  Amidase_6,  and  Amidase_02c),  and  no  structures  of 
members of these families have been deposited with the wwPDB to date (Table 2).  
 
FAMILY  PFAM‐ID  PHYLOGENY NAME ORGANISM GRAM 
AMIDASE_2  PF01510     AmiA  Staphylococcus aureus  Gram‐positive 
         AmiE  Staphylococcus epidermidis  Gram‐positive 
         PlyL  Bacillus anthracis  Gram‐positive 
         XlyA  Bacillus subtilis  Gram‐positive 
         LytA  Streptococcus pneumaniae  Gram‐positive 
         AmiD  Escherichia coli  Gram‐negative 
         AmpDh3  Pseudomonas aeruginosa  Gram‐negative 
         AmpDh2  Pseudomonas aeruginosa  Gram‐negative 
         AmpD  Citrobacter freundii  Gram‐negative 
AMIDASE_3  PF01520     AmiC2  Nostoc punctiforme  Gram‐negative 
         CwlV  Paenibacillus polymyxa  Gram‐positive 
         AmiC  Escherichia coli  Gram‐negative 
         AmiB  Bartonella henselae  Gram‐negative 
         Rv3717  Mycobacterium tuberculosis  Gram‐positive 
AMIDASE_5  PF05382  ‐ ‐ ‐  ‐ ‐ ‐  ‐ ‐ ‐  ‐ ‐ ‐ 
AMIDASE_6  PF12671  ‐ ‐ ‐  ‐ ‐ ‐  ‐ ‐ ‐  ‐ ‐ ‐ 
AMIDASE_02C  PF12123  ‐ ‐ ‐  ‐ ‐ ‐  ‐ ‐ ‐  ‐ ‐ ‐ 
 



















AtlA, AtlE,  and AtlL of  S. aureus,  S.  epidermidis and  S.  lugdunensis,  respectively,  are well‐
studied representatives of the major autolysin Atl [87, 95, 111, 112], which is highly conserved 
among  Staphylococci, especially  the  amidase domain  [113]. AtlA  is  a pre‐pro‐protein  that 
consists of a signal peptide for translocation to the extracellular space and a pro‐peptide of so 
far  unknown  function,  as  well  as  the  PGN‐processing  enzymes  AmiA 
(N‐acetylmuramoyl‐L‐alanine amidase) and NAGase  (endo‐β  ‐N‐acetylglucosaminidase)  [87, 
95, 111, 112]  (Figure 11). The two catalytic domains  (“cat”) of AmiA and NAGase are each 
linked  to  targeting  repeats  (R1‐R3),  where  AmiA‐cat  has  R1R2  located  C‐terminally  and 




























of  unicellular  bacteria  such  as  E.  coli  [90,  116].  A  stretch  of  approximately  160  residues 
contains many proline residues and connects the AMIN and catalytic domains (Figure 12). This 
proline‐rich  linker  (“ProLinker”) may  be  ordered  to  some  degree,  however,  its  secondary 
structure and its function are so far unknown (unpublished data). The catalytic domain AmiC2‐










Lehner  et  al.  demonstrated  the  importance  of  AmiC2  for  cellular  communication  by 
generating mutant  strains of N. punctiforme  that  lack  this  enzyme  and no  longer  formed 
proper  filaments, exhibited  irregular  septa,  and  lost  the  ability of differentiation  [43,  44]. 
Furthermore, intercellular calcein exchange is abolished in the absence of AmiC2 [43].  












findings  were  to  be  validated  for  AmiA  of  the  highly  pathogenic  S.  aureus.  In  order  to 
determine the substrate specificity, the mode of recognition, and the catalytic mechanism of 







intercellular  exchange  [43,  44].  An  inhibitory  α‐helix  that  covers  the  active  site  in  a 
homologous  enzyme  is missing,  and  regulation  is  therefore  likely  entirely  different.  The 






N‐acetylmuramoyl‐L‐alanine  amidases  exhibit  a  low  level  of  amino  acid  conservation, 
generally only twenty to thirty percent, although they perform the same reaction and serve 
similar  functions.  In  the  course  of  this  thesis  it  thus  became  tempting  to  speculate  that 
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solve a protein‐ligand structure as well. AmiA‐cat  is highly active even  in crystallized  form. 
Prior  to  soaking,  crystals needed  to be  inactivated by EDTA‐treatment over  three days  to 
remove the zinc ion from the active site. Muramoyltetrapeptide (MtetP) was chosen as this 
modified  ligand  containing  an  amidated  D‐Ala  and  acetylated  L‐Lys  approximates  the 













makes  one  hydrophobic  interaction,  D‐iGln  forms  the  majority  of  hydrogen  bonds  and 
contributes strongly towards binding and orientation of the ligand. D‐Ala and L‐Lys form one 













introducing  a  tetrahedral  intermediate.  H382  stabilizes  this  tetrahedral  intermediate  by 
providing a proton for the resulting oxanion. Re‐formation of a carbonyl leads to the release 
of cleaved carbohydrate backbone and peptide stem as leaving groups. 
The  entire mechanism  of  PGN  engagement  is,  however, more  complex.  To  enhance  our 






PGN  carbohydrate backbone  is  thus  likely  similar  in  all  amidases. Mapping  the  conserved 
residues onto the molecular surface and examination of the electrostatic surface potential 
gave  further  insights where  neighboring  N‐acetylglucosamines may  bind.  Based  on  NMR 
structures of PGN fragments, we were able to model two adjacent GlcNAc moieties. Similarly, 











share  the  same  type  of  PGN  (A1γ), which  AmiA‐cat  cannot  cleave.  The  substrate  in  the 
AmiD E. coli structure also contains 1,6‐anhydro MurNAc, which is not present in S. aureus PGN. 
Therefore,  this  complex  structure  is  not  suitable  to  infer  insights  into  S.  aureus  PGN 
engagement  and  thus  highlights  the  importance  of  our  findings. Moreover,  the AmiA‐cat 
complex improved previous docking studies from the homologous AmiE‐cat and presents new 
interactions that set the basis for proper structure‐based inhibitor design. 










3.2. Enabling	 cell‐cell	 communication	 via	 nanopore	 formation:	








array.  In  contrast  to  cell  splitting  amidases  that  merely  cleave  the  scissile  
amide  bond  for  proliferation,  AmiC2  drills  exactly  defined  holes  into  the  septal  disk  










AmiC2  was  detected  in  young  septa  of  the  filament  by  immunofluorescence.  A  specific 






(DRA),  which  is  based  on  the  release  of  dye  from  stained  E.  coli  PGN  upon  enzymatic 







stranded  β‐sheet, which  is  surrounded  by  six  α‐helices.  The  binding  groove  is  defined  by 
helices α2 and α4 as well as loops. However, this groove is wide and shallow, and AmiC2‐cat 
may  therefore  accommodate  the  substrate  in  various  conformations.  Zinc  coordination  is 
facilitated by H447, H515, and E462, while two additional residues, D451 and S513, help to 
properly orient the histidine side chains. We also found a buffer molecule and the N‐terminus 
of  AmiC2‐cat’s  crystallographic  symmetry  mate  in  the  binding  groove.  Both  may  have 
implications  for  substrate  binding  and  catalysis.  The  high  catalytic  activity  concurs with  a 
positive  surface potential of AmiC2 around  the active  site, which also  implies a negatively 
charged substrate.  
A  tight  spatio‐temporal  regulation  is  imperative  for  the  precise  function  of  AmiC2. 




may  need  a  rather  complex machinery.  It was  shown  that  certain  PGN‐binding  proteins 







binding  site. Comparison with  the  closely  related Amidase_2  family, where a definite and 














in  zinc  binding.  The  position  of  the  terminal NH2  group  can  also  be  occupied  by  a water 
molecule.  As  length  and  charge  of  E578  are  particularly  critical,  the  residue  likely  acts 
analogously  to  E324 of AmiA‐cat  S.  aureus.  In  cooperation with  a backbone  carbonyl,  and of 
course  the  zinc  ion, E578  correctly positions  the hydrogens and  free electron pairs of  the 
proposed water molecule. The distances and angles of these interactions fit well so that the 
water  is  ready  for an attack on  the scissile bond. A possible proton  relay, as suggested by 
Mayer  et  al.  [126],  is  nearby  and  may  assist  in  catalysis.  The  MES  molecule  from  the 
crystallization  buffer  bound  in  a  pocket  close  to  the  zinc  ion  and  might  occupy  the 
carbohydrate binding site. 
We present  the high‐resolution  structure of  the  catalytic domain of AmiC2  and  show  the 
localization to young septa. Furthermore, we highlight the importance of E578 and proper zinc 
binding. Although it was not possible to gain direct knowledge on how AmiC2 fulfills its task, 












X‐ray  crystallography  turned  one  hundred  years  old  in  2014.  To  celebrate  this  occasion, 
several prestigious  journals  including Nature and Science published special  issues  featuring 
this  key  method  in  structural  biology.  This  review  also  relates  to  that  anniversary  and 
highlights  the  importance  of  X‐ray  crystallography  for microbiology  even  today  using  the 
example of bacterial cell wall remodeling by N‐acetylmuramoyl‐L‐alanine amidases. The study 
also aims  to give non‐structural biologists a  set of guidelines  to  critically evaluate protein 
structures and to work with them. 
The  most  abundant  function  of  amidases  is  cell  splitting  in  the  septal  region,  which  is 
important for proliferation. However, there are additional amidases, for example involved in 
PGN  fragment  recycling, cellular communication, bacterial defense against competitors, or 
bacteriophage  infections.  Amidases  furthermore  have  a  close  structural  relationship  to 
eukaryotic  peptidoglycan  recognition  proteins  (PGRPs).  Nevertheless, we  focused  on  the 








Due  to  limitations  of  space  we  focused  on  catalytic  domains.  Although  the  sequence 
conservation among amidases is generally low (around 30 %), they share a globular, mixed αβ‐









histidines  and  one  aspartate  (cysteine  for  phage‐derived  amidases)  coordinate  the 
catalytically  crucial  zinc  ion.  Further  crucial  residues  that  are  conserved  include  Thr267  
for  carbohydrate  binding,  Trp310  for  hydrophobic  and  CH–π  interactions  with  L‐Lys  or  
mDAP of the substrate, and the structurally important Asn317 that also engages the substrate 







Supplementary  features  of  the  AmiD‐type  are  a  β‐loop  insertion  that  is  involved  in 
carbohydrate binding and  (except  for AmpD  C.  freundii) an additional N‐terminal extension  for 
multimerization as well as a C‐terminal domain that is possibly involved in PGN recognition. 
AmpD  C.  freundii  is  a  cytosolic  enzyme, which  has  a  recycling  function with  a  specificity  for 
PGN‐monomers, and it is the only amidase for which structural rearrangements are reported 
[98]. 
Nine  structures of  five different proteins of  the Amidase_3  family had been  solved when  
the  review was written.  Again,  a  six‐stranded  central  β‐sheet  is  stabilized  by  helices  α1,  
α3  and  α5  on  the  rear  side.  The  binding  site  is  predominantly  defined  by  loops,  not  
helices. Furthermore, it is wider and more shallow than for the Amidase_2 family. Conserved 
residues  next  to  the  active  site  facilitate  correct  orientation  of  two  histidine  side  chains 
 that bind the zinc ion together with a glutamate. Glu373 (AmiC E. coli numbering) is the catalytic 
residue,  the  carbonyl  oxygen  of  Ala266 may  aide  in  the water‐activation,  analogously  to 
Asp266  in  Amidase_2  enzymes,  and  Asp/Asn267  may  interact  with  
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MurNAc.  An  unusual  kink  in  helix  α5  of  all  enzymes  is  caused  by  side  chain–backbone 
hydrogen bonds of Ser/Thr/Asn at that position.  
Some members of the Amidase_3 family have additional residues inserted into the catalytic 







available  but  have  to  be  custom‐synthesized.  Furthermore,  most  complexes  need  non‐
cleavable substrate analogs or  inactive /  inactivated enzymes as they often exhibit residual 
activity even once crystallized.  
The  complex  structure  of  MtetP  bound  to  AmiA‐cat  S  .aureus  was  depicted  exemplarily. 
Differences compared  to other complexes  link amino acid  substitutions  in  the enzymes  to 
altered specificities. The exchange of H370 and T380 to lysine and arginine, respectively, shifts 
substrate specificity from D‐iGln in the peptide stem to D‐iGlu. Likewise, deletion of several 
residues  shrinks  the  carbohydrate  pocket  and  changes  specificity  towards  terminal  PGN‐
fragments with 1,6‐anhydro MurNAc. Additional arginine residues at the end of the binding 
groove  may  stabilize  substrates  that  carry  free  carboxylates.  The  complexes  of 
AmpDH2 P.  aeruginosa and AmpDH3 P.  aeruginosa  shed  light on PGN engagement by amidases  in a 


















the  cell wall,  e.g.  the  septum  [67]. As  de  Pedro  and  Cava  highlight  in  their  outlook,  it  is 
imperative to broaden our knowledge on peptidoglycan, e.g. with the new techniques at our 
disposal by the recent “‐omics” boom [67]. That knowledge will help to design more precise 
experiments on  activity and  specificity.  In  combination with  chemical  synthesis of  various 
compounds  of  then  identified  substrates,  structural  biology  methods  can  provide  more 
detailed and dependable insights into what most likely happens during PGN‐modulation and 
the different subsequent cellular processes. Falling in line with this, just recently, a Japanese 




Following up, more  complex  structures of amidases bound  to  their  substrates need  to be 
determined  to diversify  the database of  known  interactions. Usage of more  sophisticated 
substrate  fragments  that  contain  several  carbohydrate moieties  and  peptide  stems  is  an 
additional  long‐term  goal.  This  way,  one  can  better  determine  common  features  of  all 
amidases or particular (sub‐) families and distinct residues or patches that govern specificity 
and activity. That will likely happen first with catalytic domains. However, we also need to gain 
more knowledge on  the other amidase domains and putative  linker  regions. As shown  for 
AmiE S. epidermidis, for example, the repeat domains determine the locus of catalytic action. More 
structures of repeat and AMIN domains need to be determined in an integrated approach with 
functional  data.  That  is  ideally  accomplished  by  usage  of  full‐length  proteins  instead  of 
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full‐length amidases, due  to  its  limitation  to ensembles greater 200 kDa  [129]. While  it  is 
possible to “bulk‐up” smaller proteins with antibodies or Fab‐fragments, this is probably not 
applicable  for  these multi domain enzymes with  their  long,  flexible  linkers. Negative  stain 
electron microscopy, on the other hand, is an easy to handle method that yields immediate 




Furthermore,  it  is advisable to also  investigate other proteins that are directly or mediately 
involved in amidase activity. Such proteins may act as activators or inhibitors, and they could 
be  involved  in,  or  control  localization.  There might  also  be  adapter  proteins  that  govern 










The major  autolysin  AtlA  of  S.  aureus  and  its  close  relative  AtlE  of  S.  epidermidis  have 
undergone intensive research. The amidases of AtlA / AtlE are well characterized by structures 
of the repeat domains and the catalytic domains, including a substrate‐bound structure, many 













is  elusive  to  date,  the  third  and  last  protein  ‐  called  NAGase  ‐  also  cleaves  PGN.  The 
characterization  of  the  N‐acetylglucosaminidase,  which  processes  the  carbohydrate 
backbone, is another piece in the puzzle of AtlA action. The structure and function of NAGase 











precisely and  importantly,  the highly  resistant MRSA, a diploma student  in our  laboratory, 
Melanie Oelker, investigated the potential of fragment based screening [130]. In this process, 
a defined library of compounds is applied to a large‐scale crystallization setup. The resulting 




steps would  include  the development of  a  larger  compound  that  contains  the  interacting 
fragment and  improves pharmaceutically relevant characteristics. We expect  it to be more 
likely to  identify an  inhibitor by this technique as most fragments bound  in the active site. 
However, instead of merely stalling cell growth by the use of an inhibitor, an activator of AmiA 
is more promising to battle MRSA since such a compound could induce cell lysis.  
Another  strategy  in  treating  MRSA  infections  is  being  tested  in  cooperation  with  
Dr. Beatrix Förster  from  the Gene Center of  the Ludwig‐Maximilians‐University  in Munich. 




















In  order  to  identify  the  binding  grove  of  AmiC2‐cat,  I  am  currently  pursuing  a  complex 
structure. A  first prerequisite  is  the  inactivation of  the enzyme  to avoid crystal damage by 
flexible and  charged  reaction products, as  seen  for AmiA‐cat. Although AmiC2‐cat did not 
tolerate zinc removal in solution either by addition of the chelator EDTA or the mutation of 
the zinc binders, the zinc ion can be removed from crystallized AmiC2‐cat without destroying 













as  well  as  co‐crystallization  of  wt  and  mutant  AmiC2‐cat  with  commercially  available 
muramoyldipeptide and pentapeptide  in numerous experiments. Nevertheless, no complex 
formation could be observed even though the solvent channels are of sufficient size and the 
active  site  is  solvent accessible. The presence of mDAP  in  the  substrate may  therefore be 
crucial for tight binding in a crystal complex or for any binding at all.  
Only  recently, Wang et  al.  reported  the  successful  synthesis of PGN‐fragments  containing 
mDAP [132]. This may be a “silver lining” for future attempts to obtain complex structures of 
enzymes that process PGN of the A1γ‐type.  
We  are  curious  about  the  exact  composition  of  Nostoc’s  PGN  and  collaborate with  Ute 
Bertsche and Christoph Mayer to investigate this by characterization of PGN fragments using 
ultra‐performance  liquid  chromatography  coupled with mass  spectroscopy  (UPLC  / MS).  If 
possible, a chemical distinction of the local PGN composition in Nostoc’s septal disk can help 
in  defining  the  actual  substrate  of  AmiC2  and may  explain  the  specificity  if  substantial 
differences arise.  
To tie on that, we wonder how the  functionality of AmiC2  is regulated.  In Nostoc,  it  forms 
nanopores,  however,  in  vitro  and  heterologously  expressed  in  E.  coli,  AmiC2  exhibits 










Despite  those  open  questions,  we  learned  a  lot  about  the  fascinating  class  of  bacterial 
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6.1. Targeting	 the	gatekeeper	MET146	of	 c‐Jun	N‐terminal	kinase	3	
(JNK3)	induces	a	bivalent	halogen	/	chalcogen	bond	
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The  c‐Jun  N‐terminal  kinase  3  (JNK3)  is  a mitogen‐activated  protein  kinase  (MAPK)  and 
therefore an interesting drug target. The “gatekeeper” residue blocks the hydrophobic pocket 
of kinases and is most commonly a methionine. Threonines, leucines, and phenylalanines are 
also  found  in  that  position.  So  far,  only  classical  approaches  were  taken  to  target  the 
gatekeeper  of  JNK3  (Met146)  by  hydrophobic  interactions  that  utilize  the  flexibility  of 
methionine. Molecular design using computational, synthetic, and biophysical techniques can 
point to new strategies that involve the sulfur atom of methionine and exemplify the potential 









We  investigated halogen bonding  in quantum mechanical  (QM)  studies and generated an 
existing chlorinated pyrimidine derivative [137] and analogs of it. The chlorine was substituted 
with  hydrogen,  bromine,  and  iodine.  In  addition  to  the  in  silico  studies,  biophysical 
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characterization  by  a  Fluorescence  Polarization  assay  (FP)  and  Isothermal  Titration 
Calorimetry (ITC) of the interaction between the different compounds and JNK3 were used to 
gain experimental evidence for the positive effects of halogen bonding. The mutation of the 











Careful  inspection  of  the  complex  structure  furthermore  unveiled  the  rotameric 
























seen  for  the  complex  in  the  PDB  entry  4X21.  Other  kinds  of  interactions,  ranging  from 
hydrophobic to ionic, can also arise depending on the individual environments and improve a 
compound’s qualities.  
While  important, the adaptive behavior of a binding site  is hard to predict and different  in 






























FIGURE 6  ‐  SCHEME OF  BACTERIAL  CELL WALLS OF DIFFERENT  CLASSES WITH  RESPECTIVE  REPRESENTATIVES. THE GRAM‐POSITIVE  CELL WALL  IS 
EXEMPLARILY SHOWN FOR S. AUREUS, E. COLI REPRESENTS GRAM‐NEGATIVE BACTERIA AND N. PUNCTIFORME COVERS THE SPECIAL CASE OF 
CYANOBACTERIA. SCHEMATIC CELLS DISPLAY DIFFERENCES IN CELLULAR SHAPE AND ORGANISATION, IN THICKNESSES OF PGN (IN GREEN), AND IN 
THE PRESENCE OR ABSENCE OF AN OUTER MEMBRANE  (OM). A CLOSE‐UP ON THE CELL WALL  SHOWS THE  INDIVIDUAL PGN PATTERN AND 








PGN  (MURNAC‐L‐ALA‐D‐IGLX‐MDAP‐D‐ALA). TERMINAL MURNAC MAY PRESENT  IN THE NON‐REDUCING 1,6‐ANHYDRO FORM  (GREY). 
OTHERWISE, AS FIGURE 7. ................................................................................................................................................... 11 









































































Volker, Georg,  Irmi, obwohl  ich die Worte French Press, Server und  speziell Roboter  recht 
schnell mit  einem  über‐den‐Haufen‐geworfenen  Tagesplan  verbunden  habe,  hat  es  doch 
meist Spaß gemacht mit Euch an den entsprechenden Geräten rumzubasteln und sie wieder 
zum Laufen zu bekommen! Erik und Christina wünsche ich in Zukunft viel Spaß dabei . 
Für  die  gute  Atmosphäre  im  besten  Büro  der  Welt  gilt  mein  besonderer  Dank  in 
chronologischer Reihenfolge Dirk, Sonja, Michi, Michael, Manu and last but not least Joana. 




Allen  derzeitigen  und  ehemaligen  Labormitgliedern  danke  ich  für  die  Hilfe  und  die 
Diskussionen im wissenschaftlichen Bereich. Viel mehr möchte ich mich aber für die schöne 
Zeit  neben  der  Wissenschaft  bei  Euch  bedanken,  sei  es  beim  stets  unterhaltsamen 









Felix  Michael  Büttner,  Sebastian  Zoll, Mulugeta  Nega,  Friedrich  Götz,  and  Thilo  Stehle. 
Structure‐Function Analysis of Staphylococcus aureus Amidase Reveals  the Determinants of 
Peptidoglycan  Recognition  and  Cleavage.  J.  Biol.  Chem.  2014  289:  11083‐11094.  First 




(2016),  Enabling  cell–cell  communication  via  nanopore  formation:  structure,  function  and 











Reprinted with  permission  from:  Targeting  the  Gatekeeper  MET146  of  C‐Jun  N‐Terminal 
Kinase  3  Induces  a  Bivalent  Halogen/Chalcogen  Bond,  Andreas  Lange,  Marcel  Günther,  
Felix Michael Büttner, Markus O. Zimmermann, Johannes Heidrich, Susanne Hennig, Stefan 
Zahn,  Christoph  Schall,  Adrian  Sievers‐Engler,  Francesco  Ansideri,  Pierre  Koch,  Michael 
Laemmerhofer, Thilo Stehle, Stefan A. Laufer, and Frank M. Boeckler, Journal of the American 
Chemical  Society,  2015,  137,  (46),  14640‐14652,  DOI:  10.1021/jacs.5b07090, 
© 2015, American Chemical Society. 
Structure-Function Analysis of Staphylococcus aureus
Amidase Reveals the Determinants of Peptidoglycan
Recognition and Cleavage*
Received for publication, February 10, 2014, and in revised form, February 26, 2014 Published, JBC Papers in Press,March 5, 2014, DOI 10.1074/jbc.M114.557306
Felix Michael Büttner‡1, Sebastian Zoll‡1, Mulugeta Nega§, Friedrich Götz§, and Thilo Stehle‡¶2
From the ‡Interfaculty Institute of Biochemistry, University of Tübingen, Hoppe-Seyler-Strasse 4, 72076 Tübingen, Germany, the
§Microbial Genetics, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Auf der Morgenstelle 28,
72076 Tübingen, Germany, and the ¶Department of Pediatrics, Vanderbilt University School of Medicine,
Nashville, Tennessee 37232
Background: Autolysins ensure the plasticity of bacterial cell walls, and deletion leads to impaired cell clusters.
Results:High resolution structures of Staphylococcus aureus amidase AmiA shed light on peptidoglycan binding and cleavage.
Conclusion: AmiA distinguishes peptidoglycan mostly by the peptide, and cleavage is facilitated by a zinc-activated water
molecule.
Significance: These structures will inform strategies to develop new therapeutics against MRSA.
The bifunctionalmajor autolysinAtlA of Staphylococcus aureus
cleaves the bacterium’s peptidoglycan network (PGN) at two dis-
tinct sites during cell division. Deletion of the enzyme results in
large cell clusterswithdisordereddivisionpatterns, indicating that
AtlA could be a promising target for the development of new anti-
biotics. One of the two functions of AtlA is performed by the
N-acetylmuramyl-L-alanine amidase AmiA, which cleaves the
bond between the carbohydrate and the peptide moieties of PGN.
To establish the structural requirements of PGN recognition and
the enzymatic mechanism of cleavage, we solved the crystal struc-
ture of the catalytic domainofAmiA (AmiA-cat) in complexwith a
peptidoglycan-derived ligand at 1.55 Å resolution. The peptide
stem is clearly visible in the structure, forming extensive contacts
with protein residues by docking into an elongated groove. Less
well defined electron density and the analysis of surface features
indicate likely positions of the carbohydrate backbone and the
pentaglycine bridge. Substrate specificity analysis supports the
importance of the pentaglycine bridge for fitting into the binding
cleft of AmiA-cat. PGN of S. aureus with L-lysine tethered with
D-alanine via a pentaglycine bridge is completely hydrolyzed,
whereas PGN of Bacillus subtilis with meso-diaminopimelic acid
directly tethered with D-alanine is not hydrolyzed. An active site
mutant, H370A, of AmiA-cat was completely inactive, providing
further support for the proposed catalytic mechanism of AmiA.
The structure reported here is not only the first of any bacterial
amidase in which both the PGN component and the water mole-
cule that carries out thenucleophilic attackon the carbonyl carbon
of the scissile bond are present; it is also the first peptidoglycan
amidase complex structure of an important human pathogen.
Gram-positive, spherical staphylococci arrange in clusters
and colonize the skin or mucous membranes, causing severe
infections in infants, the elderly, transplantation patients, and
people suffering from immunocompromising diseases, such as
AIDS. Staphylococci are among the main causes of hospital-
acquired infections (1). Staphylococcus aureus and Staphylo-
coccus epidermidis are the most abundant human pathogens of
the Staphylococcus genus. Both species form a biofilm that pro-
tects them from the human immune system (2) and antibiotics
as well as contributing to persistent infections (3). In the case of
S. epidermidis, this multilayered polysaccharide matrix (4) is
responsible for infections of patients with implants, such as
intravasal catheters, prostheses, or pacemakers (2, 5). This may
require implant replacement and cause severe complications
for the affected patients (6). The biofilm of S. aureus primarily
serves as protection but also contributes to its pathogenicity (7).
S. aureus is responsible for a large number of life-threatening
infections that can result in diseases, such as endocarditis,men-
ingitis, pneumonia, septicaemia, and toxic shock syndrome (8).
Resistance against S. aureus is on the rise, posing a serious
threat to human health. There is therefore an urgent need for
the development of new antibiotics to control emerging meth-
icillin-resistant and vancomycin-resistant S. aureus strains
(MRSA3 and VRSA, respectively). Worldwide numbers are not
available, but with about 132,000 cases inGermany per year (9),
hospital-acquired MRSA currently accounts for 20% of all
staphylococcus infections (10), whereas in the early 1990s, the
MRSA fraction was only 1% (11). In high risk areas, such as
* This work was supported by the Collaborative Research Center TRR34.
The atomic coordinates and structure factors (codes 4KNK and 4KNL) have been
deposited in the Protein Data Bank (http://wwpdb.org/).
1 Both authors contributed equally to this work.
2 Towhomcorrespondence shouldbeaddressed: Interfaculty Instituteof Bio-
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thilo.stehle@uni-tuebingen.de.
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comycin-resistant S. aureus, respectively; AtlA, bifunctional major autoly-
sinof S. aureus; AmiA, amidaseof S. aureus; AmiE, amidaseof S. epidermidis;
AmiA-cat and AmiE-cat, catalytic domain of AmiA and AmiE, respectively;
AmiD, amidase of E. coli; NAGase, glucosaminidase of S. aureus; PGN, pep-
tidoglycan network; MtetP, muramyl tetrapeptide (MurNAc-L-Ala-D-iGln-L-
Lys(NHAc)-D-Ala-NH2); MTP, muramyl tripeptide (L-Ala-D-iGlu-L-Lys);
anhydro-MTP, 1,6-anhydro-MTP; MurNAc, N-acetylmuramic acid; D-iGln,
D-isoglutamine; D-iGlu, D-isoglutamic acid; Wat, water; meso-DAP, meso-
diaminopimelic acid; NAc, N-acetyl.
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intensive care units, the MRSA infection rate increases up to
37% (12), causing 5,000 deaths and leading to additional costs of
380 million € (9) per year in Germany alone. In the United
States, annual S. aureus infections have reached 475,000,
275,000 of which areMRSA-related, with $1–10 billion in extra
expenses for the health care system and 11,000 to 19,000
deaths (13, 14). Targeting staphylococcal enzymes, critical for
survival and growth of the bacterium, represents an attractive
strategy for the development of new antibiotics.
Several hydrolytic enzymes ensure the plasticity of the staph-
ylococcal cell wall by processing the complex PGN network.
One of these, the major autolysin AtlA, is composed of two
enzymeswith hydrolytic activity (an amidase (AmiA) and a glu-
cosaminidase (NAGase)) that cleave PGN at different locations
(15). In the precursor AtlA protein, the two catalytic functions
(cat) are each linked to targeting repeats (R1–R3) and also con-
nected to a propeptide and a signal peptide (Fig. 1A). Posttrans-
lational processing generates active AmiA and NAGase, which
both localize at the septal region (16), where they process staph-
ylococcal PGN during cell growth and division. S. aureus AtlA
deletion mutants show a severely impaired phenotype that is
unable to proliferate, forming large cell clusters instead (17).
These findings demonstrate the essential function of AtlA in
the S. aureus life cycle and also highlight a therapeutic potential
for specific inhibition of AtlA.
The staphylococcal Atl domain organization is highly con-
served in all of the species, with the amidase being the most
conserved domain. It has been shown that the Atl-based phy-
logenetic tree correlates well with the corresponding 16 S
rRNA- and core genome-based tree and represents a useful tool
for staphylococcal genus and species typing (18).
The catalytic domain ofAmiA (referred to here asAmiA-cat)
is a zinc-dependent amidase that cleaves the amide bond
between the peptide stem and carbohydrate backbone of PGN
(16, 19, 20). The previously proposedmechanism for hydrolysis
of the lactyl-alanine bondwas based on in silico docking studies
of the homologous catalytic domain AmiE from S. epidermidis
(19). Further data from structures of a homologous protein
originate from Escherichia coli (21). Consequently, detailed
structural information on amidase-PGN interaction in Gram-
positive bacteria is limited to date.
To determine the specificity of recognition and the mecha-
nism of catalysis of AmiA-cat, we determined crystal structures
of the enzyme in the absence (Fig. 1B) and presence (Fig. 2A)
of the muramyltetrapeptide MurNAc-L-Ala-D-iGln-L-Lys-
NHAc-D-Ala-NH2 (MtetP), a ligand that includes the previ-
ously characterized minimal ligand for the S. epidermidis ami-
dase (muramyltripeptide) (19). Both structures were solved to
high resolution, and they unambiguously establish the specific-
ity of interaction as well as the reactionmechanism used by this
essential cell wall enzyme. Our results form an excellent basis
for the design of new antibiotic lead structures.
EXPERIMENTAL PROCEDURES
Molecular Biology—The cDNA coding for AmiA-cat (resi-
dues 199–421) was cloned into a pGEX-4–3T vector for
expression. The expressed protein contains anN-terminal GST
tag fused to AmiA-cat with a six-amino acid thrombin-cleav-
able linker. Active sitemutants were created using site-directed
mutagenesis as described in the QuikChange protocol (22).
Protein Expression and Purification—Proteins were expressed
in E. coli BL21 (DE3). After induction, cultures were incubated
for 72 h at 20 °C. Harvested cells were then resuspended in
buffer (150 mM NaCl, 50 mM Tris, pH 8.0) supplemented with
PMSF and Roche Applied Science Complete protease inhibitor
mix. Filtered cell lysate was loaded onto a 5-ml GSTrap FF
column (GEHealthcare). 100 units of thrombin were added for
on-column overnight cleavage at 20 °C and release of the fusion
protein. Size exclusion chromatography removed the remain-
ing small impurities and aggregates from the protein. Purity
was confirmed by SDS-PAGE and MALDI-MS.
Protein Crystallization—AmiA-cat crystals belong to space
group C2 and contain two protomers in the asymmetric unit,
giving rise to a solvent content of 41.2%. Crystals were grown
using the hanging drop vapor diffusionmethod at 20 °C. 1l of
protein solution (11 mg/ml) was mixed with 1 l of a well solu-
tion containing 0.1 MMES/imidazole buffer at pH 6.5 and amix
of sodium formate, ammonium acetate, sodium citrate, race-
mic sodium/potassium tartrate, and sodium oxamate at con-
centrations of 0.02 M each as well as 12.5% (w/v) PEG 1000,
12.5% (w/v) PEG 3350, and 12.5% (w/v) 2-methyl-2,4-pen-
tanediol (Molecular Dimensions). Microseeding improved
crystal quantity and quality. In order to obtain catalytically
inactive enzyme, the AmiA-cat crystals were first incubated for
72 h in well solution supplemented with 20 mM EDTA to
remove the active site zinc ion. For complex formation, crystals
were next soaked for 60 h in well solution containing 20 mM
EDTA and 20mMMtetP. Crystals yielding a complex belong to
space group P21 with four protomers in the asymmetric unit
and similar solvent content. All crystals could be directly flash-
frozen in liquid nitrogen because the well solutions contained
sufficient cryoprotectant.
X-ray Diffraction—All data were collected at 100 K on
PILATUS detectors using synchrotron radiation at beamlines
X06DA and X06SA of the Swiss Light Source in Villigen,
Switzerland.
Structure Determination—Indexing, integrating, and scaling
were done with the XDS software package (23). Molecular
replacement for all AmiA-cat structures was performed with
PHASER (24, 25). Initial phases for AmiA-cat were determined
with an AmiE search model (Protein Data Bank accession code
3LAT, 81% identity). The refined AmiA-cat structure was then
used to solve the ligand structure by molecular replacement.
Model building, refinement, and validation were performed
withCoot (26, 27), theCCP4 suite (28–31), Phenix (32), and the
MolProbityWeb page (33). The coordinate and parameter files
for MtetP were obtained from the PRODRG2 server (34). Sim-
ulated annealing (Phenix) was performed to removemodel bias
for the ligand structure, especially in the active site. The ligand
was then added manually and modeled according to difference
or simulated annealing omit density maps in Coot. The final
structures contain almost all of the 223 residues, with the
exception of 13–15 poorly ordered N-terminal and 1–4 C-ter-
minal amino acids. Figures were generated with PyMOL (35),
and electrostatic potentialswere calculatedwith PBD2PQRand
APBS 2.1 (36), implemented in PyMOL.
High Resolution Complex Structure of S. aureus Amidase AmiA
11084 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 16•APRIL 18, 2014
 at U










Purificationof Peptidoglycan—PGNwas isolated fromS. aureus
SA113 (37) or Bacillus subtilisATCC 6051 using themethod of
de Jonge et al. (38) with some modifications. Briefly, cells were
grown to A578 nm of 0.6 and harvested by centrifugation at
3,000 g for 30min, boiledwith 5%SDS for 30min, and broken
with glass beads. Insoluble PGN was harvested by centrifuga-
tion at 30,000  g for 30 min and washed several times with
lukewarm water to remove SDS. Broken cell walls were sus-
pended in 100 mM Tris-HCl, pH 7.2, treated with 10 g/ml
DNase (Sigma) and 50 g/ml RNase (Sigma) for 2 h, and sub-
sequently treated with 100 g/ml trypsin for 16 h at 37 °C. To
remove wall teichoic acid, the PGN preparations were incu-
bated with 48% hydrofluoric acid for 24 h at 4 °C while stirring.
PGN was harvested by centrifugation at 30,000 g for 30 min
and washed several times with water until complete removal of
hydrofluoric acid. The final PGN product was lyophilized.
Preparation and HPLC/MS Analysis of PGN—Purified PGN
(5 mg) was resuspended in 1 ml of 25 mM sodium phosphate
buffer (pH 6.8) and digested withmutanolysin for 16 h at 37 °C.
The enzyme reaction was stopped by boiling the sample for 5
min at 95 °C, and insoluble contaminantswere removed by cen-
trifugation. 50 l of AmiA-cat, AmiA-H370A, or AmiA gel fil-
tration buffer as a negative control were added to 100 l of
mutanolysin-digested PGN and incubated overnight at 37 °C
while stirring. HPLC separation of digestion products was car-
ried out on a reversed-phase column (Poroshell 120 EC-C18
4.6 150mm, 2.7m;Agilent Technologies,Waldbronn, Ger-
many) fitted with a poroshell EC-C18, 4.6-mm guard column
using an Agilent 1200 system operating ChemStation software.
HPLC was performed using a linear 150-min gradient from
100% HPLC-buffer A (100 mM sodium phosphate, pH 2.2, and
5% methanol) to 100% HPLC-buffer B (100 mM sodium phos-
phate, pH 2.8, and 30% methanol) with a column temperature
of 52 °C. Detection was made at 205 nm. Samples were pre-
pared by mixing 100 l of the product with an equal volume of
0.5M sodiumborate buffer (pH8.0) containing freshly dissolved
sodium borohydride (10 mg/ml) and reduced for 30 min at
room temperature. The reaction was stopped, and excess boro-
hydride was deactivated by lowering the pH to 3 using 20%
phosphoric acid. 100 l of the prepared sample was injected.
LC/MS analysis of these samples was performedwith anAgi-
lent HPLC-electrospray ionization-MS system (LC/MSDUltra
Trap System XCT 6330), using a gradient of A (H2O with 0.1%
formic acid) and B (0.06% formic acid in acetonitrile) as follows:
0–10% B:A over 25min, 10% B to 27min, and 100% B to 30min
at 0.4 ml min1 at 40 °C on a Nucleosil 100 C18 3 m column
(100  2-mm inner diameter) with a precolumn (10  2-mm
inner diameter, Dr.Maisch, Ammerbuch,Germany). Detection
ofm/z values consistent with AmiA-cat digestion products was
conducted usingAgilent Data Analysis for 6300 Series IonTrap
LC/MS 6.1 version 3.4 software (Bruker-Daltonik GmbH).
RESULTS
Overall Structures of Unliganded and MtetP-bound AmiA-cat—
The structures of unliganded and liganded AmiA-cat were
determined at high resolution (1.12 and 1.55 Å, respectively,
Table 1), allowing us to analyze their salient features with con-
fidence. The proteins adopt a globular, mixed / fold that is
highly similar to that of the previously reported unliganded
AmiE-cat structure (19). Essential features of this fold are seven
-helices that surround a central six-stranded-sheet (Fig. 1B).
The rear of the -sheet is shielded by two long -helices,
whereas its front is solvent-accessible and forms the bottom of
a recessed groove. In the case of unliganded AmiA-cat, one end
of this groove accommodates a zinc ion that is required for
catalysis. Residues His-265, His-370, and Asp-384 directly
coordinate the zinc ion (Fig. 1B), and nearby residues Glu-324
and His-382 are positioned to participate in catalysis. To pro-
duce a complex with MtetP, the zinc ion was first removed by
treatment of the AmiA-cat crystals with EDTA, followed by
extensive soaking withMtetP (see “Experimental Procedures”).
Ligand binding was confirmed by a simulated annealing omit
density map that displays unbiased electron density for MtetP
over the entire tetrapeptide and as far as the N-acetylmuramic
acid (MurNAc) moiety of the ligand. The tetrapeptide portion
of MtetP is well defined by electron density (Fig. 2B), showing
that this part of the ligandbinds in an extended conformation to
the recessed groove. The lactate moiety of MurNAc linking the
peptide to the carbohydrate as well as the cyclic MurNAc moi-
ety are less well ordered, suggesting higher mobility due to
fewer defined interactions. These differences in mobility are
reflected in the B-factor distribution of the ligand (Fig. 2B). The
MtetP-bound AmiA-cat crystals contain four molecules in
their asymmetric unit, only two of which contain fully occupied
ligand binding sites. The flexible, cyclic MurNAc moiety pre-
sented sufficient electron density for model building in both
copies. The binding sites of the remaining two molecules are
less accessible due to smaller solvent channels. As a result, they
contain electron density features that suggest only partially
bound ligand.
With the exception of the active site region, unliganded and
liganded AmiA-cat exhibit no structural differences. The two
structures can be superimposed with a root mean square devi-
ation of 0.2 Å (DaliLite pairwise (39)) onto each other, demon-
strating that ligand binding does not induce larger structural
changes.
Interactions of AmiA-cat with MtetP—Inspection of the
structure of AmiA-cat in complex withMtetP reveals a sophis-
ticated interaction network that significantly extends knowl-
edge derived from earlier in silico docking (19). The tetrapep-
tide backbone of MtetP is anchored into the binding groove
along its entire length via several direct or water-mediated
hydrogen bonds to protein residues (Fig. 3). In addition, all four
amino acid side chains of MtetP (L-Ala, D-iGln, L-Lys-NHAc,
and D-Ala-NH2) are also involved in individual contacts with
the protein, accounting for specificity. These interactions are
detailed in Fig. 3 and summarized below.
Themethyl side chain of the first amino acid ofMtetP, L-Ala,
inserts into a small hydrophobic pocket formed by residues
Ala-288 and Val-290 (Fig. 3, A and C). The methyl group of
L-Ala is also only 4.4 Å away from the C carbon of the con-
served Gly-311. Lack of a side chain at position 311 contributes
to specificity because even a medium sized side chains would
lead to clashes with the L-Ala group.
The short amide side chain of D-isoglutamine (D-iGln), which
is a key determinant of ligand binding (20), projects into a shal-
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low pocket and forms direct hydrogen bonds with the hydroxyl
group of Thr-380 and N of His-370, as well as two water-
mediated hydrogen bonds toAsp-381 (Fig. 3,B andC). The side
chain of His-382 seals the pocket on one side, whereas Thr-380
is located at the other end.
The side chain of the third amino acid, L-Lys, is acetylated
(L-Lys-NHAc) inMtetP to approximate the physiologic state of
this residue in PGN, where it is linked to additional glycine
residues (see Fig. 7A). Specificity of recognition derives primar-
ily from hydrophobic interactions between the aliphatic side
chain of L-Lys-NHAc and the side chain of Trp-310. The entire
lysine side chain lies parallel to the large indole ring of Trp-310,
with distances below 4Å (Fig. 3B). In addition, awatermolecule
(Wat-7) bridges the carbonyl oxygen of D-Ala and N of L-Lys-
NHAc, thus helping to fix the orientation of the lysine side
chain. Similarly, the peptide oxygen of Lys-NHAc forms a
water-mediated (Wat-1) hydrogen bond with Asn-317.
The fourth residue, D-Ala-NH2, is engaged in backbone
hydrogen bond formation, but its side chain is at least partially
exposed to solvent. The terminal amide group of D-Ala-NH2
participates in a network of water-mediated hydrogen bonds
that help to fix its orientation with respect to the protein and
the preceding L-Lys-NHAc side chain (Fig. 3, B and C). These
interactions would still be possible in the context of either a
pentaglycine bridge or a free carboxyl terminus.
The carbohydrate moiety of MtetP engages in fewer interac-
tions with AmiA-cat than the peptide moiety, resulting in its
higher flexibility. The N-acetyl oxygen of MurNAc forms an
intramolecular hydrogen bond with the L-Ala nitrogen and via
Wat-4water-mediated contacts toAmiA-cat. TheNAc-methyl
group inserts in the hydrophobic portion (Ala-288, Val-290,
and Phe-293) of the otherwise hydrophilic binding pocket (Fig.
3,A andC). Only Thr-267, Asn-269, andGlu-277 directly bond
with MurNAc. Interestingly, the anomeric carbon is in -con-
figuration instead of -configuration.
Active Site—The bound zinc ion in the unliganded structure
marks the center of the active site of the enzyme (Fig. 1B). The
ion is coordinated by the side chains of His-265, His-370, and
Asp-384, with a water (Wat-10) completing its almost perfect
tetrahedral coordination sphere. Although the zinc had to be
removed to prepare the complexwithMtetP, its position can be
reliably inferred from superposition. Inspection of the unligan-
ded and liganded structures shows twowatermolecules (Wat-9
and Wat-10) in each case, at most shifted by 1 Å. Wat-9 is
located next to the position of the zinc ion, as well as Wat-10.
Coordination ofWat-9 involves His-370, Asp-384, andWat-10
(Fig. 3A). A fourth hydrogen bond is formed between Wat-9
and the carbonyl group of the scissile amide bond between
L-Ala and the lactate of MurNAc in the ligand (Fig. 3, A and C).
The highmobility or partial occupancy ofWat-9, indicated by a
high B-factor, make a vital role unlikely. However, it may sup-
port stabilization of intermediate states during catalysis. The
scissile bond is positioned directly adjacent toWat-10, suggest-
ing that the reaction mechanism proceeds by a Wat-10-medi-
TABLE 1
Data collection and refinement statistics for AmiA-cat (Protein Data Bank code 4KNK) and liganded AmiA-cat (Protein Data Bank code 4KNL)
Values for the highest resolution bin are given in parentheses.
Parameters AmiA-cat Liganded AmiA-cat
Beamline X06DA (PX III) X06SA (PX I)
Space group C2 P21
Cell dimensions (Å) a 96.9, b 81.7, c 68.7 a 67.7, b 82.8, c 77.6
  90°.  128.8°   90°.  95.9°
Wavelength (Å) 1.00000 1.00605
Detector Pilatus 2M Pilatus 6M
Resolution (Å) 50-1.12 (1.15-1.12) 50.0-1.55 (1.59-1.55)
Measured reflections 885,445 (14,326) 442,448 (27,121)
Unique reflections 146,370 (6,937) 122,742 (8,927)
Rmeas (%) 4.7% (60.3%) 6.5% (82.3%)
Completeness (%) 92.6% (59.7%) 99.5% (98.1%)
Redundancy 6.0 (2.0) 3.6 (3.0)
I/ (I) 21.1 (1.8) 13.9 (1.7)
CC1/2 (%) 100 (71.7) 99.9 (69.7)
Resolution (Å) 40.9-1.12 48.2-1.55
Rwork/Rfree 12.09/13.89 17.12/19.81








Mean 16.9 (7.9–41.8) 25.9 (11.9–69.9)
Protein 15.1 (7.9–38.8 ) 25.3 (11.9–69.9)
Water 27.9 (9.0–41.8) 33.1 (14.8–55.9)
MtetP 36.7 (18.0–61.5)
Zn2 12.5 (12.2–12.8)
Others 27.8 (11.0–38.7) 37.0 (18.8–53.0)
Root mean square deviations
Bond length (Å) 0.009 0.012
Bond angles (degrees) 1.389 1.380
Ramachandran plot
Most favorable (%) 97.4 97.6
Allowed (%) 2.6 2.4
Disallowed (%) 0.0 0.0
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ated nucleophilic attack. Two residues, Asp-266 and Glu-324,
lie next toWat-10 and probably serve to enhance its nucleophi-
licity, thus favoring an attack on the lactyl amide bond. The
carbonyl atom of the scissile amide bond ofMtetP is hydrogen-
bonded to His-382, which helps to orient the lactic acid moiety
in the active site. We note that the His-382 side chain has dif-
ferent orientations in the unliganded and liganded AmiA-cat
structures.
Putative Reaction Mechanism—The architecture of the active
site and the observed interactions between protein and sub-
strate are very much consistent with a reaction mechanism in
whichWat-10 attacks the scissile bond. Thiswater is hydrogen-
bonded to the Asp-266 carbonyl and Glu-324 carboxyl groups,
which would lead to both hydrogens of Wat-10 facing toward
these residues and the free electron pairs of theWat-10 oxygen
facing toward zinc and the bond connecting the lactyl and pep-
tidemoieties (Fig. 4A). The likely role of the zinc ion is to polar-
ize the oxygen of Wat-10, rendering it more reactive. The
remaining free electron pair of the Wat-10 oxygen would then
be able to perform a nucleophilic attack on the scissile bond of
MtetP. His-382 could provide a proton for stabilization of the
resulting oxyanion, whereas Glu-324 could accept a hydrogen
fromWat-10 (Fig. 4B). Stabilization of the tetrahedral interme-
diatewould involve the zinc ion andN ofHis-382, which could
each interact with one of the resulting hydroxyl groups as well
as the side chains of Asp-266 and Glu-324. In the next step, the
tetrahedral intermediate again forms a carbonyl group but with
the peptide moiety as the leaving group rather than the previ-
ously attacking water molecule, leading to the separation of the
carbohydrate and peptide moieties of PGN (Fig. 4C). At the
same time, the N terminus of the new peptide is poised to
accept a hydrogen fromGlu-324, whereas His-382 can accept a
hydrogen atom from the tetrahedral intermediate. Finally, the
cleavage products are released from the active site (Fig. 4D).
Implications for PGN Binding and Cleavage—The MtetP
compound is a substrate for AmiA-cat, which cleaves large
PGN structures in its physiologic setting. It is possible and
indeed likely that additional contacts between PGN compo-
nents and AmiA-cat exist and that the interactions between
PGNandAmiA-cat are somewhatmore complex than depicted
here. Nevertheless, analysis of surface properties provides at
least some clues as to howAmiA-catwould engage components
of PGN that extend beyond the muramyltetrapeptide (i.e. the
MurNAc-GlcNAc glycan polymer and the pentaglycine bridge)
(Fig. 5A).
Anumber of residues largely conserved amongbacterial ami-
dases (Fig. 5,B andC) define the spacious carbohydrate binding
pocket. Thr-267 and Glu-277 together with Met-281 and Phe-
293 form the bottom of the pocket, whereas Tyr-280 on one
side and Ala-268, Asn-269, and Ser-273 on the other side
enclose the carbohydrate and form the lateral edges. Analysis of
the complex shows thatMurNAc does not engage inmany spe-
cific contacts on its own. Based on chemical and geometric
restraints, we therefore modeled a plausible conformation of
GlcNAc-MurNAc-GlcNAc in the carbohydrate pocket (Fig.
5A), which is concurrent with a previously proposed three-di-
mensional structure of PGN (40) and nicely follows the carbo-
hydrate groove. Steric constraints lead to a minor shift of
MurNAc out of the binding pocket in the presence of -1,4-
linked GlcNAc molecules. Hydrogen bonds formed with O1 of
MurNAc fall away in this model, whereas hydrophobic interac-
tions and hydrogen bonds of the NAc moiety remain. Never-
theless, only the oxygen atoms O6 of preceding and succeeding
GlcNAc may each form additional hydrogen bonds (preceding
GlcNAc with His-382 or Wat-5 and succeeding GlcNAc with
Gly-276, Glu-277, and Wat-66; data not shown). Physiologi-
cally, weaker interactions with MurNAc and the glycan strand
make sense because the enzyme achieves its specificity through
engagement of the tetrapeptide stem and must dissociate from
the PGN after cleavage has occurred.
Investigation of the electrostatic surface of AmiA-cat gives
two plausible orientations in terms of uncharged contact area
for the pentaglycine bridge linked to L-Lys in PGN (Fig. 5A),
although C and N would not superimpose with the complex.
In both cases, glycines would be able to loosely interact with
conserved (Fig. 5B) and uncharged AmiA-cat surface residues.
Previous data showed that the presence or absence of the gly-
cine bridge has little effect on catalysis (19, 20), indicating that
interactions of the glycines with AmiA-cat contribute little
binding energy. Nonetheless, the pentaglycine bridge is most
likely important for specificity.
Substrate Specificity—In order to relate the structural data to
functional experiments, we investigated wild-type AmiA-cat
and an active site mutant AmiA-H370A for its ability to digest
FIGURE 1. Prepro-AtlA holoenzyme and structure of AmiA-cat. A, domain
arrangement of AtlA with sites of post-translational cleavage indicated by
arrows. SP, signal peptide; PP, propeptide; cat, catalytic domain; R, repeat
domain. This figure was adapted and modified from Ref. 19. B, mixed/ fold
of unliganded AmiA-cat in a schematic representation with a transparent sur-
face. The zinc ion (orange) and its coordinating residues (dark gray) are
highlighted.
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PGN from S. aureus as well as B. subtilis. Both PGN structures
were first predigested with mutanolysin, which cleaves the gly-
cosidic bond between GlcNAc and MurNAc, to facilitate the
digestion. AmiA-cat completely hydrolyzed S. aureus PGN,
whereas the AmiA-H370A mutant was inactive (Fig. 6, A–C).
Analysis by HPLC shows that the main product generated by
FIGURE 2. AmiA-cat in complex withMtetP. A, AmiA-cat (semitransparent gray surface) bound MtetP (yellow sticks) in the active site. B, the close-up on MtetP
surrounded by omit density illustrates that the ligand is well defined. Still, the B-factor distribution of MtetP displays the elevated flexibility of its MurNAc
moiety. The difference omit map is shown at a  level of 2.0, and the color scale for B-factors ranges from blue (20 Å2) to red (50 Å2).
FIGURE3. InteractionsbetweenAmiA-catandMtetP.A, interactionsofAmiA-catwith theMurNAcmoietyandL-AlaofMtetPat theactive site. Thezinc ion fromthe
nativestructure (orangesphere) is superimposedontheAmiA-catcomplex (gray)withMtetP (yellow).B,close-upof the interactionsof thepeptidemoietyofMtetPwith
AmiA.C, ChemSketch (57)plotof interactionsbetweenMtetPandAmiA-cat. Van-der-Waals interactionsaredepictedasgreen arcs, andhydrogenbondsare shownas
black dashed lines. Coordination of Wat-9 involves His-370, Asp-384, and Wat-10 and a hydrogen bond with the carbonyl oxygen of the scissile amide bond in the
ligand, which itself is positioned by interaction with His-382. Wat-10 lies next to Asp-266, Glu-324, Wat-9, and the carbonyl carbon of the scissile bond. MurNAc forms
an intramolecular and four furtherhydrogenbondswithGlu-277, Thr-267, andAsn-269.Hydrophobic interactionsof themethylgroups involveAla-268andPhe-293,
respectively. L-Ala inserts into a small hydrophobic pocket formed by residues Ala-288 and Val-290. The amide side chain of D-iGln forms direct hydrogen bonds with
Thr-380 and His-370 as well as two water-mediated hydrogen bonds to Asp-381. The carbonyl oxygen bonds with Gly-313 and Asn-317. L-Lys is stabilized by
interactionswithAsn-287aswell asAsn-317,whereas theacetylated side chainengages inhydrophobic interactionswithTrp-310.Awater (Wat-7 (w7)) bridgesNof
L-Lys-NHAc and the carbonyl oxygen of D-Ala, which engages additional water-mediated interactions with AmiA-cat residues Asn-287, Ala-314, and Gly-379.
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AmiA-cat is the disaccharide GlcNAc-MurNAc, with amass of
m/z 496 (Fig. 6, B and F). Interestingly, the intensity of the
GlcNAc-MurNAcpeak (Fig. 6B) represents the sumof the PGN
oligomers seen in Fig. 6A, indicating that 95% of the PGN
substrate was digested.
In contrast to S. aureus, B. subtilis PGN could not be hydro-
lyzed by AmiA-cat (Fig. 6, D and E). The major differences in
PGN structure of S. aureus and B. subtilis are illustrated in Fig.
7. B. subtilis incorporates D-isoglutamic acid into the peptide
linking the glycan chains (Fig. 7B), whereas S. aureus converts
this amino acid to D-iGln (Fig. 7A). It is, however, unlikely that
this difference is solely responsible for the inability of AmiA-cat
to cleave B. subtilis PGN because the homologous AmiE
enzyme still hydrolyzed synthetic substrates composed of
MurNAc-L-Ala-D-iGlu-L-Lys, albeit with lower efficiency (20).
We consider it more likely that two other alterations in the
PGN structures are responsible for the observed difference in
activity. The B. subtilis PGN carries a meso-diaminopimelic
acid (meso-DAP), which has an amidated -carboxylate and a
free-carboxylate and also features a directly cross-linked pep-
tide stem (Fig. 7B), without the pentaglycine bridge found in the
S. aureus PGN. These twomajor differences probably prevent a
proper fit of the B. subtilis PGN structure into the binding cleft
of AmiA-cat.
DISCUSSION
We have determined high resolution structures of the cata-
lytic region of the S. aureus amidase AmiA in its unliganded
form and in complex with a compound that includes MurNAc
and the tetrapeptide L-Ala-D-iGln-L-Lys-D-Ala. To crystallize
the wild-type enzyme in complex with ligand while avoiding
cleavage, it proved critical to first remove the catalytic zinc ion
through extensive incubation with EDTA and then soak crys-
tals with ligand, whose high concentrations reflect the environ-
ment in PGN. Analysis of the two structures provides insights
into the parameters that govern specificity as well as the cata-
lytic mechanism.
AmiA-cat folds into a compact structurewith a long, exposed
ligand binding groove that appears ideally suited to access its
specific cleavage sites within the dense, highly cross-linked
PGN structure. In addition to the catalytically active AmiA-cat
domain, the mature enzyme also contains four repeat domains
(Fig. 1A). Analysis of the highly homologous S. epidermidis
amidase has shown that these repeats probably anchor the pro-
tein to lipoteichoic acid protruding from the staphylococcal cell
wall (41). Importantly, the repeats are flexibly linked to the cat-
alytically active domain, allowing cleavage to proceed effi-
ciently (41). The position of the boundMtetP ligand sheds light
FIGURE 4. Proposed reaction mechanism of AmiA. A, Wat-10 (w10) is hydrogen-bonded to Asp-266 and Glu-324, and its free electron pairs face toward the
scissile bond. Zn2 is complexed by His-265, His-370, and Asp-384 and probably renders Wat-10 more reactive, enabling a nucleophilic attack. B, tetrahedral
intermediate is stabilized by hydrogen bonds of the resulting hydroxyl groups with N of His-382 as well as Asp-266, Glu-324, and zinc, respectively. C,
reformationof a carbonyl groupwith thepeptidemoiety as leavinggroup.His-382 canaccept ahydrogenatom fromthe tetrahedral intermediate,whereas the
peptide is poised to accept a hydrogen from Glu-324. D, product release.
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on the interaction of amidases with more complex, branched
PGN fragments. Thus, the structure of liganded AmiA-cat
allows us to visualize how the enzyme acts in a physiologic
setting. In addition to the groove that accommodates the tetra-
peptide of MtetP, AmiA-cat contains surface features that
probably allow for binding of MurNAc-GlcNAc polymers at
one end and a pentaglycine bridge at the other end of the
groove. The peptide composition of PGN in staphylococci is
FIGURE 5. AmiA-cat binding to PGN. A, electrostatic surface of AmiA-cat with MtetP (yellow), zinc (orange), and modeled PGN components (dark gray, black,
and light gray). Uncharged (white surface area), positively charged (blue areas), and negatively charged residues (red surface) are shown. The spacious hydro-
philic pocket harboring the zinc ion and active site also accommodates MurNAc. Adjacent GlcNAc rings (dark gray sticks) shift MurNAc slightly when modeled
as a polymer. The lower peptide moiety of MtetP binds in the mostly uncharged region of the binding cleft. Two conformations for the pentaglycine bridge
(black and light gray sticks, respectively) linked to L-Lys of MtetP were modeled according to uncharged surface area and possible hydrogen bonds. B, a
multisequence alignment of bacterial amidases with identical residues colored by conservation from light to dark blue. Residues forming the carbohydrate
binding pocket, marked by dark gray boxes, are highly conserved among all compared amidases. Surface-exposed amino acids near the two pentaglycine
bridges are marked in black and light gray for the respective conformation models. Conservation, especially among staphylococci is high for both. Alignment
was calculated using Clustal Omega (58), and the output was created using Jalview (59). C, conserved residues mapped on the AmiA-cat surface according to
the color scheme used in A and B.
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FIGURE 6. RP-HPLC profile of mutanolysin-digested PGN fragments after incubation with enzyme. A, S. aureus PGN fragments incubated with elution
buffer of AmiA-cat as control. Three peaks around 28 min contain monomer species of one peptide stem with carbohydrates, peaks at 58 min comprise species
with two peptide stems, peaks at 73 min cover fragments with three peptide stems, and continuing accordingly. B, S. aureus PGN fragments incubated with
AmiA-cat result in completely digested polymers with GlcNAc-MurNAc fragments remaining. C, S. aureus PGN fragments incubated with active site mutant
AmiA-H370A show no catalytic activity. D, B. subtilis PGN fragments incubated with elution buffer of AmiA-cat result in a pattern similar to A but with specific
retention times for B. subtilis. E, B. subtilis PGN fragments incubated with AmiA-cat exhibit no activity of the staphylococcal amidase for B. subtilis PGN. F, mass
analysis of the major product shown in B, which corresponds to the disaccharide GlcNAc-MurNAc (m/z 496).
FIGURE 7.Schematic andmolecular illustration of the PGN structures. A, in S. aureus, the PGN subunit is composed of D-isoglutamine and L-lysine and
is cross-linked via a pentaglycine bridge (43). It comprises C-terminally either D-Ala-D-Ala or D-Ala-pentaglycine. B, B. subtilis PGN from vegetative cells
(53, 55), however, contains D-isoglutamic acid and amidated meso-DAP and lacks a D-alanine at the meso-DAP -carboxyl group, and it is directly
cross-linked with D-alanine of the next subunit. In addition, B. subtilis PGN has 1,6-anhydro-MurNAc, shown in gray, at its terminus instead of a reducing
MurNAc.
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well conserved, typically using a pentaglycine bridge that con-
nects D-Ala of one peptide stem with the N from L-Lys of
another stem (42–44). Variations in S. aureus and among sub-
species exist (43, 44) but are rare. Also, they concentrate on the
variation of the pentaglycine bridge in terms of length and com-
position. The number of glycines may vary from four to six, or
one glycinemay be substituted by a serine or an alanine (43, 44).
Although structures of several bacterial amidases have been
determined (19, 45–52), the amidase AmiD from E. coli is the
only catalytically active amidase for which structural data of an
uncleaved ligand-enzyme complex have been available prior to
this work (21).
The PGN of E. coli and B. subtilis is highly similar (42) and
belongs to the type of variationA1 (43). It differs in amino acid
composition (D-iGln and L-Lys are substituted with D-iGlu and
meso-DAP, respectively) as well as direct cross-linkage of
amino acids 3 and 4 (no interpeptide bridge) from the PGN of
S. aureus (42), which has a PGN of the A3 type of variation
(43). Additionally, E. coli and B. subtilis PGN has anhydro-
MurNAc at the terminus of the carbohydrate backbone (42,
53), whereas PGN of S. aureus always presents reducing
MurNAc (54). Further differences within the E. coli and the
B. subtilis A1 type of variation include deviations in the pres-
ence or absence of an unlinked, terminal D-Ala and amidation
ofmeso-DAP carboxyl groups (53, 55).
The inability to digest B. subtilis PGNpresumably is a cumu-
lative effect because D-iGlu instead of D-iGln is tolerated (20),
and a meso-DAP, which is amidated at its second carboxyl
group, itself is flexible enough to be accommodated at the lysine
binding site of AmiA-cat. In addition, Asn-317 could partially
compensate for a negative charge resulting from the absent,
unlinked, terminal D-Ala of B. subtilis PGN. However, the
direct cross-linkage is most likely to cause a clash with AmiA-
cat due to a high rigidity and bulky side chain compared with a
pentaglycine bridge. Since each of these differences is likely
tolerated on its own, we suggest that the combined differences
account for substrate specificity.
Although the E. coli enzymeAmiD andAmiA both belong to
the amidase 2 family and are zinc-dependent, the two enzymes
share a sequence identity of only 21%, have different substrates,
and exhibit large structural differences (Fig. 8), including differ-
ences in the active site shown by a 2.0-Å root mean square
deviation of-carbon atoms (Dali server (56)). For example, the
proton donor in AmiD is a lysine instead of a histidine residue
(His-382 in AmiA). His-370 and Thr-380 that stabilize D-iGln
in AmiA are replaced by a histidine and an arginine, which are
better suited to bond with D-iGlu fromA1-PGN variants. The
free carboxylate of meso-DAP or D-Ala could be stabilized by
another arginine of AmiD. Interestingly, this is not the case in
the two available complex structures of AmiD (cocrystallized
with tripeptide L-Ala-D-iGlu-L-Lys (MTP) and soaked with
anhydro-MurNAc-L-Ala-D-iGlu-L-Lys (anhydro-MTP)) due to
crystal contacts. Also, lysine was used as the third amino acid of
the peptide stem instead of meso-DAP. Because anhydro-
MurNAc does not occur in S. aureus PGN and the carbohy-
drate binding pocket of AmiD is smaller than in AmiA, one can
draw only limited conclusions for binding and catalysis of
staphylococcal PGN from these structures. Moreover, the
AmiD complex structure of anhydro-MTP lacks space for both
the zinc ion and a watermolecule in the active site, which could
be activated by the zinc ion and attack the scissile bond. Thus,
the structure of AmiA-cat from S. aureus presented here pro-
vides new information both about how the ligand is contacted
and also about how catalysis is performed.
The presented results also significantly extend prior knowl-
edge obtained from in silico molecular docking of a tripeptide
into the highly homologous amidase structure of S. epidermi-
dis, AmiE-cat (19). Although the overall model and the orien-
tation of the ligand agree with our structure, the ligand used for
docking AmiE-cat lacked the C-terminal D-Ala and the acetyl
group at the L-Lys side chain. The latter resulted in a non-
physiologic positive charge due to the protonated N of the
lysine. Although some of the predicted hydrogen bonds and
hydrophobic interactions could be validated by our complex
structure, the majority of interactions identified in this work
were not projected. Furthermore, the docking model did not
take the nucleophilic water in the active site into account, caus-
ing the substrate to locate closer to the zinc ion. Additionally, a
non-physiological zinc ion caused the backbone to shift at res-
idue 63 (Ala-268 in AmiA-cat), making the carbohydrate bind-
ing pocket smaller.
Inspection of the liganded AmiA-cat structure directly sug-
gests strategies for inhibition. A competitive inhibitor of AmiA
should contain the tetrapeptide stem of MtetP because all four
residues make strong interactions with the enzyme. D-Ala,
however, contributes least and could therefore be omitted or
replaced. The main contact maintained by L-Lys is the hydro-
FIGURE 8. Comparison of the AmiA-cat complex (gray schematic) with
AmiD from E. coli (cyan schematic; Protein Data Bank code 3D2Y). Super-
imposition of the two bacterial amidases reveals a similar fold solely around
the binding and active site. AmiD deviates by a 2.0-Å root mean square devi-
ation (DaliLite pairwise) from the AmiA-cat main chain, amino acids in the
active and binding sites differ, and AmiD contains additional motifs at its N
and C termini. Ligand positioning of anhydro-MTP (green sticks) to AmiD is
comparable with the AmiA-cat complex with MtetP (yellow sticks). However,
anhydro-MTP has an overall shift in relation to MtetP, and interactions of
enzyme with ligand are unalike. Additionally, the MurNAc moiety, including
the scissile bond, lies in thedirect vicinity of the zincbinding residues and is in
the anhydro form, which does not occur in staphylococci. Zn2 from the
unliganded AmiA-cat structure in orange was superimposed.
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phobic interaction with Trp-310. L-Ala and especially D-iGln
are conserved in staphylococcal PGN and should be part of a
lead structure. Changes in these residues are not tolerated by
the enzyme (19) and would therefore not lead to a competitive
compound. A reasonable approach would be the introduction
of an noncleavable, peptide-mimicking group at the position
of the L-Ala-lactyl peptide bond. Suitable bioisosteres are
hydroxyethylene or dihydroxyethylene that imitate the tetra-
gonal transition state. Modification of the carbohydrate (e.g. at
C1 to forma salt bridgewithGlu-277)would also increase affin-
ity for AmiA-cat. On the other hand, it may be advantageous to
exchange the sugar moiety and end the lead structure with a
non-cleavable lactate analog linked to a cyclic compound
because carbohydrate synthesis is expensive.
In conclusion, we have solved the complex structure of
AmiA-cat with its ligand, the PGN component MtetP, at high
resolution. Inspection of the interactions observed in the com-
plex leads to a plausible model for catalysis and allows us to
predict the binding locations of the adjacentGlcNAcmolecules
and the pentaglycine bridge. We show that the crystallized
enzyme is active and that it possesses a narrow specificity that
enables it to digest PGN structures from S. aureus but not from
B. subtilis. The complex structure offers plausible explanations
for these differences in catalytic activity. Our work moreover
provides new data on the mechanism of the crucial amidase
reaction that may help in the development of therapeutics
against MRSA.
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To orchestrate a complex life style in changing environments, the ﬁlamentous
cyanobacterium Nostoc punctiforme facilitates communication between
neighboring cells through septal junction complexes. This is achieved by
nanopores that perforate the peptidoglycan (PGN) layer and traverse the cell
septa. The N-acetylmuramoyl-L-alanine amidase AmiC2 (Npun_F1846;
EC 3.5.1.28) in N. punctiforme generates arrays of such nanopores in the sep-
tal PGN, in contrast to homologous amidases that mediate daughter cell sep-
aration after cell division in unicellular bacteria. Nanopore formation is
therefore a novel property of AmiC homologs. Immunoﬂuorescence shows
that native AmiC2 localizes to the maturing septum. The high-resolution
crystal structure (1.12 A) of its catalytic domain (AmiC2-cat) differs signiﬁ-
cantly from known structures of cell splitting and PGN recycling amidases.
A wide and shallow binding cavity allows easy access of the substrate to the
active site, which harbors an essential zinc ion. AmiC2-cat exhibits strong
hydrolytic activity in vitro. A single point mutation of a conserved glutamate
near the zinc ion results in total loss of activity, whereas zinc removal leads
to instability of AmiC2-cat. An inhibitory a-helix, as found in the
Escherichia coli AmiCE. coli structure, is absent. Taken together, our data
provide insight into the cell-biological, biochemical and structural properties
of an unusual cell wall lytic enzyme that generates nanopores for cell–cell
communication in multicellular cyanobacteria. The novel structural features
of the catalytic domain and the unique biological function of AmiC2 hint at
mechanisms of action and regulation that are distinct from other amidases.
Database
The AmiC2-cat structure has been deposited in the Protein Data Bank under acces-
sion number 5EMI.
Abbreviations
AmiC2-cat, catalytic domain of AmiC2; AMIN, amidase N-terminal domains of AmiC2; DRA, dye release assay; MES, (2-(N-morpholino)
ethanesulfonic acid); PGN, peptidoglycan; RBB-PGN, peptidoglycan coupled to remazol brilliant blue; RT, room temperature.
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Introduction
Cyanobacteria are widely distributed in the illuminated
biosphere. As a result of numerous adaptation
mechanisms, including an exceptional variety of
morphologies among bacteria, cyanobacteria ﬂourish
in many different habitats. Through the invention of
oxygenic photosynthesis, they laid the ground for the
evolution of higher organisms [1,2]. Although multicel-
lularity refers commonly to eukaryotes, the ﬁlamen-
tous cyanobacteria of the order Nostocales are true
multicellular organisms [3]. Their cells are embedded
in a cell wall, a giant macromolecule that spans the
entire ﬁlament and is surrounded by the outer mem-
brane [4–7]. The periplasm is consequently continuous
along the ﬁlament [8,9]. Different cells within a ﬁla-
ment perform different tasks for a common goal:
adaptation and proliferation. With one of the largest
genomes among bacteria [10], Nostoc punctiforme
ATCC 29133 (furthermore: N. punctiforme) can adapt
to many environmental changes. The ﬁlament differen-
tiates into akinetes (spore-like cells) to survive harsh
environmental conditions. Under more favorable con-
ditions, akinetes give rise to new ﬁlaments [11,12]. In
response to nitrogen starvation, heterocysts are formed
in a semi-regular pattern along the ﬁlament. Hetero-
cysts perform nitrogen ﬁxation and therefore provide
the ﬁlament with suitable nitrogen sources. In
exchange, heterocysts receive carbon sources from sur-
rounding vegetative cells [11]. Hormogonia are small
motile ﬁlaments that infect mosses and other plants to
start a symbiosis [13–15].
Exchange of signal molecules and nutrients within a
ﬁlament is pivotal for this complex lifestyle. Two
routes within a ﬁlament are currently discussed. Mole-
cules can be released to the periplasm and diffuse
along the ﬁlament to be taken up by other cells down-
stream of a ﬁlament [8]. A faster way to exchange
information is via cell–cell connections, referred to as
microplasmodesmata, septosomes, channels or septal
junctions [9,16–19]. Septal protein complexes may span
the periplasm and connect neighboring cells as chan-
nels [20]. To cross the septal cell wall, a nanopore
array consisting of approximately 150 pores of 20 nm
in diameter is present in the septal peptidoglycan
(PGN) [4,17,21]. These nanopores are essential for
cell–cell communication [4,5,17,22]. Mutational analy-
sis showed that N-acetylmuramoyl-L-alanine amidases
(EC 3.5.1.28) are involved in nanopore formation in
N. punctiforme (Npun_F1846 or AmiC2) and
Anabaena sp. PCC 7120 (Alr0092 or AmiC1ANA). The
DamiC2 mutant strain of N. punctiforme shows a
pleiotropic phenotype. Aberrantly placed septal planes
lead to distorted ﬁlaments that can no longer differen-
tiate into specialized cells. Therefore, diazotrophic
growth is not possible, and movement of ﬂuorescent
marker molecules between cells is abolished [5].
The cyanobacterial amidases are homologs of
amidases that mediate daughter cell separation in
unicellular bacteria [23]. Initially, the function of the
cyanobacterial amidases was elusive. However, when it
became clear that these enzymes have a pore-forming
function, it became intriguing to deﬁne the structural
features that allow the enzyme to adapt to its new
task. In line with their unusual task, AmiC amidases
of heterocyst-forming ﬁlamentous cyanobacteria differ
in architecture (Fig. 1A) compared, for example, to
the homologous E. coli enzyme AmiCE. coli [4,22]. In
ﬁlamentous cyanobacteria, AmiC amidases comprise
two AMIN (amidase N-terminal) domains [24] instead
of the single AMIN domain found in the enzymes of
unicellular bacteria. Furthermore, they carry a long,
proline-rich linker domain of approximately 160 resi-
dues that separates the AMIN and catalytic domains
(Fig. 1A). The AMIN domain was shown to be
responsible for septal localization of AmiCE. coli in
E. coli [25,26]. Moreover, there are differences in
transport because the N. punctiforme AmiC2 enzyme is
secreted to the periplasm in an unfolded state via a
Sec-signal sequence, whereas AmiCE. coli is transported
to the periplasm in its folded state via the Tat
translocon.
AmiC2 belongs to the Amidase_3 protein family
(PF01520) [27], whose structure–function relationship
remains under-investigated. Five Amidase_3 enzymes
have been structurally determined previously [28–31
and Protein Data Bank (PDB) codes: 1JWQ, 3CZX];
however, only AmiCE. coli and its close ortholog
AmiB from Bartonella henselae, as well as Rv3717 of
Mycobacterium tuberculosis, were also functionally
characterized. The Rv3717 amidase lacks AMIN
domains and is considered to play a role in PGN
recycling [28,29], whereas AmiCE. coli possesses one
AMIN domain, carries an inhibitory a-helix obstruct-
ing the active site and thus requires activation of
associated proteins to facilitate daughter-cell separa-
tion [30,31]. Such a helix is not present in the
N. punctiforme AmiC2, and regulation of activity is
therefore elusive.
To deﬁne the mechanism of AmiC2 action, we
undertook a structure–function analysis of this unu-
sual enzyme. We located native AmiC2 to the septa of
a ﬁlament using immunoﬂuorescence. We furthermore
solved the crystal structure of the catalytic domain of
AmiC2 (AmiC2-cat) at high resolution, and found that
key features of the enzyme differ signiﬁcantly from
2 The FEBS Journal (2016) © 2016 Federation of European Biochemical Societies
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those of cell separation amidases in unicellular bacte-
ria. Interestingly, an inhibitory a-helix that covers the
active site in the E. coli homolog is missing in AmiC2,
implying an entirely different regulation mechanism of
the Nostoc amidase. Finally, we showed that AmiC2-
cat is highly active in a dye release assay (DRA),
whereas mutation of zinc binders or otherwise removal
of zinc leads to precipitation. Mutation of the poten-
tial catalytic glutamate 578 (Glu578) causes total loss
of function.
Results
Localization of AmiC2 in ﬁlaments of
N. punctiforme
In previous studies, use of AmiC2 (Npun_F1846) with
a fused GFP-tag and under the export signal of a
cloned N-terminal TAT signal peptide provided pre-
liminary information on the septal localization of this
cell wall lytic enzyme in ﬁlaments of N. punctiforme
[4,5]. Because native AmiC2 is translocated via the Sec
system and not the Tat-translocation system, we rein-
vestigated the localization in the wild-type ﬁlaments
using immunoﬂuorescence. A polyclonal peptide anti-
body against a region solely present in AmiC2
(Fig. 1A) was used to detect native AmiC2 protein
in situ. In western blots of N. punctiforme wild-type
and DamiC2 crude cell extracts, this antibody recog-
nized the 69-kDa full length protein and a 55-kDa
truncated version of AmiC2 in the wild-type extract
only (Fig. 1B). The unique peptide region is not pre-
sent in the very similar AmiC1 protein (Npun_F1845);
hence, the antibody did not show cross-reactivity with
AmiC1 in the DamiC2 crude extracts. The observation
that a 55-kDa fragment is also detected in fractions of
the puriﬁed protein suggests that this fragment is pro-
duced by auto-proteolysis [4]. The highly speciﬁc anti-
body was used for the subsequent in situ studies. As
seen in the immunoﬂuorescence micrograph, AmiC2
primarily localized to young septa and was less abun-
dant in old septa and lateral walls (Fig. 1C, frames 1
and 2, respectively). Septum maturation is a slow pro-
cess that results in old septa, which show advanced
constriction visible in phase contrast images (Fig. 1C,





Fig. 1. Domain structure and localization of AmiC2 in N. punctiforme (A) Domain architecture of AmiC2, which is composed of a sec-signal
peptide (SP), the AMIN-A and -B domains, followed by a proline-rich linker region and the catalytic domain. The peptide sequence used for
antibody production is shown above the scheme, and residues of respective domains are given below. (B) Immunodetection of AmiC2 in
crude cell extracts of the wild-type N. punctiforme and the DamiC2 mutant (20 lg total protein) and puriﬁed AmiC2-6xHis protein (20 ng)
probed with the peptide antibody. (C) Immunoﬂuorescence images of a N. punctiforme ﬁlament using the peptide antibody. AmiC2 localized
preferentially to young septa (e.g. frame 1) and was less abundant in older septa (e.g. frame 2). BF, bright ﬁeld; AF, autoﬂuorescence; FITC,
ﬂuorescein isothiocyanate. (D) Three-dimensional projection of AmiC2 localization within septa of different of constriction stages. Top: side
view on the septa (as in C) with respective scale bars (= 1 lm). Bottom: top view on the septal plane.
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dimensional projection enabled localization of AmiC2
within septa of different stages of septum formation
(Fig. 1D). In an early state of septum formation,
AmiC2 localizes as a circular structure, resembling the
Z-ring at the site of septum formation. AmiC2 moves
inwards with the invaginating cell wall and ﬁnally
occupies the entire discoid surface of the young
septum. Because of the resolution limit of light micro-
scopy, it is not possible to further resolve the
ﬁne-structured localization of AmiC2 on the discoid
surface. In old septa and in the lateral cell walls, only
traces of AmiC2 could be detected. This localization is
in line with a function of AmiC2 in drilling nanopores
in the septal PGN during septum formation.
AmiC2 catalytic activity
From our previous study using full-length AmiC2 pro-
tein, we knew that this cyanobacterial amidase shows
activity against E. coli crude cell extracts in zymogram
analysis [4]. To characterize the enzymatic activity of
the AmiC2 protein in more detail, AmiC2-cat, which
lacks the N-terminal part of AmiC2 including the
AMIN domains and the linker domain (Fig. 1A), was
overexpressed as a GST-fusion protein in E. coli and
puriﬁed. Using a DRA, the lytic activity of the puriﬁed
catalytic domain was analyzed against puriﬁed
peptidoglycan from E. coli MG1655 coupled to rema-
zol brilliant blue (RBB-PGN) (Fig. 2A). Remarkably,
the activity of AmiC2-cat was very high in comparison
to lysozyme. A concentration of 0.08 lM AmiC2-cat
resulted in saturation of the reaction after only 30 min
of incubation. Heat-inactivated AmiC2-cat protein did
not show any activity, conﬁrming the enzymatic origin
of the dye release (Fig. 2A). To investigate a possible
lytic activity of the N-terminal parts of AmiC2, we
investigated a possible activity of the puriﬁed AMIN
domains (A + B) (Fig. 2B). No dye release, and thus
no activity, was observed for this part of AmiC2.
Overall structure and active site architecture of
AmiC2-cat
To advance an understanding of the enzyme, we
solved the structure of AmiC2-cat at 1.12 A resolu-
tion. Excellent data and reﬁnement statistics (Table 1)
provide a highly accurate basis for the analysis of the
overall structure and the description of its features.
AmiC2-cat adopts a mixed ab-fold that is characteris-
tic for Amidase_3 enzymes (Fig. 3) [32]. This fold
comprises a central, six-stranded b-sheet that is sur-
rounded by six a-helices. Helices a1, a3, a5 and a6
shield the rear of the b-sheet, whereas the remaining
two helices, a2 and a4, cover part of its front.
A B
Fig. 2. Catalytic activity of AmiC2 domains (A) Supernatants of a
DRA. Blue color indicates hydrolytic activity on RBB-PGN. Heat-
inactivated catalytic domain or buffer alone did not cause dye
release. (B) DRA of lysozyme, AmiC2-cat and AMIN domains (AB).
All samples were incubated for 30 min each, and all proteins were
used at equimolar concentration of 0.08 lM. Mean  SD are based
on three technical replica (n = 3).
Table 1. Data and reﬁnement statistics for AmiC2-cat. Values for
highest resolution bin are given in parentheses. Coordinates are





Cell dimensions (A) 35.0 62.8 65.3
() 90 90 90
Wavelength (A) 1.000
Detector PILATUS 2M
Resolution (A) 50–1.12 (1.15–1.12)
Measured reﬂections 626 001 (18 460)
Unique reﬂections 52 924 (2806)
CC 1/2 100 (88.4)









Bond lengths (A) 0.009
Bond angles (°) 1.426
Ramachandran plot
Most favorable (%) 98.4
Allowed (%) 1.6
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Together with loop regions, helices a2 and a4 also
deﬁne a wide and shallow cavity that harbors the
active site and a bound zinc ion. The zinc ion is coor-
dinated by two histidines (His447, His515) and a
glutamate (Glu462) at the upper end of a wide and
shallow cavity (Fig. 3A,B). The conserved GHGG
motif of residues Gly446, His447, Gly448 and Gly449
after strand b1 permits two close turns and the tight
folding at the top of the active site by the absence of





Fig. 3. Structure and topology of AmiC2-cat (A) The structure of AmiC2-cat in cartoon representation with a semi-transparent surface
reveals a mixed ab-fold in an arrangement typical for the Amidase_3 family. A central, six-stranded b-sheet builds the core of AmiC2-cat,
which is stabilized by six surrounding a-helices and loops. Residues H447, E462 and H515 (green sticks) coordinate a zinc ion (purple
sphere) and mark the center of the active site. The neighboring E578 (orange–yellow sticks) plays a pivotal role upon PGN cleavage. The
a-helices are shown in red, b-strands in yellow and loops in grey. (B) Electrostatic surface representation of AmiC2-cat showing a strong
electropositive potential around the active site. A patch of electronegative potential at the termini of AmiC2-cat is seen at the left edge of
the enzyme. (C) The topology diagram depicts the fold of AmiC2-cat. Green stars highlight the positions of the zinc-binding residues H447 in
a loop, E462 at the start of helix a1 and H515 at the end of strand b3. Furthermore, the catalytic residue E578 is located at the end of
strand b6 (orange–yellow star). In accordance with (A), a-helices are shown as red cylinders and b-sheets as yellow arrows. (D) The active
site forms a shallow cavity with a pocket to the left of the zinc ion. The zinc-binding residues H447, E462 and H515 have distances of 2.1 A
each towards the zinc (highlighted by black dashes). Side chains of D451 and S513 (grey sticks) help orient the respective zinc-ligating side
chains of H447 (2.8 A) and H515 (3.2 A) by hydrogen bonds (shown as orange dashed lines).
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chain of Asp451, lying near His447, facilitate proper
orientation of the imidazole residue by a hydrogen
bond (2.8 A), whereas Ser513 anchors the side chain
of His515 in a similar manner (3.2 A) (Fig. 3D). These
features, as well as the hydrogen bonds, enable accu-
rate zinc binding by AmiC2-cat. Furthermore, a 2-(N-
morpholino)ethanesulfonic acid (MES) molecule from
the crystallization buffer and the N-terminus of a sym-
metry copy bound in the active site; they represent
crystallographic artifacts (not shown).
Surface features and conservation
The structurally known and related enzyme from a
unicellular bacterium, AmiCE. coli, differs from
AmiC2-cat in terms of the shape of the active site
region (Fig. 4A). AmiCE. coli has a narrower groove
that could accommodate the substrate, whereas
AmiC2-cat has a much more open and wider binding
region. Moreover, the active site of AmiCE. coli is cov-
ered with an inhibitory a-helix that must change posi-
tion for substrate to be processed. Because of these
differences, few conclusions for substrate binding of
AmiC2-cat can be drawn from a comparison with the
AmiCE. coli structure despite their ability to cleave the
same substrate (Fig. 2). There is no enzyme–substrate
complex structure available for AmiCE. coli, although
the structure of the catalytic domain of the Staphylo-
coccus aureus amidase (AmiA-catS. aureus) was recently
solved bound to its substrate [33] (Fig. 4A). AmiA-
Fig. 4. Surface conservation of AmiC2-cat (middle), AmiCE. coli (left) and AmiA-catS. aureus (right). (A) Surface representations of the three
selected amidases reveal no recessed binding cleft for AmiC2-cat (middle) and AmiCE. coli (left). The inhibitory a-helix of AmiCE. coli also
gives no clear indication on substrate binding. By contrast, the S. aureus amidase AmiA-catS. aureus shows a clear Y-shaped binding grove
where its ligand is bound. (B) AmiC2-cat, a member of the Amidase_3 family, only displays conservation in the zinc-binding region of the
protein, whereas the surface of AmiA-catS. aureus (an Amidase_2 family member) is conserved along the entire binding groove of the bound
substrate muramoyltetrapeptide. This conservation enables substrate modelling options for Amidase_2 enzymes but none for an
Amidase_3. The level of conservation is depicted by a color bar. Seed sequences from the PFAM database, ClustalOmega and Chimera
were used to generate images in (B).
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catS. aureus also features a narrow, groove-like binding
region that engages the linear substrate through
numerous contacts. Comparison of the binding
surfaces shows that AmiC2-cat does not have such a
narrow groove, indicating that the enzyme could con-
ceivably accommodate several different substrate ori-
entations, perhaps in the form of PGN monomers, as
well as highly cross-linked PGN (Fig. 4A).
To gain insight into regions that might be involved
in ligand binding, we mapped conserved residues onto
the surface of the AmiC2-cat structure (Fig. 4B). A
bioinformatic analysis of seed sequences from the
PFAM database was chosen over BLAST hits to
exclude bias from the alignment and conservation
analysis. The zinc-coordinating residues His447,
Glu462 and His515, as well as Glu578 and the active
site residues highlighted in Fig. 3, are strongly con-
served among members of the Amidase_3 family, indi-
cating a generally conserved mechanism of cleavage.
However, a surprisingly small number of surface-
exposed amino acids are conserved beyond the active
site (Fig. 4B) and most of these are conserved because
of structural requirements. For example, the conserved
Pro573 enables a tight turn just before strand b3 with
the zinc-coordinating Glu578 at its end and, similarly,
the conserved Gly481 allows the two amino acid turn
between helix a1 and strand b2. The analysis of con-
servation does not allow us to delineate a putative sub-
strate binding groove for AmiC2-cat (Fig. 4B). This is
in contrast to representatives of the Amidase_2 family,
where such analyses revealed putative substrate bind-
ing regions in AmiA-catS. aureus homologs [34,35].
Mutational analysis
Based on the AmiC2-cat structure and sequence con-
servation, we designed several single point mutations
in the active site. The three zinc-binding residues
His447, Glu462 and His515, as well as Asp451, were
separately mutated to alanine (H447A, E462A, H515A
and D451A, respectively), and the four mutant pro-
teins were expressed and puriﬁed similarly to the wild-
type protein. However, all four mutants were unstable
and aggregated during size exclusion chromatography
(data not shown) and they could therefore not be ana-
lyzed for residual activity (Fig. 5B). Because the four
point mutations likely affected zinc binding, we con-
clude that the zinc ion is important for protein stabil-
ity and the integrity of the overall fold. In support of
this, removal of zinc from wt AmiC2-cat using the
chelator EDTA in solution also led to precipitation of
the protein (data not shown).
According to a previously proposed catalytic mecha-
nism for the related AmiA-catS. aureus amidase, a con-
served glutamate accepts a proton from a nucleophilic
water next to the zinc, enabling it to attack the PGN
and facilitate cleavage [33]. To analyze whether this
conserved glutamate, Glu578 in AmiC2-cat, is also rel-
evant for the catalytic activity of AmiC2-cat, single
point mutants of Glu578 to alanine, glutamine, aspar-
tate and asparagine (E578A, E578Q, E578D and
E578N, respectively) were generated. These mutations
were designed to evaluate the potential importance of
charge and side chain length for enzymatic activity.
The resulting proteins could easily be puriﬁed after
Fig. 5. AmiC2-cat mutant stability and activity. (A) CD spectroscopy with stable mutants revealed unaltered folding compared to wild-type
AmiC2-cat. (B) DRA of AmiC2-cat and E578 mutants shows total loss of activity for all substitutions. The activities of other mutants could
not be determined as a result of protein instability and aggregation. ND, not determined. Mean  SD are based on three technical replica
(n = 3). (C) The active site is depicted similar to Fig. 3D with backbone of A516 (grey sticks) and the E578 side chain (orange–yellow sticks).
The position of the N-terminal amino group of a crystallographic symmetry-related molecule that bound in the active site is substituted with
a water molecule ‘w’ in orange. This water molecule is in perfect distance to the zinc ion (2.2 A, grey dashes) and the assisting residues
E578 and A516 (3.0 A each, grey dashes). Thus, the water is well positioned for activation and performing a nucleophilic attack on the
scissile bond of the substrate.
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adaptation of the puriﬁcation protocol (see Experimen-
tal procedures). Analytical size exclusion chromatogra-
phy (data not shown) and CD spectroscopy (Fig. 5A)
conﬁrmed stability, as well as proper folding, without
any signiﬁcant difference from the wild-type AmiC2-
cat. The Glu578 mutants were investigated using the
DRA. None of the Glu578-variants exhibited dye
release, suggesting that this residue is indispensable for
catalysis (Fig. 5B). Thus, the Glu578 side chain likely
activates the water molecule located next to the bound
zinc ion.
Discussion
With the formation of nanopore arrays, the cell wall
amidase AmiC2 fulﬁlls a pivotal function in ﬁlamen-
tous N. punctiforme [4]. Such arrays consist of approx-
imately 150 nanopores that are located in the center of
the septal PGN, and allow for the formation of cell–
cell communication structures. A Nostoc mutant lack-
ing AmiC2 forms aberrant septa during cell division,
cannot differentiate specialized cell types and cannot
establish cell–cell communication via septal junction
proteins [5]. In general, cell wall lytic enzymes must be
under stringent control to avoid cell lysis. In case of
the highly speciﬁc AmiC2 amidase, however, the
enzyme has to be spatiotemporally regulated. The for-
mation of the nanopore array requires precise activa-
tion of AmiC2 on distinct spots on the septal disc at a
certain time during septum maturation. In E. coli,
LytM domain proteins such as NlpD and EnvC fulﬁll
the regulatory task by displacing an obstructing a-helix
from the active site of AmiCE. coli during cell division
by an unknown mechanism [30,31,36]. We performed
in situ localization studies, as well as biochemical and
structural analyses of AmiC2, aiming to deﬁne the
substrate speciﬁcity of the enzyme and the mechanism
of regulation of its lytic activity.
In situ immunoﬂuorescence conﬁrmed the septal
localization of AmiC2 and allowed us to correlate the
distribution of AmiC2 with the state of septum forma-
tion. The cellular localization of the enzyme correlates
well with its proposed function in nanopore formation
in the septal cell walls [4]. In old septa, the formation
of new nanopores may not be needed anymore, and
hence the amidase protein disappears. Nevertheless, the
time course of amidase activation is still unclear and
could occur in two different ways: the AmiC2 protein
is either active from the beginning of septum formation
or AmiC2 is present from the beginning (as shown
here) but activated after the septum has completely
formed, and then disappears completely. In E. coli, the
AMINE. coli domain, which binds to the PGN, has
been shown to be necessary for the correct localization
of amidases to the septum during cell division [24,31].
Because the AMIN domains of AmiC2 from N.
punctiforme do not contribute to lytic activity, it is
probable that they help to mediate septal localization.
The DRA demonstrates that the puriﬁed AmiC2-cat
domain has a signiﬁcantly elevated activity compared
with lysozyme. The substrate used in all DRA was
Gram-negative E. coli PGN. This compound is similar
to the cyanobacterial PGN, which is considered to be
Gram-negative because of the presence of an outer
membrane. Nevertheless, the PGN of most cyanobac-
terial strains is thicker than in typical Gram-negative
bacteria. Its thickness is estimated at approximately
12 nm versus approximately 6 nm in E. coli [9,37–41].
The higher activity of AmiC2 may therefore reﬂect the
need for efﬁcient processing of the thicker, more
complex PGN in cyanobacteria.
It is not known whether the structure and composi-
tion of septal PGN of ﬁlamentous cyanobacteria dif-
fers from lateral murein or PGN of unicellular
organisms. Hence, the septal PGN could contain struc-
tural features that are involved in activation of AmiC2
and its special function in drilling nanopores. The
N-terminal domains of AmiC2, such as the AMIN
domains and/or the proline-rich linker, may be
involved in regulation. Limited proteolysis could be
another possibility for governing AmiC2 activity.
Recently, Singh et al. [42] showed that a murein
endopeptidase is regulated by a two-protein system
comprising NlpI, an outer membrane lipoprotein, and
Prc, a periplasmic protease. Because shorter fragments
of AmiC2 appear in western blot analysis with crude
cell extracts, as well as with puriﬁed AmiC2, the possi-
bility of regulation by (auto-) proteolysis should be
considered and deserves further investigation.
A complex machinery of catalytic regulation may be
required to drill pores of uniform size and shape with
a precise spatial distribution across the septum surface.
In the closely-related strain Anabaena sp. PCC 7120,
the protein SjcF1 was found to inﬂuence the size of
the nanopores, and a sjcF1 mutant was hampered in
cellular exchange of molecules [43]. In addition, SjcF1
was shown to interact with the putative channel form-
ing FraC and SepJ proteins, which also have inﬂuence
on the formation of the nanopore array [17]. However,
protein interaction with PGN processing proteins such
as AmiC1 or AmiC2 has not yet been investigated.
The high-resolution crystal structure of AmiC2-cat
reveals a typical Amidase_3 family fold [27,32].
Although ﬁve Amidase_3 structures have previously
been determined, only AmiCE. coli [30,31] and Rv3717
of M. tuberculosis [28,29] were also functionally char-
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acterized. The structure of AmiCE. coli [31] differs
mostly by the insertion of a regulatory a-helix and the
elongation of helix a3 (Fig. 6A). The inserted a-helix
blocks the active site and prevents catalysis. Inhibition
of AmiCE. coli even occurs, if a deletion mutant is sup-
plemented with the missing obstructing a-helix [31].
The interaction with LytM domains, which are part of
the divisome machinery that forms a septal ring below
the inner membrane, induces a displacement of the
regulatory a-helix in a possibly ATP-dependent man-
ner [30,31]. Rv3717 of Mycobacterium tuberculosis has
broad-spectrum activity [28] and carries an insertion
that forms a 310-helix and an additional b-hairpin that
is stabilized by a disulﬁde bridge (Fig. 6B) [28,29]. The
insertion acts as a lid for the binding site and gener-
ates a tunnel that can accommodate substrate but lim-
its the activity to smaller PGN fragments [29].
Furthermore, product fragments and a docked Mur-
NAc are located in this tunnel. Both studies also
assume a regulatory function of the insertion because
Rv3717 lacks a cell wall binding domain. Along with
functional data, the structure of AmiC2-cat is there-
fore the ﬁrst to characterize a subclass of the Ami-
dase_3 family that features no regulatory insertions
and is thus distinct in regulation.
The zinc ion bound to AmiC2-cat likely serves an
essential function for enzyme stability as zinc removal
by EDTA or mutation of zinc-coordinating residues
led to protein aggregation. Although some amidases
can tolerate zinc removal, such as AmiE [44], Ply-PSA
[45] and Rv3717 [29], others exhibit similar sensitivity,
such as Rv3717 [28] and AmiA (F. M. B€uttner, per-
sonal communication). Furthermore, the electrostatic
surface potential reveals strong, mostly electropositive
features in the active site (Fig. 3B). Thus, the PNG
substrate of AmiC2-cat likely carries an overall nega-
tive charge. PGN of cyanobacteria belongs to type
A1c and comprises building blocks with free carboxyl
groups such as meso-diaminopimelic acid, as well as
unlinked D-Ala and feasibly non-amidated D-iGlu
[38,46], thereby possibly supporting substrate speci-
ﬁcity.
Mutational analysis of Glu578 demonstrates the rel-
evance of this residue for catalysis, and provides evi-
dence for a reaction mechanism that is based on the
activation of a water molecule next to the zinc ion,
consistent with reaction mechanisms described for
other zinc-dependent amidases. The mutants show that
even a small change in side chain length (E578D) or a
change in charge (E578Q) leads to a large reduction in
Fig. 6. Structural comparison of Amidase_3 enzymes with AmiC2-cat by Ca-rmsd color plot. (A) Rv3717 (PDB code: 4M6G, Ca rmsd of
1.5 A; 29% sequence identity) deviates from AmiC2-cat by an insertion of a 310-helix and a b-hairpin that acts as a lid on the active site
(shown in red). The resulting tunnel reduces substrate variability and indicates PGN recycling activity of Rv3717. Helix a3 is extended, and
the loop connecting helix a3 with strand b5 further constricts the lower end of the binding site. The inner core, however, aligns very well
with AmiC2-cat, as indicated by a low Ca-rmsd (blue). (B) AmiCE. coli (PDB code: 4BIN, Ca rmsd of 1.5 A; 34% sequence identity) exhibits
two major differences compared to AmiC2-cat, both being involved in regulation. An inhibitory a-helix with long connecting loops that is
inserted between strand b4 and helix a3 blocks the active site, thereby inactivating the enzyme. In addition, helix a3 is signiﬁcantly
extended, allowing the movement of the inhibitory a-helix in and out of the active site upon interaction with LytM domains. AmiC2-cat and
the respective enzymes were aligned, and rmsd values for positions of every Ca atom were calculated. The rmsd values were used to color
the respective enzymes from no deviation in blue to 4 A or more deviation in red. Three N- and one C-terminal residues of Rv3717 (4M6G),
as well as the AMIN domain along with 13 N-terminal residues of AmiCE. coli (4BIN), were omitted from this representation for clarity.
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activity, suggesting that proper placement of the E578
side chain is essential for the reaction mechanism. In
the AmiC2-cat crystals, N-terminal residues of a sym-
metry-related molecule reach into the active site and
participate in zinc binding, completing the almost per-
fect octahedral coordination. A water molecule is
likely to coordinate the zinc at this position in a more
physiologic setting. Contacts with the backbone car-
bonyl of Ala516 and the Glu578 carboxylate (3.0 A
each) and the zinc ion with 2.2 A (Fig. 5C) would
enable this water to initiate a nucleophilic attack on
the scissile amide bond of PGN between the peptide
stem and the carbohydrate backbone. Although
Glu578 could temporarily accept a proton from this
water molecule, the glutamine amide group could not
be protonated at physiologic pH. The nearby hydro-
philic surface-exposed residues Asn517, Glu529 and
Arg560 are partly conserved, and they might partici-
pate in substrate binding or form part of a proton
relay system for Glu578, as suggested by Mayer et al.
[47] for a bacteriophage amidase.
AmiC2-cat has surprisingly few conserved surface
residues, which is perhaps in keeping with its unusual
function in nanopore formation. By providing a large
groove that can host large PGN molecules, as present
in cyanobacteria, the open and shallow binding surface
of AmiC2, along with the lack of conservation, sug-
gests that its substrate may be accommodated in some-
what different orientations. This would also be in line
with the observed high enzymatic activity against
E. coli PGN in vitro and in vivo because fast substrate
processing requires easy access of the substrate to the
active site, and quick dissociation of the products.
Moreover, an electropositive potential was shown to
be critical for (and even enhanced) amidase activity in
the Amidase_2 enzymes PlyA and XlyA [48]. Likewise,
the electropositive potential of AmiC2-cat could con-
tribute to its high activity, perhaps by facilitating sub-
strate binding and docking into the active site through
long-range electrostatic forces. It is tempting to specu-
late that MurNAc could ﬁt into the pocket to the left
of the zinc ion where a MES molecule of the crystal-
lization buffer bound. This would position the scissile
bond near a zinc-activated water molecule that would
engage the nucleophilic attack. The remaining portion
of the PGN chain substrate would then lie across the
shallow binding region.
Taken together, the data reported in the present
study shed light on the pivotal role of the N-acetyl-
muramoyl-L-alanine amidase AmiC2 in context of cel-
lular communication in N. punctiforme ﬁlaments. Our
results provide an excellent basis for further studies
involving the molecular mechanism, as well as sub-
strate and site speciﬁcity.
Experimental procedures
Strains and growth conditions
E. coli strains were grown in LB medium [49]. Strain
MG1655 grew without the addition of antibiotics, and trans-
formed clones of E. coli BL21 were selected on 100 lgmL1
ampicillin. N. punctiforme and its DamiC2 mutant strain
were grown in medium of BG11 supplemented with NO3
[15]. The mutant was grown in presence of 50 lgmL1 neo-
mycin. Both cyanobacterial strains were cultivated under
horizontal shaking (80 r.p.m.) and permanent light [5].
Immunodetection
A 50 mL culture of N. punctiforme ﬁlaments was har-
vested (20 000 g and 4 °C) and the ﬁlaments resuspended
in 1 mL 50 mM Hepes. Cells were broken by sonication,
and the protein concentration determined according to
Bradford [50]. The AmiC2-6xHis protein was puriﬁed as
described previously [4]. After separation by SDS/PAGE,
the proteins were blotted on a poly(vinylidene diﬂuoride)
membrane [51], which was blocked in blocking solution
(19 PBS 0.1% Tween 20, +5% skim milk) for 1 h at
room temperature (RT). Peptide antibodies were used at a
dilution of 1 : 100 in blocking solution and incubated
overnight at 4 °C. After three washes, the membrane was
incubated with a horseradish peroxidase-conjugated sec-
ondary antibody (dilution 1 : 10 000; Sigma-Aldrich,
Munich, Germany) for 2 h at RT. After four rounds of
washing, the LumiLight mixture (Roche, Basel, Switzer-
land) was used and the luminescence captured by the
Gel Logic 1500 imaging system (Kodak, Rochester,
NY, USA).
Immunoﬂuorescence localization
A polyclonal peptide antibody was raised in rabbits
against the synthetic peptide RTSPINPPKNGMLAARV
(Fig. 1A) by Dr J. Pineda Antik€orper-Service (Berlin, Ger-
many). N. punctiforme ﬁlaments from exponentially grow-
ing cultures were harvested and washed with 2–5 mL of
PBS. The cells were ﬁxed by 2 mL of HistoChoice Tissue
Fixative (Sigma-Aldrich) for 10 min at RT, followed by
incubation at 4 °C for 30 min. After three washes with
PBS, the cells were resuspended in 1 mL of ice-cold 70%
EtOH, again washed, and resuspended in 2 mL of GTE
buffer (50 mM glucose, 20 mM Tris-HCl, pH 7.5, 10 mM
EDTA). Next, 2 mgmL1 lysozyme (Sigma Aldrich) was
added and left at RT for 5 min. Then, 200 lL of the cell
suspension were transferred to Polylysine slides (Thermo
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Scientiﬁc, Waltham, MA, USA) and dried. After rehydra-
tion with 200 lL of PBS for 5 min at RT, the slides were
blocked by 200 lL of 2% BSA in PBS for 20 min and
then incubated with primary antibody (dilution 1 : 5 in
PBS containing 2% BSA) at 4 °C overnight in a wet
chamber. After eight washes with PBS, the FITC coupled
secondary antibody (Sigma Aldrich; dilution 1 : 200 in
PBS/BSA) was incubated for 2 h at room temperature in
a dark wet chamber and washed eight times with PBS.
One drop of Mounting Medium H1200 (Vector Laborato-
ries, Inc., Burlingame, CA, USA) was added to each slide
and then overlaid with cover glasses (24 9 60 mm) and
sealed with transparent nail polish. The slides were stored
at 4 °C in the dark.
To capture ﬂuorescence and bright ﬁeld images, a
DM5500B microscope (Leica Microsystems, Wetzlar, Ger-
many) was used with a 9100/1.3 numerical aperture oil
objective lens. Image acquisition was carried out using a
DFC360FX monochrome camera (Leica Microsystems). A
BP470 40 nm excitation ﬁlter and a BP525 50 nm emis-
sion ﬁlter were used for detection. The exposure time was
adjusted according to green ﬂuorescence background in
samples without primary antibody incubation. Autoﬂuo-
rescence of cyanobacterial cells was monitored with a ﬁlter
cube of BP535 50 nm excitation ﬁlters and a BP610
75 nm emission ﬁlter. Exposure times ranged from 6 ms
(bright ﬁeld) to 80 ms (ﬂuorescein isothiocyanate) and
170 ms (autoﬂuorescence). Images were taken as Z-stacks
with 0.1 lm intervals. Z-stacks were used to perform
three-dimensional deconvolution using the built-in
function of the LEICA ASF software (Leica Microsystems).
Images were recolored by the LEICA ASF software based on
the ﬁlter used, and intensity levels were adjusted using
ADOBE PHOTOSHOP CS3 (Adobe Systems Inc., San Jose, CA,
USA).
PGN isolation from E. coli MG1655
The PGN of E. coli was puriﬁed according to the protocol
of Glauner [51], with some modiﬁcations. Bacteria grown
overnight at 37 °C in LB broth were cooled to 4 °C and
harvested (4000 g for 30 min at 4 °C). Cells were resus-
pended in ice-cold distilled water (0.2 gmL1) and added
dropwise to an equal volume of 8% boiling SDS. Boiling
was continued for 30 min under vigorous stirring. After
cooling to RT, the SDS insoluble fraction was collected
(100 000 g for 45 min at RT). The pellet was freed from
SDS by repeated washing and/or dialysis against water.
The SDS content was controlled by methylene blue assay
[52]. Subsequently, the pellet was resuspended in H2O.
Then, 100 lg of a-amylase (from Bacillus subtilis; Fluka
BioChemika, Buchs, Switzerland) per mL were added and
incubated at 37 °C for 2 h. To inhibit the activity of con-
taminated lysozyme in the amylase preparation, 0.32 M imi-
dazole was added. Spatula tip amounts of DNAse and
RNAse (Genaxxon, Ulm, Germany) were also added.
During 2 h of incubation (37 °C), pronase (from Strepto-
myces griseus; Merck, Darmstadt, Germany) was pre-
treated for 90 min at 60 °C followed by the addition of
200 lgmL1 pronase to remove lipoproteins covalently
bound to the PGN. Again, the sample was added to an
equal volume of 8% SDS and boiled for at least 15 min.
SDS was removed afterwards.
DRA
Coupling of PGN to RBB and DRA was performed
according to Rocaboy et al. [31] with some modiﬁcations:
500 lL of RemazolBrilliantBlue (1% w/v H2O), 500 lL of
H2O and 100 lL (20 g of Na2SO4, 2.32 g of Na3PO4 9 12
H2O in 10 mL of H2O) were added to 1 mL of puriﬁed
PGN and incubated at 50 °C for 30 min. Afterwards, the
PGN was washed with 50 mM sodium phosphate buffer
(pH 7) until the supernatant was clear. For measuring
hydrolytic activity, 50 lL of RBB-PGN were added to
0.16 lM enzyme in 50 mM TrisHCl, 150 mM NaCl buffer,
pH 7.8 (ﬁnal enzyme concentration: 0.08 lM) and immedi-
ately incubated at 28 °C by horizontal shaking with
300 r.p.m. Heat-inactivated samples were denatured at
95 °C for 20 min prior to addition to RBB-PGN. The reac-
tion was stopped at deﬁned time points by adding 100 lL
of 20% (w/v) TCA. The samples were centrifuged (1700 g
for 10 min at RT) and 150 lL of the supernatant was
added to 150 lL of H2O in micro-cuvettes. The absorbance
was measured at 595 nm. All activities were normalized to
a control containing solely RBB-PGN and buffer. Graphs
were prepared using PRISM, version 6.07 (GraphPad Soft-
ware, La Jolla, CA, USA).
Cloning
Plasmids and primers used for cloning are listed in
Tables S1 and S2. Whole cells of N. punctiforme were
used as template to amplify the AmiC2-cat fragment in
PCR using primers No 993 and 994, introducing restric-
tion sites (BamHI-EcoRI) for cloning, and high ﬁdelity
Q5-polymerase (NEB, Ipswich, MA, USA). The ampliﬁed
fragment was ligated into a pGEX-4T-3 vector, resulting
in an N-terminal fusion of GST-tag to the AmiC2-cat
domain. The sequence encoding the AMIN domains was
ordered as an optimized sequence (MWG Euroﬁns, Ebers-
berg, Germany) and delivered in the pEX-K standard
cloning plasmid. PCR was performed with primers No
997 and 998 introducing restriction sites BamHI and
EcoRI and the resulting fragment ligated in pGEX-4T-3.
All plasmids were transformed in E. coli BL21(DE3). The
integrity of all PCR-based products was veriﬁed by
sequencing.
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Mutagenesis
Site-directed mutagenesis was used to generate point muta-
tions of zinc-coordinating residues (H447A, E462A and
H515A), as well as active site residues (D451A, E578A,
E578Q, E578D, E578N). Oligonucleotides introducing the
mutations are given in Table S2. The reactions were per-
formed as described in the QuikChange protocol (Agilent
Technologies, Santa Clara, CA, USA).
Protein expression and puriﬁcation
Wild-type AmiC2-cat carrying an N-terminal GST-tag was
expressed in E. coli BL21 (DE3) cells in auto-induction med-
ium (ZYM-5052) [53] over 72 h at 21 °C. Harvested cells
were resuspended in buffer (150 mM NaCl, 50 mM Tris,
pH 8), supplemented with 1 mM PMSF and 1% Tween 20,
and lysed with a FrenchPress (EmulsiFlexC3; Avestin,
Ottawa, ON, Canada). The cell lysate was ﬁltered and incu-
bated with 2 mM ATP + 10 mM MgSO4 for 15 min, when
rotating at 37 °C. The supernatant was applied to a GSTrap
FF column (GE Healthcare, Little Chalfont, UK). After
thorough washing, a buffered salt gradient reaching 1 M
NaCl removed impurities. Thirty units of thrombin per mil-
ligram fusion protein were added for on-column cleavage at
4 °C over 3 days and released AmiC2-cat. The remaining
impurities and aggregate were removed by size exclusion
chromatography with a 215 nm detection system (Super-
dex75 on an €AKTA FPLC; GE Healthcare).
AmiC2-cat mutants were expressed and initially pro-
cessed as described for the wild-type enzyme. In a modiﬁca-
tion of the above protocol, the fusion protein was eluted
using buffer supplemented with 15 mM reduced glutathione
after afﬁnity chromatography and then size exclusion chro-
matography was performed. In the case of H447A, E462A
and H515A, as well as D451A, the proteins all ran in the
aggregate peak. Fusion proteins of E578A/Q/D/N,
however, were stable and could be cleaved in solution over
60 h. GST and thrombin were removed by GSTrap FF
and Benzamidine FF columns (GE Healthcare) before ﬁnal
gel ﬁltration.
AmiC2_AMIN-AB was cloned similarly to AmiC2-cat,
with an N-terminal GST-tag, expressed using E. coli BL21
(DE3) cells in auto-induction medium over 3 days, and
puriﬁed using the same protocol.
Purity of proteins was conﬁrmed by SDS/PAGE and
analytical size exclusion chromatography, their identity was
veriﬁed by MALDI and proper folding was analyzed using
circular dichroism.
Circular dichroism spectroscopy (CD)
Wild-type AmiC2-cat and AmiC2-cat mutants stored in gel
ﬁltration buffer were concentrated to approximately 3.0–
3.5 mgmL1 and subsequently diluted with ddH2O to
abolish interference by chloride ions. The ﬁnal concentra-
tion of the proteins was approximately 0.2 mgmL1 in
diluted buffers of approximately 9 mM NaCl and 3 mM
Tris. All samples were transferred into a 1 mm quartz cuv-
ette and measured using a J-720 spectrometer (Jasco,
Gross-Umstadt, Germany). Spectra were recorded at room
temperature with an accumulation of 10 in the range 250–
199 nm. The spectra manager (Jasco) was used to subtract
the buffer baseline, smoothen the spectra and calculate
molar ellipticity values. Because of imprecise measurements
of the ﬁnal protein concentrations, the molar ellipticity val-
ues of all AmiC2-cat mutants needed to be scaled to wild-
type AmiC2-cat. The individual scaling factors were deter-
mined by the ratio of molar ellipticity of wild-type at
220 nm over the molar ellipticity of mutant at 220 nm and
applied to all values of the respective mutant. CD spectra
were prepared using PRISM.
Crystallization
AmiC2-cat was concentrated to 3.7 mgmL1, and 1 lL
of protein was mixed with 1 lL of well solution
containing 120 mM alcohols (mixture of 1,6-hexanediol,
1-butanol, 1,2-propanediol, 2-propanol, 1,4-butanediol
and 1,3-propanediol), 100 mM MES/imidazole (pH 6.5)
and 37.5% poly(ethylene glycol)1000 / poly(ethylene
glycol)3350 / 2-methyl-2,4-pentanediol using the hanging
drop vapor diffusion method. Orthorhombic crystals grew
over 2 weeks at 20 °C and were directly ﬂash frozen in
liquid nitrogen.
Data collection and structure determination
Data were collected at 100 K using a PILATUS 2M detec-
tor at beamline X06DA of the Swiss Light Source (Villigen,
Switzerland). Indexing, integrating and scaling were
performed using POINTLESS [54] implemented in the CCP4
suite [55] and XDS [56]. The structure of Cwlv, an amidase
from Bacillus (Paenibacillus) Polymyxa var. colistinus (PDB
code: 1JWQ), with 38% sequence identity was modiﬁed
using CHAINSAW [57], also implemented in CCP4, to serve as a
search model for molecular replacement by PHASER [58].
Iterative model building, reﬁnement and validation were per-
formed with COOT [59] and PHENIX [60]. All 178 residues and
the two-residue linker were built in the ﬁnal model. Images
were generated using PYMOL [61] and CHIMERA [62], exploit-
ing bioinformatic information from NCBI (http://
www.ncbi.nlm.nih.gov), CLUSTAL OMEGA [63] and PFAM [27].
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a b  s  t  r  a c t
The  molecular  structure  of  matter  deﬁnes its  properties  and  function.  This is especially  true for biological
macromolecules  such  as proteins,  which  participate  in  virtually all biochemical  processes.  A  three  dimen-
sional  structural  model  of  a  protein is thus  essential  for the  detailed  understanding  of  its  physiological
function  and  the  characterization  of  essential  properties  such  as  ligand  binding  and  reaction  mechanism.
X-ray  crystallography  is  a well-established  technique that has been  used  for many years,  but it  is  still by
far  the most  widely  used  method  for structure determination.  A particular strength  of  this  technique  is
the  elucidation  of  atomic  details  of  molecular interactions,  thus providing  an invaluable  tool  for a  multi-
tude  of  scientiﬁc  projects  ranging  from  the  structural  classiﬁcation  of macromolecules  over the  validation
of  enzymatic  mechanisms  or  the  understanding  of  host–pathogen  interactions  to structure-guided  drug
design.  In  the ﬁrst  part  of  this  review, we  describe essential  methodological  and practical  aspects  of
X-ray  crystallography.  We provide  some  pointers  that  should  allow  researchers  without a  background
in  structural  biology  to assess the overall  quality and  reliability  of  a  crystal  structure.  To  highlight  its
potential,  we  then  survey the  impact  X-ray  crystallography  has had  on  advancing  an  understanding  of a
class  of  enzymes  that modify  the  bacterial  cell  wall.  A substantial  number  of different bacterial amidase
structures  have  been solved,  mostly  by  X-ray  crystallography.  Comparison  of  these structures highlights
conserved  as  well  as divergent  features.  In  combination  with functional analyses,  structural  informa-
tion  on  these enzymes  has therefore  proven  to be  a valuable  template  not  only for understanding  their
mechanism  of  catalysis,  but  also for targeted  interference  with substrate  binding.
© 2015  Elsevier  GmbH. All  rights reserved.
X-ray crystallography: principles, possibilities and
challenges
Overview
The  determination of the crystal structure of diamonds by
William Henry Bragg and his son William Lawrence Bragg in 1913
can be viewed as the birth of X-ray crystallography. Thus, this
method has only recently turned one hundred years old, and can
now look back on a  century in which it has often enriched and
sometimes revolutionized scientiﬁc research. To mark the occa-
sion, the year 2014 has been announced as the “International Year
of  Crystallography” (iycr2014, 2014) and the journals Nature and
∗ Corresponding  author at: Interfaculty Institute of Biochemistry, University of
Tübingen, Hoppe-Seyler-Straße 4, 72076 Tübingen, Germany.
Tel.:  +49 7071 29 73043; fax:  +49 7071 29 5565.
E-mail address: thilo.stehle@uni-tuebingen.de (T. Stehle).
Science have dedicated special issues to review the historical mile-
stones of X-ray crystallography, its  achievements, developments,
and future prospects (NATURE, 2014; SCIENCE, 2014). The increas-
ing level of automation in the crystallographic pipeline over these
last 100 years has led to a  tremendous and constantly growing
number of structures deposited in the PDB today, the PDB features
over 100.000 structures. In combination with the rapid technical
evolution of X-ray crystallographic techniques in areas such as
membrane protein structure determination or room-temperature
structure determination at synchrotrons, as well as the possibilities
offered by  free electron laser X-ray (XFEL) sources (Garman, 2014),
this promises that macromolecular crystallography will continue
to have considerable impact in a broad range of scientiﬁc research
ﬁelds in the future.
X-ray  crystallography is  not a direct imaging technique that
focuses visible light scattered from objects through refractive
lenses to create a  magniﬁed image of the object. Rather, it exploits
the fact that X-rays with wavelengths between 0.05 and 5.0 nm
are scattered by the electron shells of atoms and thus provide the
http://dx.doi.org/10.1016/j.ijmm.2014.12.018
1438-4221/© 2015 Elsevier GmbH. All rights reserved.
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possibility to obtain structural information of molecules at  near-
atomic resolution. However, due to the refractive index of X-rays
in different materials, which is essentially equal and close to unity,
it is not possible to obtain direct atomic resolution images of a
single protein molecule (or other macromolecule) through simple
focusing of scattered X-rays (Rupp, 2010; Sumner, 2014). Never-
theless, diffraction images can be obtained from protein crystals
in X-ray diffraction experiments. These images carry information
about the content of the crystal’s unit cell (the protein of inter-
est), but this information is encoded in intensity distributions of
reﬂections in “reciprocal space” and thus not easily accessible.
With the help of Fourier transformations, this information can
be “translated” back into molecular “real” space, giving rise to an
image of the crystallized molecule. The Fourier transformation is  a
straightforward mathematical operation that requires two terms as
Fourier coefﬁcients: (i) the structure factor amplitudes, which can
be  obtained from the recorded diffraction spot intensities, and (ii)
the  relative phase angle corresponding to each observed diffraction
spot (Rupp, 2010). Since these phase angles are not directly accessi-
ble by experimental methods, they must be obtained in additional
so-called phasing approaches, which can involve further experi-
ments or molecular replacement calculations with the help of the
phases from related known structures. This is  generally known as
the “phase problem” in crystallography, and it is  one reason X-ray
crystallographic structure determinations can remain challenging
even today. Once initial phases are determined, a  ﬁrst electron den-
sity map  can be calculated, and this map  provides the basis for
molecular model building and structural reﬁnement (Fig. 1).
Experimental  approach and challenges
An X-ray crystallographic structure determination requires one
or typically several crystals of the molecule of interest. In 1937
James Sumner demonstrated that proteins can be crystallized
and must therefore have a regular, ordered structure (Sumner,
1937). Despite efforts to standardize and automate this process,
growing crystals remains a major bottleneck in crystallography.
Crystal formation requires sufﬁcient amounts of  highly pure pro-
tein, which is usually obtained using recombinant expression
systems in bacteria, yeast, insect cells, or  mammalian cell lines.
Using these approaches, even challenging proteins carrying post-
translational modiﬁcations or  membrane proteins can often be
expressed.
Although the parameters governing the process of protein crys-
tallization are now better understood, it is  not  yet possible to
predict the conditions under which a particular protein will crystal-
lize (Garman, 2014), and thus crystallization conditions have to be
screened empirically. Moreover, since diffraction power can vary
tremendously from crystal to crystal, several additional rounds
of ﬁne-screening and crystal optimization are often necessary to
obtain diffraction-quality crystals. Even with the use of robotic
platforms that can routinely dispense low-volume drops (as low
as 50 nL protein + 50 nL of precipitant solution), this screening
typically still requires milligram amounts of pure, homogeneous
protein solutions that are not always easy to obtain.
Wavelength (energy) and brilliance (ﬂux) of the X-ray beam
itself are also important factors inﬂuencing diffraction power and
data quality. In some cases, such as in experimental phasing strate-
gies with the help of anomalous scatterers, it  is even necessary
to record several data sets (see below) at  different wavelengths.
The evolution of storage ring sources to the currently available
third-generation synchrotron sources with tunable wavelengths
in conjunction with fast and accurate X-ray detectors has greatly
facilitated the performance and efﬁciency of X-ray crystallography
in the last decades. Nowadays, even weakly diffracting or  smaller
crystals can be used for structure determination (Garman, 2014).
Fig. 1.  X-ray crystallographic workﬂow. Schematic diagram showing the  workﬂow
for  macromolecular structure determination by X-ray crystallography.
Once X-ray data from a  crystal are available, the intensities
of the reﬂections need to be extracted from the data images and
processed further. Here, all spots recorded on the diffraction images
are indexed according to the crystal’s space group, and their inten-
sities are subsequently integrated. The processed data (the “data
set”) then forms the basis for phase determination. A number of
streamlined program packages are available nowadays that can
overcome many difﬁculties in data interpretation and phasing with
limited user adjustment. In some cases, crystallographic software
packages are even capable of solving structures without human
intervention. However, since data processing and phasing have
a major impact on the resulting structural information, while
leaving room for dramatic misinterpretations at several stages,
it is  still essential to assess their outputs for biochemical plau-
sibility. Moreover, the automated approaches typically fail when
challenging macromolecules, such as large, poorly diffracting com-
plexes or complicated crystal packing arrangements are analyzed.
Therefore, the input of human intelligence and experience is  still
essential.
Evaluating crystal structures
A  typical scientist does perhaps not need to understand the
intricate details and challenges of molecular structure determina-
tion, but he or she must be able to critically evaluate a  structure
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that has been published. With very few exceptions, X-ray crys-
tallographic structures are deposited in the Protein Data Bank
(PDB) (www.pdb.org). The PDB employs a  set of quality controls
which ensure that the deposited structures conform to standard
geometrical parameters, such as bond distances, bond angles, or
protein backbone torsion angles. Bond distances and bond angles
are commonly reported using root mean square (rms)-deviations
that describe how far (in Å  or degrees, respectively – see below)
bonds or angles deviate from ideal values. A  trustworthy struc-
ture might have rms  deviations of <0.015 A˚  and <1.5◦ for its  bonds
and angles, respectively. Usually protein geometry is  also evalu-
ated in a Ramachandran diagram, which is  a  highly useful indicator
of the stereochemical quality of the backbone conformation of
a structural model (Ramachandran, 1963). In such diagrams, the
conformation of the backbone of a  protein is plotted with two
separate torsion angle values for each amino acid, and as very
few values are allowed for the backbone of protein residues, the
diagram can serve to highlight suspect amino acids. Ideally, a
trustworthy structural model should have favorable torsion angle
values for over 90% of its residues, and no residues in disallowed
regions.
Important parameters assessing how well a model ﬁts the
experimental data are the so-called reliability values (R-values:
Rwork and Rfree). Rwork numerically quantiﬁes the overall agreement
between  the observed diffraction amplitudes and “virtual” ampli-
tudes calculated using the structural model. A model that agrees
well with its diffraction data will give rise to calculated amplitudes
that are very similar to the observed ones, and this is  reﬂected in
a low Rwork value. Rwork is reported as a  percentage value, with a
good value ranging from 15% to 25%. The typically also reported
Rfree is a cross-validation R-value. Its careful monitoring helps to
prevent overparameterization of the model during model building
and reﬁnement. The Rfree value is  calculated in the same way as
the Rwork, but only from a small subset of the experimental data
that is separated from the working data set and  not used during
structural reﬁnement. The Rfree should closely track the value for
Rwork. A small difference between them (≤5%) is acceptable, while
a difference >10% might well indicate a  problem with the structure
determination or  the quality of the model. B-factors (or tempera-
ture factors) provide important information on the mobility of the
crystallized protein or  its components (such as ligands or solvent).
Here, a high value (e.g. 80 A˚2) might indicate a  problem, particularly
if ligand atoms have signiﬁcantly elevated B-factors compared to
surrounding amino acids. In such a  case, the ligand may  not be
bound well in the binding pocket, and might have high mobility
and/or low occupancy.
Last  but not least, the resolution to which reﬂections could be
measured on the diffraction images gives an impression on how dis-
tinct and reliable atomic details can  be deduced from the electron
density map, and thus how signiﬁcant conclusions on molecular
interactions are. Good resolutions in X-ray crystallography range
from 1.5 to 2.5 A˚ (1 A˚ = 0.1 nm), but higher resolutions of 1.0 A˚ and
beyond have also been achieved. Most structures deposited in the
PDB  have a resolution between 1.5 and 2.5 A˚ (www.pdb.org), but
there are also quite a  few structures at low resolution >3 A˚. While
these structures also can provide valuable information about over-
all fold and domain organization, the interpretation of details such
as  hydrogen bond distances or side chain conformations must be
done with caution.
Apart  from interpreting the statistics for a  published structural
model, a good strategy to evaluate its reliability is  to inspect the
electron density map, which can also be downloaded from the PDB
for many structures. This allows for an easy assessment of how well
a  structural model agrees with a  corresponding electron density
map. Structures that contain bound ligands, such as cofactors, ions,
or  substrates, can also be evaluated in this manner, and inspecting
electron  density maps can often provide clues about how well a
ligand is bound to a binding site, and how reliable the assigned
contacts are.
A  case study of the impact of X-ray crystallography: the cell
wall  remodeling enzyme class of
N-acetylmuramoyl-l-alanine amidases
Introduction
The impact of X-ray crystallography on our detailed understand-
ing of biological systems can of course be illustrated with many
different examples. We have chosen to examine the contribution
this method has made to the characterization of a class of bacte-
rial cell wall remodeling enzymes. We focus on structurally and
functionally similar domains of  a  range of N-acetylmuramoyl-l-
alanine  amidases. These enzymes cleave the amide bond between
the carbohydrate and peptide moieties of the bacterial peptid-
oglycan (PGN), a  major component of the bacterial cell  wall.
Composed of the alternating carbohydrates N-acetylmuramic acid
and N-acetyl glucosamine as well as a  peptide stem, the PGN
forms the backbone of all bacterial cell walls. While it serves
as a  barrier that protects bacteria, the cell wall is  necessarily
also a  very dynamic polymer that undergoes constant change, or
remodeling. Synthesis, degradation, and recycling of components
by a  broad variety of enzymes are responsible for this plastic-
ity. Interestingly, N-acetylmuramoyl-l-alanine amidases exhibit
rather low amino acid conservation although they perform gen-
erally similar functions, and it  is  tempting to speculate that the
sequence diversity is  linked to differential recognition of  substrates
and different interaction mechanisms with additional domains.
Thirty-three amidase structures of  ﬁfteen different bacterial N-
acetylmuramoyl-l-alanine amidases are currently known, and the
majority of  these have been determined by X-ray crystallography
(www.pdb.org). Given this substantial data base of structures, a
structural comparison is warranted to better understand the func-
tion, targeting, and regulation of bacterial cell wall amidases and to
unravel generally conserved structural features, as well as distinct
properties.
Bacterial amidases
Bacterial cell walls are divided into two major classes: Gram-
positive and Gram-negative. Gram-positive cell walls consist of
one lipid bilayer and a thick PGN layer, as well as associated pro-
teins and teichoic acids. Gram-negative bacteria have an inner
and an outer lipid bilayer, associated proteins, lipopolysaccharides,
and a thin PGN-layer separating the two membranes. In  addi-
tion, the amino acid composition differs between the two types
of cell walls (reviewed by Schleifer and Kandler (1972)). The PGN
of Gram-positive bacteria generally contains l-lysine and a  pen-
taglycine bridge between two connected peptide stems, while
Gram-negative bacteria incorporate meso-diaminopimelic acid
(meso-DAP) instead of lysine and link the peptide stems directly
with each other. Furthermore, different species modify their PGN
in manifold ways. A prominent representative of Gram-positive
bacteria, S.  aureus, has a PGN of subtype A3, meaning its  PGN com-
prises l-Ala-d-iGlu-l-Lys-d-Ala-d-Ala and a  pentaglycine linker (de
Jonge  et al., 1992; Schleifer and Kandler, 1972). Moreover, S. aureus
does not form anhydro-MurNAc (Boneca et al., 2000), but amidates
isoglutamate to form isoglutamine. Further variations such as dif-
ferent linker lengths or substitution of glycines with alanine or
serine residues may  also occur (de  Jonge et al., 1992; Schleifer and
Kandler, 1972). On the other hand, the PGN of bacteria such as B.
subtilis and E. coli belong to the A1 type, indicating a  direct linkage
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and use of meso-DAP (Schleifer and Kandler, 1972). Modiﬁcations
in these PGN include anhydro-MurNAc at the carbohydrate termi-
nus, the occasional absence of unlinked, terminal d-Ala residues,
and different amidation patterns of meso-DAP carboxyl groups,
whereas the backbone isoglutamate is not amidated (Atrih et al.,
1999; Schleifer and Kandler, 1972; Warth and Strominger, 1971).
It  is not surprising that the variability of PGN in different species
is reﬂected by differences in the speciﬁcity of amidases that process
these networks. In addition to cleaving PGN at deﬁned locations,
amidases have a large number of additional requirements. They
are needed for mother-daughter cell separation during cytokinesis
(AmiA (Heilmann et al., 1997)), they play a  crucial role in recycling
of PGN components (AmpD (Carrasco-Lopez et al., 2011), Rv3717
(Prigozhin et al., 2013)), and they are even required for intercellu-
lar communication and nutrient exchange in ﬁlamentous bacteria
(AmiC2, Lehner et al., 2011). Amidases furthermore play a role in
bacterial defense, as some types are secreted to digest the cell walls
of  adversaries (T6SS, (Chou et al., 2012)) and bacteriophages utilize
these enzymes to infect their hosts more efﬁciently. The eukaryotic
peptidoglycan recognition proteins (PGRPs) are structurally closely
related to bacterial amidases. They share the discussed Amidase 2
fold  (see below) and recognize similar structural motifs. While all
PGRPs trigger an immune response against bacteria upon infection,
some are even able to cleave PGN (Wang et al., 2003).
Structural biology techniques have contributed signiﬁcantly to
a  better understanding of the function, targeting, and regulation
of bacterial amidases. The analysis of crystal structures, partic-
ularly of complexes with ligands or ligand components, allows
the identiﬁcation of key residues of the enzymes, providing a
direct link to function in catalysis or ligand binding. Insights into
the binding mode and the catalytic mechanism obviously facil-
itate the development of substrate-based ligand mimetics that
can serve as inhibitors. Although the current research focus still
lies mostly on acquisition of basic knowledge on bacterial mech-
anisms, therapeutic interests are a  major long-term objective in
the structure/function analyses of amidases. Enzymes of potentially
pathogenic organisms such as S.  aureus, S.  epidermidis, P. aeruginosa,
E. coli, Mycobacterium tuberculosis, and Neisseria meningitides have
been investigated, with one of the goals being the development of
new  antibiotics.
Phylogeny and composition of  amidases
Amidases are divided into families, and the Pfam database
(Bateman et al., 2002) lists Amidase 2 and Amidase 3  as the two
major families. Both are Zn2+-dependent hydrolases in which the
catalytic domains adopt a  globular, mixed -fold. Three other
amidase families, Amidase 5,  Amidase 6,  and Amidase 02C, are
listed, however, knowledge on them is very limited and  no struc-
tures of members of these families have been solved to date. We
will therefore review structural features of the Amidase 2 and  Ami-
dase 3 families.
Most  amidase domains are embedded in larger protein chains
that contain additional domains, often called repeat or AMIN
domains. These domains typically play a role in targeting and
anchoring the amidase to the desired environment (Zoll et al.,
2012). The repeats may  also act as regulatory domains, which can
be  connected by a  variable and often ﬂexible linker to the catalyt-
ically active amidase. Repeat domains can lie N-terminally (Zoll
et  al., 2012), as well as C-terminally (Rocaboy et al., 2013) of the
catalytic domains, and they are present in different numbers in dif-
ferent amidases. Due to space limitations, we will focus here on a
comparison of catalytic amidase domains (Fig. 2).
A  growing number of amidase structures are available in the
PDB, the majority of which were published within the last ﬁve
years (Fig. 2A). However, these structures are still from relatively
few  organisms, and so far a  comprehensive view of amidase struc-
tures is lacking. The sequence homology is  generally low among the
currently solved structures, and conservation is  limited to a small
number of residues (Fig. 2B and C). Surprisingly, however, the ami-
dases nevertheless share similar folds, demonstrating that even a
low level of amino acid conservation can still lead to the same fold.
Sequence analysis of  all  fourteen enzymes solved by X-ray crys-
tallography reveals a  phylogenic tree with three major branches
(Fig. 2A, Rv3717 being listed twice). The upper two  belong to the
Amidase 2 family, whereas the lower branch represents structures
of the Amidase 3  family. Interestingly, the two  branches within the
Amidase 2 family correlate with the Gram-characteristics of the
source organisms. The three branches will subsequently be referred
to as AmiA-type, AmiD-type, and AmiC-type (see Fig. 2A). More-
over, the two  protein families both have a  globular, mixed -fold,
but present distinct differences that render structural comparison
amongst families less meaningful. The assessment of all currently
published bacterial amidase structures is therefore divided into two
chapters that discuss the Amidase 2  and Amidase 3  family mem-
bers separately.
The  Amidase 2 family
Nine  Amidase 2  enzymes have been crystallized, with 23 total
structures in native, mutant, or  liganded states. The secondary
structure features are depicted in Fig. 2B, and they are almost com-
pletely conserved among the Amidase 2 enzymes. Superposition of
all  structures (Fig. 3A) shows that a  six-stranded, mostly parallel,
-sheet forms the central structural element. The back of this sheet
faces two of  the -helices (4, 7), stabilizing the overall fold, while
its front is  largely solvent accessible and forms the bottom of the
substrate binding groove. This narrow groove is built by the ﬂanking
helix 2 on the right side and two  additional -helices (5, 6) on
the left hand side (Fig. 2B  and 3A). The shape and size of the groove
varies substantially among the family members, in accord with the
somewhat different PGN structures found in bacteria, which results
in different ligand structures bound by the enzymes. The groove is
also  bordered by  a  loop and  harbors the three zinc-binding as well
as catalytically and structurally stabilizing residues. The  catalytic
zinc ion is typically coordinated by histidines 265 and 370 (num-
bering and described interactions according to AmiA (Büttner et al.,
2014) for whole Amidase 2  section) and aspartic acid 384 (Fig. 2B).
In  two  enzymes, PlyL and XlyA, which are annotated as “bacterial”
enzymes but have a  bacteriophage background, this aspartate is
replaced with a  cysteine.
Although  the Amidase 2  sequences are highly divergent apart
from the zinc-ligating residues, some additional amino acids are
highly conserved in all  structures, and these conservations provide
clues about residues required for function. Threonine 267 is  likely
a part of the carbohydrate binding site and forms contacts with
MurNAc, while tryptophan 310 interacts with l-lysine or  meso-DAP
of PGN. Asparagine 317 stabilizes the tertiary structure of the area
and  also interacts with the backbone carbonyl oxygen atoms of
d-Ala and l-Lys/meso-DAP of PGN. Glutamate 324 is the catalytic
residue that acts as proton acceptor during catalysis, enabling a
water molecule to attack the scissile amide bond of  PGN. Histidine
382 or  a  lysine stabilize the tetrahedral intermediate state during
catalysis, while proline 385 enables the correct positioning of the
preceding, zinc binding aspartate 384 (or  cysteine in PlyL and XlyA)
with unusual angles. The remaining well conserved and largely
hydrophobic residues play a  structural role as they ﬁx secondary
structures and stabilize the amidase fold.
AmiD, AmpDh2, and AmpDh3 have an additional -loop that
is inserted between strand 5 and helix 4. Martinez-Caballero
and colleagues propose that this loop plays an important role in
carbohydrate binding, and they could indeed show for AmpDh2
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Fig. 2. Multivalent analysis of N-acetylmuramoyl-l-alanine  amidases. (A) N-acetylmuramoyl-l-alanine  amidases structures solved to  date, with a phylogram obtained from
the  ClustalW2 webserver (Larkin et al., 2007) using the sequences deposited with the  PDB ﬁles. The respective organism, Gram-stain, enzyme state, PDB-code, resolution,
and original publication are listed in each case. The upper part of the panel presents the  Amidase 2 family (in blue), subdivided into AmiA and AmiD type, the lower part
shows the Amidase 3  family (in green). (B) Multisequence alignment of Amidase 2 sequences listed in panel A. Secondary structure features are represented with yellow
arrows for -strands, red ribbons for -helices, and gray lines for loops. Identical residues are indicated with a blue background, with the color increasing in intensity for
higher conservation; zinc-coordinating residues are highlighted with purple boxes; green lines mark omission of unconserved residues. (C) Multisequence alignment of the
Amidase 3 sequences listed in panel A, using the same color code  as in  panel B.
that the loop shifts upon binding of a tetrasaccharide (Martinez-
Caballero et al., 2013). The additional C-terminal domain (Fig. 3A),
which contains four -helices, may  participate in PGN-binding or
enhance substrate speciﬁcity and  binding of larger PGN-fragments
(Kerff  et  al., 2010). The N-terminal extension plays a  role in the
dimerization of these enzymes. AmiD and AmpDh2 are thought to
be  dimers, while AmpDh3 is a  tetramer (Lee et al.,  2013; Martinez-
Caballero et al., 2013). In addition, the N-terminus of one copy
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Fig. 3. Structures of N-acetylmuramoyl-l-alanine  amidases. (A) Collage of nine known native Amidase 2 enzyme structures placed next to an overlay of all Amidase 2
structures. Secondary structure features are represented with yellow arrows for -strands, red ribbons for -helices and gray (overlay) or green (single structures) lines for
loops. Names and pdb codes are listed next to each structure. (B) Collage of the ﬁve known native Amidase 3 enzyme structures next to  an overlay of all Amidase 3 structures,
with the color code introduced in panel (A). (C) Structure of the AmiA amidase domain, a member of the Amidase 2 family, bound to its ligand muramyltetrapeptide (MtetP).
Coloring and orientation of AmiA are as in (A), MtetP is  shown in green (carbons), red (oxygens) and blue (nitrogens). Hydrogen bonds are depicted as black dashes.
completes the peptide stem binding site of the other. Models with
larger PGN-fragments hint at  an explanation for how the AmiD-
type amidases can bind and cleave polymeric PGN. AmpD is  the
only cytosolic enzyme of  the AmiD-type, and it becomes involved
in PGN-recycling once PGN subunits have been cleaved by a lytic
transglycosylase and transported into the cell by AmpG. It there-
fore has a preference for PGN-monomers with anhydro-MurNAc
and lacks the additional features discussed for AmiD, AmpDh2, and
AmpDh3 (Carrasco-Lopez et  al., 2011). Especially interesting is the
comparison of the X-ray structure of AmpD in an active “open”
state with its NMR-structure in an inactive “closed” state. Major
rearrangements, as much as 17 A˚ shifts of loops at  the N-terminus
and  after strands and helices 2, 5,  and 5 along with break-
ing several salt bridges converts the enzyme between states. In
order to elucidate the consequences of these rearrangements, the
authors performed molecular dynamics calculations, and these hint
at  an allosteric triggering of the rearrangement (Carrasco-Lopez
et al., 2011). As no such rearrangements have been reported for
other Amidase 2  members, the described activation mechanism
may only be required for a cytosolic amidase.
AmiE and LytA have been extensively studied, with focus on
the substrate speciﬁcity and the role of anchoring cell wall binding
domains, including small angle X-ray scattering (SAXS) to deter-
mine the structures of these multi-domain enzymes in solution
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(Mellroth et al., 2014; Zoll et  al., 2010, 2012). Although AmiE is
excreted into the periplasm and LytA resides in the cytosol, sim-
ilar patterns of substrate recognition were observed. However, in
contrast to AmiE, LytA forms dimers, and the dimer is signiﬁcantly
more active compared to the monomer (Mellroth et al., 2014).
Investigation of the closely related AmiA from S. aureus led to the
identiﬁcation of a dense interaction network between enzyme and
substrate, and subsequently the speciﬁcity as well as a plausible
reaction mechanism (Büttner et al., 2014). Since the participating
residues are highly conserved, this mechanism likely is  used by all
Amidase 2 enzymes (Büttner et al., 2014; Paget et al., 1999).
The  phage-derived enzymes XlyA and PlyA were instigated with
a  special focus on lytic activity. XlyA and a  mutant with altered sur-
face charge were tested, and a  positive charge increased activity. In
addition to that, the cell  wall binding domain seems not to sig-
niﬁcantly interact with the catalytic domain (Low et al., 2011). In
contrast, PlyA is likely to be regulated by the C-terminal regula-
tor and cell wall binding domain, which also may  play a  role for
speciﬁcity of the target (Low et al., 2005).
The Amidase 3 family
The  Amidase 3 family is  less well characterized, and only ﬁve
different enzymes with a  total of eight structures are deposited in
the  PDB (Fig. 2A). This smaller data base compared to the Ami-
dase 2 family may  be the reason for a  seemingly better sequence
conservation and less additional features to the common fold of the
AmiC-type amidases (Fig. 2C). The overall fold is  again determined
by a central six-stranded and mostly parallel -sheet (Fig. 3B). The
rear site interacts with the three stretched -helices one, three,
and ﬁve, forming the hydrophobic core. The front of the -sheet is
again solvent accessible and forms the bottom of the binding cleft,
however, in contrast to the Amidase 2  family the binding groove is
bordered by loops, not helices. Furthermore, the putative active site
with the coordinated zinc ion and binding region for peptide stem
as well as carbohydrate backbone is  much wider than for Amidase 2
enzymes, such as AmiA or  AmiD.
The zinc-binding residues histidine 196, glutamate 211, and his-
tidine 265 (numbering according to AmiC (Rocaboy et al., 2013))
are located next to conserved proline, glycine and serine residues,
and these latter residues probably are required for correct position-
ing and orientation of the zinc ion (Fig. 2C). The carbonyl oxygen
of alanine 266 likely stabilizes an intermediate state during catal-
ysis, analogous to aspartate 266 of AmiA (Büttner et al., 2014).
Asparagine or aspartate 267 are well positioned to engage contacts
with MurNAc, again analogous to threonine 267 of AmiA. Gluta-
mate 373 is the catalytically active residue, whose carboxyl group is
within  5 A˚ of the zinc ion and well positioned to act as co-activator
of the water molecule conducting the nucleophilic attack on the
scissile amide bond. Threonine 388 forms hydrogen bonds with
pre- and succeeding backbone amide and carbonyl atoms, enabling
an unusual kink of helix 5 toward the rear of the central -sheet
that occurs in the absence of known helix breakers. The  threonine
is not strictly conserved, but other hydrophilic residues such as ser-
ine,  asparagine, or  aspartate can act similarly. Again, the remaining
well conserved and largely hydrophobic residues play a structural
role as they anchor secondary structures and stabilize the fold.
Rv3717  of Mycobacterium tuberculosis possesses no cell wall
binding domain but an insertion of twenty amino acids that forms a
short  310-helix and a disulﬁde-bonded -hairpin (Fig. 3B) (Kumar
et al., 2013; Prigozhin et al., 2013). This insertion is  close to the
active site and may  play a  role in autoregulation, as Rv3717 has no
potential regulating cell-wall binding domain (Kumar et al., 2013).
The disulﬁde bond is  not needed for activity, however, zinc and
glutamate 200 (glutamate 373 in AmiC) are required for cleav-
age. Limited proteolysis of peptidoglycan and complex structure
analysis  suggest that the insertion may  regulate speciﬁcity and
that Rv3717 is  involved in PGN-fragment recycling (Prigozhin et al.,
2013). CwlV from Paenibacillus polymyxa (Ishikawa et al., 1999) and
the  putative amidase from Neisseria meningitides (Tettelin et al.,
2000) are not yet well investigated, but the published structures
show the Amidase 3  core fold without additional features, suggest-
ing unrestricted amidase activity. AmiC of E. coli (Rocaboy et al.,
2013) and the orthologous AmiB from Bartonella henselae (Yang
et al., 2012) have an  insertion of over forty amino acids after -
sheet 4.  A proposed self-regulatory -helix lies within the binding
groove as catalytic-domain-internal repressor (Fig. 3B), contacting
the catalytic zinc ion by a glutamate or  glutamine and blocking the
active site via predominantly hydrophobic interactions. A ﬂexible
loop, not visible in the crystal structures, connects the insert to helix
3,  which is signiﬁcantly longer in AmiB and AmiC. LytM activators
associated with septal ring factors allow a  conformational shift of
the  inhibiting -helix out of the binding site and therefore trigger
amidase activity (Rocaboy et al., 2013; Yang et al., 2012).
Structures of complexes – a challenging task to obtain liganded
enzyme  structures
Obtaining an enzyme-substrate complex is usually a  challenging
task, and even more so for amidases. As PGN is a  variable and  heavily
modiﬁable biopolymer and the afﬁnity of amidases for peptidogly-
can is  comparatively low due to its  catalytic environment with high
local  substrate concentration, the particular substrates usually are
not commercially available and need to be produced by customized
synthesis in sufﬁcient quantities. To avoid merely fragment-bound
structures, leading to incomplete data on enzyme-substrate inter-
actions, it is  further necessary to inactivate the amidase by removal
of zinc or mutation, or synthesis of a non-cleavable substrate ana-
log.
As an example, Fig. 3C shows the enzyme-substrate complex
of AmiA (4KNL, (Büttner et al., 2014)). A dense network of direct
and water-mediated interactions orients the peptide stem of PGN
within the narrow, elongated AmiA binding groove. As described
above, conserved residues coordinate the zinc ion and key areas
of the ligand. Comparison with the complex structures of AmiD
(3D2Y and 3D2Z, substrates (Kerff et al., 2010)), AmpD (2Y2B,
reaction product (Carrasco-Lopez et al., 2011)), AmpDh2 (4BOL,
4BPA, pentapeptide and tetrasaccharide (Martinez-Caballero et  al.,
2013)), and AmpDh3 (4BXD, 4BXE, pentapeptide and pentapeptide-
tetrasaccharide (Lee et al., 2013)) reveal that minor substitutions
are able to modulate substrate speciﬁcity. Histidine 370 and threon-
ine  380 for example stabilize the PGN-isoglutamine, and histidine
382 the tetrahedral reaction intermediate in AmiA, whereas a  lysine
and arginines stabilize the PGN-isoglutamate and the tetrahedral
intermediate in AmpD. The positive charge of arginine is better
suited to stabilize the negative charge of glutamate, thus adapt-
ing speciﬁcity. The  incorporation of arginines at  the end of the
binding groove enables binding of a  substrate that contains free car-
boxylate(s) at terminal d-Ala and/or meso-DAP, as seen for AmpD,
AmpDh2 and AmpDh3. This effect is  not seen in AmiD due to crys-
tal contacts preventing the stabilization. The deletion of few amino
acids in AmiD after the ﬁrst zinc-binding histidine shortens a  loop
and reduces the size of  the carbohydrate binding pocket, leading to
a  preference for anhydro-MurNAc.
The  complex structures of AmpDh2 and AmpDh3 with pen-
tapeptide and tetrasaccharide ligands in combination with a
cross-linked PGN, based on a solution NMR-structure of a larger
PGN fragment, provide the basis for a plausible model of how these
enzymes engage PGN. The only complex structure of an Amidase 3
is  of Rv3717 (4M6G, reaction product (Prigozhin et al., 2013)). The
position of the bound reaction products in a pocket, created by the
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additional -hairpin motif, supports the assumption of a  recycling
function of Rv3717.
Conclusions and outlook
As  we have shown here, structural analyses of a  signiﬁcant num-
ber of amidases have been performed. Some of these enzymes
have little sequence homology and were not expected to share
the same fold prior to the determination of the structures. In this
context, X-ray crystallography has helped to uncover close struc-
tural relationships among these enzymes. The amidase fold is  even
conserved in human proteins such as the PGRPs that serve a  very
different function. It is  clear that, taken together, the different struc-
tural analyses are able to provide general insights into the function
of these enzymes that each structure, standing alone, does not.
Moreover, in most cases there are also interesting differences in
amidase structures, and these offer clues about the binding modes
of the substrates, which also differ among species. Finally, some
amidases have been modiﬁed with loops or extra domains to gain
speciﬁc additional functions in cell wall anchoring and regulation. It
is  important to keep in mind that the amidases discussed here are
embedded into larger protein chains, and we still lack an under-
standing of how the amidases interact with neighboring domains.
Deciphering the interplay among these domains, and what this
means for regulation and targeting, remains one of the major chal-
lenges for this ﬁeld of research. Even so, the knowledge available
today on the ligand binding properties and reaction mechanisms of
so  many bacterial amidases is  poised to lead for the development of
a  new class of antibacterial drugs as it is  clear that amidases, such
as the AmiA from S. aureus, are required for proper cell division of
bacteria.
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ABSTRACT: We target the gatekeeper MET146 of c-Jun N-
terminal kinase 3 (JNK3) to exemplify the applicability of X···S
halogen bonds in molecular design using computational,
synthetic, structural and biophysical techniques. In a designed
series of aminopyrimidine-based inhibitors, we unexpectedly
encounter a plateau of aﬃnity. Compared to their QM-
calculated interaction energies, particularly bromine and iodine
fail to reach the full potential according to the size of their σ-
hole. Instead, mutation of the gatekeeper residue into leucine,
alanine, or threonine reveals that the heavier halides can
signiﬁcantly inﬂuence selectivity in the human kinome. Thus, we demonstrate that, although the choice of halogen may not
always increase aﬃnity, it can still be relevant for inducing selectivity. Determining the crystal structure of the iodine derivative in
complex with JNK3 (4X21) reveals an unusual bivalent halogen/chalcogen bond donated by the ligand and the back-pocket
residue MET115. Incipient repulsion from the too short halogen bond increases the ﬂexibility of Cε of MET146, whereas the rest
of the residue fails to adapt being ﬁxed by the chalcogen bond. This eﬀect can be useful to induce selectivity, as the necessary
combination of methionine residues only occurs in 9.3% of human kinases, while methionine is the predominant gatekeeper
(39%).
■ INTRODUCTION
In the past decade halogen bonding has increasingly gained
attention in life sciences and drug discovery.1−8 This attractive
interaction can typically be described as a R−X···D−R′ contact,
where X represents chlorine, bromine, and iodine (as electron
pair acceptor) and D can be any kind of Lewis base.9 For a
broader recognition of halogen bonding in molecular design,
we have recently studied halogen bonding contacts with
diﬀerent interaction partners in protein binding sites.4−7 From
these studies it is evident that halogen bonds can provide
innovative ideas, how to access interesting parts of the
biological space (e.g., therapeutic targets) from hitherto widely
neglected parts of the chemical space (chemotypes featuring
halogen bonds as essential key recognition motifs in the
binding mode).
On the basis of the lack of directional interactions toward
methionine (MET) in classical interactions, this amino acid has
been particularly diﬃcult to target, except for using hydro-
phobic contacts. Only recently, Meanwell and colleagues have
highlighted the role of noncovalent sulfur interactions in drug
design.10 Recently, we have studied the targetability of MET by
halogen bonding systematically on a quantum chemical level of
theory.4 One of our goals was to provide new insights for
utilizing halogen···sulfur contacts in molecular design. Here, we
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target the gatekeeper MET146 of c-Jun N-terminal kinase 3
(JNK3) to exemplify the applicability of X···S halogen bonding
in molecular design using computational, structural and
biophysical techniques. Figure 1a shows the percentage
distribution of gatekeeper residues in all human kinases. The
term “gatekeeper” is commonly used to describe the residue in
a kinase that blocks the hydrophobic pocket and, therefore, is a
key feature of the recognition elements in the ATP-binding site
of the kinase.11 From Figure 1a, it is obvious that methionine
(with ∼39%) is by far the most common gatekeeper in human
kinases. It is followed by threonine (with ∼19%), leucine
(∼17%), and phenylalanine (∼16%). All other amino acids
together are only found in a small fraction (∼10%) as
gatekeeper residues. JNK3 is a member of the mitogen-
activated protein kinases (MAPK) family and a popular target
for drug discovery.12,13 Because of the lack of speciﬁc ways to
target the gatekeeper methionine residue (MET146) of JNK3,
traditional drug discovery approaches have focused on utilizing
the side chain ﬂexibility of this residue to shift it into a position
granting access to the hydrophobic pocket.14 However, an
exhaustive PDB survey revealed that MET146 can be targeted
by halogen bonding (Figure 1b,c). Actually, Alam et al. had
reported a crystal structure of the complex between 4-{[5-
chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperi-
dine-1-carboxamide (7b) and JNK3 (PDB-ID: 2P33, further
referred to as 2P33), in which a chlorine is interacting with
MET146.15
In this study, we generated the halogen/hydrogen analogues
to complete the series of matched molecular pairs (Figure 1d).
We used quantum chemical methods to assess the diﬀerence in
Vmax, the maximal positive electrostatic potential representing
the size and strength of the σ-hole. We plotted the electrostatic
potential isosurfaces of the halogenated analogues (Figure 1e−
g) and optimized all four ligands in the binding pocket using
TPSS-D2/SV(P). We synthesized all four ligands, establishing a
new route to obtain the bromine and iodine derivatives. We
expressed and puriﬁed JNK3 to characterize the diﬀerences in
ligand aﬃnities using biophysical techniques such as diﬀerential
scanning ﬂuorimetry (DSF), ﬂuorescence polarization (FP),
and isothermal titration calorimetry (ITC). Since JNK3 and
p38α MAP kinase (p38α) are notoriously similar in structure,
we also assessed the ligand selectivity against p38α. To
elucidate the contribution of the halogen bond, we prepared
the gatekeeper mutants JNK3-M146A, JNK3-M146L, and
JNK3-M146T and investigated mutant-induced changes in
the binding aﬃnity compared to JNK3 wildtype (JNK3-wt) by
FP competition experiment. In order to rationalize our ﬁndings,
we have determined the crystal structure of JNK3-wt in
complex with the iodine derivative (7d).
■ RESULTS
1. Halogen Bond Tuning (Vmax) and Rationalization of
the Designed MMPs by Quantum Chemistry. The
chlorine···sulfur distance dX···S = 336 pm and the σ-hole angle
αC‑X···S = 160.4° suggest that the halogen bond to the
gatekeeper MET146 in 2P33 is favorable (Figure 1b). Derived
from previous4 and current theoretical work,17 we also
rationalized that the spherical geometry is beneﬁcial (Figure
1c). The spherical geometry can be represented by the spherical
coordinates (distance, azimuth, elevation) of iodine with
respect to the methionine sulfur as the center of the sphere.
Therefore, we generated in this study the matched molecular
pairs complementing the crystallized ligand (7b) with the
Figure 1. (a) Percentage distribution of gate keeper residues in human kinases based on kinase sequence alignments16 obtained from http://kinase.
com/human/kinome/phylogeny.html. (b) 4-{[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide interacting with
the gatekeeper MET146 of JNK3 (PDB: 2P33).15 The chlorine···sulfur distance (dX···S = 336 pm) and the σ-hole angle (αC‑X···S = 160.4°) are
depicted explicitly. (c) Data from a spherical interaction scan on the MP2/TZVPP level of theory using iodobenzene as a model ligand and
dimethylsulﬁde as a model for methionine4,17 were plotted onto MET146, indicating that the substitution of chlorine by iodine should be favorable
(color gradient from red: very favorable to purple: unfavorable). Spherical interaction scans were prepared previously4 by systematically rotating the
ligand system around the methionine sulfur as the center of the sphere, while maintaining the orientation of the model ligand, i.e., the same σ-hole
angle αC‑X···S. The exact spherical orientation of any ligand interacting through a halogen bond with methionine can be described by the spherical
coordinates of the iodine atom (distance dS···X, azimuth and elevation angle with respect to a certain plane of symmetry of dimethylsulﬁde) and the σ-
hole angle αC‑X···S. The ﬁgures in panel (b) and (c) were prepared using PyMOL.
18 (d) Structures of the designed matched molecular pair series
comprising the hydrogen (7a), chlorine (7b), bromine (7c), and iodine derivative (7d). (e−g) ESP isosurfaces (MP2/TZVPP) of compounds 7b−
d. Negative ESP isosurfaces contoured at an energy of −0.009 au are colored in dark blue, while positive ESP isosurfaces contoured at 0.009 au are
colored in red. Toward the heavier halides, the σ-hole (positive potential) on the halogen in elongation of the R−X bond (indicated by a black
arrow) increases. All pictures were prepared with MOLCAD.19,20
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analogues containing bromine (7c), iodine (7d) or hydrogen
(7a) in position ﬁve of the pyrimidine ring (Figure 1d).
The strength of a halogen bond is tuned by the scaﬀold.21−23
To elucidate this tuning eﬀect, we calculated the electrostatic
potential isosurfaces and the Vmax value (most positive
electrostatic potential on the σ-hole when mapping the ESP
onto the isodensity surface) for each halogenated compound
(MP2/SV(P), Figure 1e−g). 7b appears to be hardly tuned,
showing a Vmax value of 0.123 au (chlorobenzene: 0.117 au,
ΔVmax = 0.006 au). 7c and 7d, however, possess increasingly
tuned σ-holes, as expected. 7c has a Vmax value of 0.168 au
(bromobenzene: 0.150 au, ΔVmax = 0.018 au) and 7d has a
value of 0.219 au (iodobenzene: 0.182 au, ΔVmax = 0.037 au).
With the Vmax value being almost twice as large for iodine as for
chlorine, a signiﬁcantly stronger halogen bond should result
from the proposed halogen exchange.
We further investigated, whether these tuning diﬀerences
translate into changes of the binding mode. Using calculations
on a TPSS-D2/SV(P) level of theory and a carefully selected
binding site model to rationalize the designed MMPs. A
detailed report about the protocol and results is provided in the
Supporting Information. Essentially, the hydrogen bond
network to the hinge binding region appeared to be intact in
all compounds. The halogen bond geometry of chlorine is
preserved perfectly. Despite their size, the iodine and bromine
atoms in 7c and 7d are located 10 and 14 pm closer to the
sulfur atom of MET146, respectively. This can reﬂect that the
stronger σ-hole tuning permits a closer contact to the sulfur,
but could also indicate an onset of an increasingly repulsive
contact.
2. Synthesis. Compounds 7a and 7b were synthesized
according to a route (Scheme S1) published by Alam et al.15
with some modiﬁcations. Further details can be found in the
Supporting Information. On the basis of a modiﬁed Bredereck
synthesis,24 we utilized a linear route including a pyrimidine
cyclization for the synthesis of compounds 7c and 7d as
depicted in Figure 2.
To prevent N-methylation during step ii, we ﬁrst protected
the nitrogen of commercially available 3-acetylindole as a
benzenesulfonamide using already described conditions.25
Further treatment of 10 with dimethylformamid-dimethylace-
tale under neat and reﬂuxing conditions aﬀorded 11 in high
yields. The following cyclization conditions utilizing guanidine
carbonate and sodium methoxide in reﬂuxing MeOH resulted
in both, the formation of the 2-aminopyrimidyl product 12
including the cleavage of the benzenesulfonamide group in the
same step in acceptable yields. According to Rossignol et al.26
2-amino-4-indolylpyrimidines can be regioselectively halogen-
ated using N-halosuccinimides in polar solvents. It is note-
worthy that we isolated 5c and 5d in moderate yields without
the occurrence of regioisomeric halogenated side products
under the depicted conditions in contrast to our attempts in
halogenating 3a or 4a (Scheme S1, Supporting Information),
suggesting a crucial role of the primary 2-amino group in
selective electrophilic halogenation. The 2-aminopyrimidines
13c and 13d can be smoothly converted into the secondary
amines 14c and 14d via reductive amination in DCM using
TFA as acid and sodium triacetoxy borohydrid as reducing
agent at room temperature without cleavage of the Boc
protective group or reductive dehalogenation.27 Again, we used
20% TFA in DCM to quantitatively remove the Boc group
from the 4-aminopiperidino side chain and successfully
introduced the urea structure via electrophilic addition to
ethyl isocyanate under basic conditions in DCM at room
temperature to yield 7c and 7d in moderate overall yields.
3. Biophysical Characterization. 3.1. Fluorescence Po-
larization (FP) Assay. We used a ﬂuorescence polarization
assay as the primary biophysical method to determine KI values
for 7a−d. When suitable ﬂuorescent reporter molecules are
available, the FP assay is an elegant, rapid, and dependable
Figure 2. Synthesis of compounds 7c and 7d. Reagents and conditions: (i) MeOH, KOH, acetone, benzenesulfonyl chloride, rt, 92%; (ii)
dimethylformamide-dimethylacetale, reﬂux, 24 h, 89%; (iii) MeOH, guanidine carbonate, sodium methoxide, reﬂux, 48 h, 61%; (iv) DMF, N-
halosuccinimide, rt, overnight, 59−65%; (v) DCM, N-Boc-piperidin-4-on, sodium triacetoxy borohydride, TFA, rt, 70−80%; (vi) DCM, TFA, rt, 2 h;
(vii) DCM, triethylamine, ethyl isocyanate, overnight, 40−59% (yield for step (vi) + (vii)).
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method to assess a broad range of aﬃnities (over several orders
of magnitude).28,29 On the basis of a previously reported
ﬂuorescein-labeled analogue of SB20358030 (RN4646) as a
high-aﬃnity ﬂuorescent probe for p38α (KD of 7.3 nM) and a
novel ﬂuorescein-labeled, pyridinylimidazole-based high-aﬃnity
probe for JNK3 (PIT0105016, KD of 4.0 nM),
31 we were able
to determine both, aﬃnities and selectivities, with good
precision. Figure 3 shows the curve ﬁts of three individual
competition binding experiments per compound for 7a−d.
Every individual curve is based on 11 concentrations, each
Figure 3. Fluorescence polarization-based competition binding experiments using compounds 7a−7d and JNK3-wt, the JNK3 mutants M146A,
M146L, and M146T, or p38α. The polarization signal (in mP units) was read using a BMG CLARIOstar reader. The values were normalized to a
range from 100% to 0% polarization. Eleven concentrations of the respective inhibitor were measured in quadruplicate and each competition binding
experiment was repeated three times, except for 7b with p38α, where limited compound availability allowed only one experiment. Because of the
onset of ligand precipitation, concentrations >100 μM were neglected and removed from the plot. The four parameter logistic nonlinear regression
model was used for all curve ﬁts. For JNK3-M146A and JNK3-M146T the asymptote for full displacement was ﬁxed to 0% normalized polarization.
Plots were prepared using KaleidaGraph.33
Table 1. Results of the Normalized FP-Assay for JNK3 and p38α
JNK3
wt M146A M146L M146T p38α JNK3-wt preference













PIT0105016a 4.0 ± 0.2 2.3 ± 0.2 31 ± 3.5 3.0 ± 0.2 n.d. 0.58 7.8 0.75 −
RN4646b n.d. n.d. n.d. n.d. 7.3 ± 1.3 − − − −
7ac 270 ± 7.9 56000 ± 6000e 270 ± 15 14000 ± 470e 27000 ± 1100 210 1.0 52 100
7bc 68 ± 9.1 4800 ± 230e 31 ± 4.6 12000 ± 1400e 14000d 71 0.46 180 210
7cc 58 ± 2.3 3300 ± 100e 61 ± 5.5 12000 ± 280e 4800 ± 220 57 1.1 210 83
7dc 72 ± 2.5 4500 ± 96e 160 ± 5.6 28000 ± 4400e 21000 ± 1300 63 2.2 390 290
aPIT0105016 is a novel ﬂuorescein-labeled, pyridinylimidazole-based high-aﬃnity probe for JNK3.31 bRN4646 is a ﬂuorescein-labeled analogue of
SB203580.30 KD values of both reporter ligands were determined by three independent direct titrations with 12 concentrations of protein measured
in quadruplicate. cThe KD values have been determined by three individual competition binding assays with 11 compound concentrations measured
in quadruplicate. KD values were derived using the KI calculator of Shaomeng Wang and co-workers (http://sw16.im.med.umich.edu/software/calc_
ki/).32 dBecause of the limited availability of 7b, p38α aﬃnity was only determined as a single measurement of 11 concentrations of 7b in
quadruplicate. eBecause of low aﬃnities and limited compound solubility of 7a−d, no complete displacement of the reporter ligand could be
observed. The normalization was, therefore, done by using the average FP values of the reporter ligand in buﬀer as the expected minimum of the
curve. From the other experiments we can deduce that the given KD values are the lower limit of the possible values obtainable from curve ﬁtting.
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measured in quadruplicate. Mean values and standard
deviations for the KD values were obtained by three individual
direct titrations of the reporter compounds (PIT0105016 and
RN4646) and the KI values of 7a−d were obtained by three
individual competition experiments (Table 1).
For JNK3 (wt = wildtype), well-deﬁned, reproducible
sigmoidal curves were obtained, showing only small standard
deviations for each concentration measured in quadruplicate. 7c
exhibits the highest aﬃnity with a KI of 58 nM, followed by 7b
with 68 nM, and 7d with 72 nM. For the unsubstituted ligand
7a, a KI value of only 270 nM is obtained. According to
ANOVA applying the Bonferroni post hoc test, the diﬀerence
between 7a and all other ligands is highly signiﬁcant (p <
0.0001); however, the results for 7b−d are not signiﬁcantly
diﬀerent. Consistent with our QM-based analysis of the
proposed interactions and previous DSF experiments (see
Supporting Information: Figure S3 and Table S3), there is little
diﬀerence between 7c and 7d. In addition, all halogenated
ligands exhibit better binding to JNK3 than 7a. However, it is
surprising that 7b seems to have the same aﬃnity for JNK3 as
7c,d.
We tested 7a−d on p38α, as well, to evaluate similarities and
diﬀerences in JNK3 selectivity. JNK3 and p38α are both MAPK
kinases, showing a sequence identity of 51% and substantial
three-dimensional similarity, particularly in the binding site.14
Still, some crucial residues in the binding site are well-known
for inducing selectivity. For example, the gatekeeper in JNK3 is
a methionine (MET146), whereas in the p38α the gatekeeper is
a threonine (THR106). Another important diﬀerence between
these two proteins is located in the hinge region, where ASP150
in JNK3 corresponds to GLY110 in p38α, which facilitates a
ﬂipped conformation in the hinge that can be used to obtain
highly selective ligands for p38α.34 According to DSF
experiments with p38α, we expected to ﬁnd only weak binding
(see Supporting Information). The results are given in Figure 3
and summarized in Table 1. On the basis of the decrease of
aﬃnity for p38α, we had to increase the ligand concentration
up to 200 μM. We encountered that limited solubility of all
compounds under the given buﬀer conditions at concentration
higher than 100 μM leads to an onset of precipitation.
Consequently, these concentrations were removed from the
normalized plots. To still provide a reasonable curve ﬁtting to
the remaining data, we normalized the ﬂuorescence polarization
using the polarization of the labeled compound alone in buﬀer
(∼70 to 50 mP) as the lowest possible value. 7a is the weakest
binder (27 μM), followed by 7d (21 μM) and 7b (14 μM).
Interestingly, 7c shows the highest aﬃnity for p38α with a KI
value of 4.8 μM. According to ANOVA applying the Bonferroni
post hoc test, all measured KI values are diﬀerent with high
statistical signiﬁcance (p < 0.005). In the case of 7b only one
independent experiment could be conducted based on
substance limitations. Thus, assessment of statistical signiﬁ-
cance is invalid in this case.
To evaluate the contribution of the σ-hole interaction of the
halogens with the gatekeeper residue M146 to the observed
structure-aﬃnity relationships, we exchanged methionine into
alanine, leucine, and threonine by side-directed mutagenesis.
Expression and puriﬁcation of all mutants was done as for
JNK3-wt. Conﬁrmation of the correct mutation was obtained
by plasmid sequencing (GATC) and determination of the
molecular mass of the mutant protein by ESI-MS. JNK3-
M146A was used as control for the loss of the direct interaction
(σ-hole bond or other) with methionine. The aﬃnity of the
halogenated ligands 7b−d is reduced by a factor of 57-fold to
71-fold (Table 1), while the unsubstituted ligand 7a even
suﬀers a 210-fold loss in aﬃnity. Because of the limited
solubility of all compounds and the increased aﬃnity of the
ﬂuorescence reporter PIT0105016 for JNK3-M146A, the
highest concentration of the compounds displaced
PIT0105016 by only up to 50%. Therefore, the ﬂuorescence
polarization signal of PIT0105016 in buﬀer was used as the
target value for full displacement of PIT0105016 and the
asymptote for full displacement was ﬁxed to 0% normalized
polarization when performing the curve ﬁt using a four
parameter logistic nonlinear regression model (Figure 3). In
the context of all other FP experiments, it can be deduced that
the KD values obtained for JNK3-M146A are at the lower limit
of the values expectable without the given intrinsic compound
property limitations. The overall size of the aﬃnity loss is very
well in line with the importance of the gatekeeper interactions,
whether they are based on σ-hole bonding or not.
With 16.5%, leucine is one of the most frequent gatekeeper
residues found in the human kinome. It has a rather similar size
compared to methionine, however, lacking electron pair donor
functions, it cannot engage in σ-hole bonds. Thus, JNK3-
M146L was prepared as an interaction-speciﬁc control,
indicating possible changes in the selectivity proﬁle in human
kinases. As expectable, 7a did not show any aﬃnity diﬀerence
for JNK3-M146L versus JNK3-wt. However, there is a clear
diﬀerentiation for the halogenated ligands: Bromine (7c) shows
no signiﬁcant diﬀerence (KD = 61 nM), while chlorine (7b)
beneﬁts with statistical signiﬁcance (2.2-fold; p < 0.01; KD = 31
nM) from the exchange into leucine. In contrast, iodine binds
with signiﬁcantly less aﬃnity to JNK3-M146L (KD = 160 nM),
resulting in a 2.2-fold preference for JNK3-wt (p < 0.001). A
plausible explanation of this observation is that several
dispersive CH-X interactions onto the negative electrostatic
potential of the halogen can compensate for the loss of the
halogen bond. For the smaller chlorine, these can even
overcompensate the eﬀect of the halogen bond, while bromine
is indiﬀerent and the potential repulsion of the larger iodine
leads to a reduced aﬃnity. This data highlights that, although
there is a plateau of aﬃnity in this ligand series, the type of
halogen (Cl, Br, I) actually has an important inﬂuence on the
selectivity proﬁle.
The JNK3-M146T mutant was prepared as link between
JNK3 and p38α. In addition, threonine is the second most
frequent gatekeeper residue (19%) in human kinases. Thus, this
control provides important information about the extended
selectivity proﬁle. The aﬃnities obtained for JNK3-M146T
closely resemble the data obtained for p38α, as we expected. In
contrast to the M146A mutant, 7a shows a smaller decrease in
aﬃnity (52-fold, KD = 14 μM), whereas 7b−d prefers JNK3-wt
by a factor of 180-fold (7b) to 390-fold (7d). This strong
aﬃnity loss for all halogenated compounds implies that no
alternative halogen bond can be formed onto the threonine
oxygen. We also conclude that the interaction toward the
gatekeeper residue threonine is the most inﬂuential parameter
for p38α/JNK3 selectivity. Similar to the M146A mutant, the
ﬂuorescence reporter PIT0105016 could not be fully displaced
by increasing concentrations of 7a−d. Nevertheless, we can
infer from other experiments that the given KD values (obtained
by setting the asymptote for full displacement of PIT0105016
to the ﬂuorescence polarization of PIT0105016 in buﬀer)
represent the lower limit of the possible KD values.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.5b07090
J. Am. Chem. Soc. 2015, 137, 14640−14652
14644
The FP-assay clearly conﬁrms moderate to good JNK3
selectivity in the investigated compounds, similar to the DSF
data. Using the point mutations M146A, M146L and M146T,
we have shown that (a) the gatekeeper contact is important for
maintaining good kinase aﬃnity, (b) threonine as a gatekeeper
is not able to accept a halogen bond with its hydroxyl oxygen
atom, (c) threonine is also not able to engage in any other
alternative, attractive interaction (neither dispersive/hydro-
Figure 4. Results of the reverse ITC experiment. Protein concentration was 115 μM and compound concentration was 10 μM (for 7a, 7c, and 7d)
and 8 μM (for 7b).
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phobic, nor polar) to compensate for the loss of interaction, (d)
not only halogen bonds, but also dispersive/hydrophobic
interactions can preserve ligand aﬃnity, however, (e) leucine
diﬀerentiates between the halogens, preferring the small
chlorine featuring a less pronounced σ-hole over the large
iodine with a strongly pronounced σ-hole. As a consequence,
halogen bonds by diﬀerent halogens can aﬀect not only aﬃnity,
but also selectivity, making them interesting tools for kinase
drug discovery.
3.2. Isothermal Titration Calorimetry (ITC). Using iso-
thermal titration calorimetry, we aimed for an independent
technique with a complementary biophysical readout in order
to conﬁrm our ﬁndings in the FP-assay and to resolve the
binding constants into their thermodynamic parameters. We
optimized the titration protocol to obtain well-deﬁned binding
isotherms with suitable c-values for 7a−d in the range of 60 to
380. Under these conditions both, KD and ΔH, can be derived
from the binding isotherm with good reliability.29 To achieve
this, we had to apply a reverse ITC setup, based on the lack of
solubility of the halogenated compounds. The sample cell was
ﬁlled with a solution of 7a−d in buﬀer containing 5% DMSO
(at a concentration of 8−10 μM). A JNK3 protein solution in
buﬀer containing 5% DMSO (at a concentration of 115 μM in
the syringe) was titrated into the sample cell. Raw data and the
corresponding binding isotherms of a characteristic titration
experiment for each ligand are presented in Figure 4. Statistics
for the relevant thermodynamic parameters from four
independent titrations per compound are summarized in
Table 2.
The KD values obtained by ITC are in good agreement with
the aﬃnities measured in the FP-assay. Small diﬀerences
between the ITC and FP results might arise from the intrinsic
characteristics of both biophysical techniques/experimental
protocols (direct binding vs competition experiment, equilibra-
tion times, titration vs simultaneous measurement of all
concentrations, solubility-based errors, etc.), as well as from
diﬀerences in the buﬀer conditions (2 mM TCEP for ITC
experiments vs 10 mM β-mercaptoethanol for FP experiments).
While 7a binds clearly weaker (198 nM) than any of the
halogenated compounds, there seems to be a slight trend
toward better aﬃnities for the heavier halogens (57 nM for 7b,
50 nM for 7c, and 36 nM for 7d). However, by applying one-
way ANOVA with Bonferroni post hoc testing, it becomes
evident that there is no statistical signiﬁcance in the diﬀerent
KD values found for 7b−d. Only 7a is diﬀerent to all other
compounds with high statistical signiﬁcance (p < 0.0001).
Thus, we conclude that the insigniﬁcant diﬀerence found with
both methods for 7b−d clearly show that for this series of
matched molecular pairs, no gain of aﬃnity can be induced by
replacing chlorine by the heavier halides. Interestingly, there is
also no apparent loss of aﬃnity.
Decomposition of the free energy of binding into enthalpy
(ΔH) and entropy (−T·ΔS) contributions, however, draws
attention to some important diﬀerences between 7b, 7c, and
7d. The enthalpy decreases from −11.3 kJ/mol for the chlorine
derivative 7b to −10.3 kJ/mol for the bromine derivative 7c,
and −8.3 kJ/mol for the iodine derivative 7d. On the basis of
the slightly higher standard deviation for bromine, ANOVA
with Bonferroni post hoc analysis clearly shows that only the
diﬀerence between 7d and the others is signiﬁcant (p < 0.015).
Considering that iodine could in principle form a much
stronger halogen bond than bromine or chlorine, this result is
at least surprising. To elucidate the reason for this behavior, we
solved the crystal structure of 7d in complex with JNK3.
From Table 2, it is also evident that for the heavier halides
the entropic contribution to the free energy of binding becomes
more favorable, compensating almost exactly the loss of
enthalpy. Thus, although ΔG is hardly aﬀected by the type of
halogen forming the halogen bond to MET146, the
thermodynamic parameters are clearly deviating between
chlorine, bromine, and iodine. Similar to ΔH, ANOVA with
Bonferroni post hoc testing showed a signiﬁcant diﬀerence in
ΔS only between iodine (7d) and the other compounds (p <
0.01), which again might be attributed to the high standard
deviation of 7c. A summary plot of ΔH, −T·ΔS, and ΔG
highlighting the enthalpy−entropy compensation in 7b−d, can
be found in the Supporting Information (Figure S4).
We likewise tried to perform ITC experiments with 7a-d and
p38α. However, because of the limited solubility of the
compounds and their weak binding to p38α, neither direct nor
indirect titration experiments yielded satisfying c-values and
interpretable binding isotherms.
4. Crystal Structure of 7d in Complex with JNK3
(4X21) and its Comparison to 2P33. In order to ﬁnd
possible explanations for the signiﬁcantly diﬀerent thermody-
namics of 7d, we have solved the structure of 7d soaked into a
JNK3 crystal at a resolution of 1.95 Å with a ﬁnal Rwork/Rfree of
19.86/22.30 (PDB code 4X21; for further reﬁnement statistics
see Table 3). During model building, it was not possible to
trace the peptide chain between ALA211 and VAL225, as well
as ILE375 and ASP391 due to lack of electron density. Poorly
deﬁned electron densities for these comparatively ﬂexible loops
were also encountered in previous crystal structures of
JNK3.14,35,36
The crystals contain two structurally very similar copies of
ligand-bound JNK3 in their asymmetric unit. Because of the
higher overall B-factors in chain B, we will ﬁrst describe the
binding situation of chain A. Although we provide comparisons
and measurements on the pm scale, it should be emphasized
that the possible coordinate error of the crystal structure (Table
3) certainly limits the interpretability of the very small
diﬀerences sometimes observed. Therefore, we have addition-
ally performed some accompanying calculations to elaborate on
the meaning of the observed trends. Figure 5a shows that 7d
binds tightly to the hinge region and forms a halogen bond to
MET146. The hydrogen bond distance to the hinge region is
205 pm for N···NH and 206 pm for NH···OC. This slightly
exceeds the predicted values by 20 or 14 pm, respectively (see
Table S1). In contrast, the CH···OC weak hydrogen bond
involving the GLU147 backbone was found to be 241 pm long,
Table 2. Results of the ITC Measurements of the Compounds with JNK3
N K [M−1] KD [nM] c-value ΔH [kcal·mol−1] ΔS [cal·mol−1K−1]
7a 1.20 5.06 × 107 198 ± 28 60 −10.7 ± 0.5 −5.12 ± 2.04
7b 1.39 1.75 × 107 57 ± 5 180 −11.3 ± 0.5 −4.95 ± 1.50
7c 1.48 2.00 × 107 50 ± 7 300 −10.3 ± 1.1 −1.17 ± 3.58
7d 1.36 2.80 × 107 36 ± 7 380 −8.3 ± 0.7 6.13 ± 2.10
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as predicted by the QM model. The iodine···sulfur distance dI···S
in chain A is with 315 pm rather short, featuring an excellent σ-
hole angle of 170.3°. Thus, our prediction (319 pm/165°)
closely matches the experimentally found parameters. The
ligand in chain B binds in an almost identical mode to JNK3
(see Figure S5). The hydrogen bonds to the hinge in chain B
have a length of 204 pm (N···NH) and 215 pm (NH···OC),
deviating by only 1 and 9 pm from chain A. The distance of the
weak hydrogen bond in chain B (dCH···OC = 234 pm) also
closely matches chain A. The halogen bond has a distance of
only 305 pm and a σ-hole angle of 168.4°. The deviation of the
σ-hole angle is only marginal and the shortening of dI···S by 10
pm appears small. Still, this very short contact can be actually
detrimental for the energy of the system. Indeed, as
demonstrated in Figure 5d, the attractiveness of the interaction
is further decreased at a distance of 305 pm. However, this very
short length can also be explained by signiﬁcant radiation
damage to the iodine of 7d in chain B. In addition, there is also
a small change in the geometry of the residues lining the
binding site, caused by a crystallization interface in chain A and
another in chain B. We provide a detailed account of these
structural changes and their eﬀect on the ligand binding in the
Supporting Information (Figure S7). It should be noted that in
chain B, the electron density of the N-ethylcarboxamide moiety
is more clearly deﬁned, conﬁrming that the 180° ﬂipped
orientation of the ethyl group in comparison to the structure of
7b in 2P33 is likely favored.
Figure 5b shows chain A (orange) superposed onto the
crystal structure of 2P33 (cyan). Both share an almost identical
binding mode. The hydrogen bonds to the hinge in chain A of
4X21 only deviate by 2 pm (N···NH) and 9 pm (NH···OC)
from 2P33. The distance of the weak hydrogen bond (CH···
OC) is likewise altered by 3 pm only. The diﬀerence in the
hinge binding geometry, thus, appears negligible. The halogen
bond of the iodine in 4X21 is 21 pm shorter than for chlorine
and the σ-hole angle improves by ∼10° to an almost linear
arrangement. While the small deviation of the σ-hole angle is
almost optimal, the signiﬁcantly shorter dI···S could imply an
improved, tighter binding, but could also represent a repulsive
contribution. Similar to 7b, 7d binds to LYS93 via an interstitial
water molecule. The hydrogen bond network around LYS93 in
4X21 appears to be slightly extended by another water
molecule, deﬁned with good electron density and a low B-
factor.
In summary, the comparison of both crystal structures
demonstrates that 7d and 7b are both tightly bound by their
hydrogen bonding network involving the hinge region
(GLU147, MET149) and the bridged interaction with LYS93.
From the QM-based prediction we inferred that the indole-
substituted 2-aminopyrimidine scaﬀold will not shift signiﬁ-
cantly to accommodate the larger iodine, because the stronger
σ-hole of iodine leads to a decreased halogen bond length of
319 pm, in comparison to 333 pm for chlorine. Despite a
reasonably good consistency between our QM-model and the
crystal structure (see Table S1), we deemed it interesting that
the halogen bond length for chlorine (7b) was predicted to be
slightly shorter, while the length for iodine (7d) was predicted
to be slightly longer than in the crystal structure.
5. Bivalent, Mixed Halogen and Chalcogen Bonding
and Torsional Flexibility of the MET146 χ3 Dihedral
Angle δCβ‑Cγ‑S‑Cε. In order to analyze the relative strength of the
experimentally found halogen bond with a distance of 315 pm,
we employed QM calculations on a TPSS-D2/TZVPP level of
theory including the entire ligand 7d together with the capped
methionine (cMET146 = 2-acetamido-N-methyl-4-
(methylthio)butanamide). We also used this model system to
determine another crucial parameter: During reﬁnement of the
crystal structure 4X21, the electron density of the Cε of
MET146 is not as well-deﬁned as the rest of the residue. The
electron density map for the neighbor atom sulfur is spherically
elongated, making two alternative, preferential orientations of
the terminal Cε most plausible. It should be noted that the lack
of electron density for this atom clearly indicates a higher
ﬂexibility, which might be connected to the stronger entropy
contribution to binding of 7d, which we observed in ITC
experiments.
Even more importantly, the orientation of Cε is of utmost
importance for the strength of the halogen bond.4 The highest
electron densities (of the “lone pairs”) are found almost
perpendicular to the plane deﬁned by Cγ, S, and Cε, located
above and below the sulfur. In plane, the sulfur exhibits σ-holes
of itself, eﬃciently preventing a halogen bond to be formed in
this orientation. Thus, the MET146 χ3 dihedral angle δCβ‑Cγ‑S‑Cε
has an essential inﬂuence on the energy evaluation of the
system. From the experimental electron density, we concluded
that the most likely dihedral angle is δ(Cβ−Cγ−S−Cε) = −95°.
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Bond angles (deg) 1.241
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aValues in parentheses are for the highest-resolution shell. bRfree
represents a 5% subset of the total reﬂections, that are excluded
from reﬁnement. cThe overall mean B-factor is found to be in good
agreement with the Wilson B-factor. dThe overall coordinate error was
calculated as approximately 0.2 Å.
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Closer inspection of the proximal amino acids in the back
pocket behind MET146, reveals an unexpected, but highly
interesting contact featured consistently in both chains of 4X21,
however, not in 2P33. MET115, located in helix αC, adopts a
diﬀerent rotameric state in 4X21, forming a chalcogen bond
with the sulfur electron density of MET146 from the opposite
direction of the halogen bond (Figure 5c). Similar to halogens,
the heavier chalcogens such as sulfur show an anisotropic
electron distribution, leading to σ-holes (positive electrostatic
potentials) in elongation of the Cγ/ε-S bond vectors.
39−43 The
distance dS···S between MET115 and MET146 corresponds with
387 pm (or 382 pm in chain B) quite well to the minima
Figure 5. Crystal structure of the 5-iodopyrimidine derivative (7d) in complex with JNK3 and computational analysis of the iodine···sulfur halogen
bond. (a) The binding site of chain A of 4X21 is presented with emphasis on the tight hydrogen bond network toward the hinge region and via two
bridging water molecules toward LYS93. The protein is shown as a bright orange cartoon representation, with selected residues in the cavity depicted
as stick models. The ligand is shown as an orange stick model, and hydrogen bonds are highlighted with broken, orange lines. The weak hydrogen
bond (CH···OC) involving GLU147 is indicated by light blue, broken lines. The halogen bond targeting the gatekeeper MET146 is shown as a
red line, while the σ-hole angle is depicted as a curved, dotted, red line. Characteristic distances and the σ-hole angle are denoted explicitly (see also
Table S1). An unbiased simulated-annealing omit electron-density map (Fo − Fc) for the ligand is shown at a contour level of 3.0 σ. Only density
within a maximal distance of 220 pm of any atom of the ligand is displayed for clarity reasons. The N-ethyl-substituent of the piperidinyl-1-
carboxamide moiety of 7d protruding from the cavity was not clearly resolved in the crystal structure. (b) Overlay of chain A of 4X21 (bright orange)
and 2P33 (bright cyan). The respective ligands 7d of 4X21 and 7b of 2P33 are colored in orange and cyan. The polar interactions (hydrogen, weak
hydrogen and halogen bonds) are depicted similar to panel (a). For better diﬀerentiation between the structures, the color code of the ligands is
likewise used for the interactions. Alignment and superposition has been done in MOE.37 Pictures have been prepared and rendered in PyMOL.18
(c) MET146 is engaged in a bivalent halogen bond (red) and chalcogen bond (purple) donated by 7d and MET115, respectively. Distances (dI···S
and dS···S) and σ-hole angles (αC‑I···S and αCγ‑S···S) characterizing the quality of the interactions are depicted in the model system (shown as sticks).
This consists of 7d and the two capped methionine residues (cMET = 2-acetamido-N-methyl-4-(methylthio)butanamide) in position 146 and 115.
The ﬂexibility of the χ3 dihedral angle (δCβ‑Cγ‑S‑Cε) is represented by partially transparent replicas of the Cε-S bond of MET146. (d) The depicted 3D
plot shows the results (white dots) of the systematic variation of δCβ‑Cγ‑S‑Cε in increments of 10° and dI···S between 295 and 405 pm in steps of 10 pm.
Adduct formation energies (in kJ/mol) were calculated on a TPSS-D2/TZVPP level of theory by subtracting the DFT-energy of the three educts
(7d, cMET146, and cMET115) from the DFT-energy of the complex. Fitting a surface to the data, which was color coded with a gradient
representing the adduct formation energies, and projection of the energy proﬁle onto the xy-plane was done in Origin9.1.38 The point of intersection
between the two black lines plotted in the projected map indicates the most reasonable experimental geometry. (e) 3D bar chart depicting the
number of human kinases for each possible combination of gatekeeper residue and their proximal residue in the αC-helix. Residues were identiﬁed
and statistics derived based on kinase sequence alignments16 obtained from http://kinase.com/human/kinome/phylogeny.html. Red 2D bar charts
projected onto the side and back of the 3D plot provide the relative overall distribution of residues for both positions in 486 human kinases. The red
3D bar highlights 45 diﬀerent kinases (including JNK3) featuring methionine in both positions. (f) Distribution of these 45 kinases highlighted in
the dendrogram of human protein kinases according to Manning et al.16 by red dots. For clarity, JNK3 is represented by a green dot.
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reported in the literature for a similar model system (403
pm).39 An almost linear arrangement (αCγ‑S···S = 180°) indicates
a good alignment of the σ-hole of the donor methionine with
the sulfur of the acceptor methionine. We ﬁnd a deviation of
only ΔαCγ‑S···S = 26.0° for chain A and 20.3° for chain B.
Additionally, a very good overlap of the donor σ-hole of
MET115 with the highest electron density (lone pairs) above
the Cγ−S−Cε plane of MET146 is observed for χ3 dihedral
angle δCβ‑Cγ‑S‑Cε close to −95°. Hence, the chalcogen bond
donated from MET115 and the halogen bond donated from 7d
are engaged in a bivalent interaction with MET146. As shown
in Figure 5c, we have therefore extended our model system by
the capped MET115 (cMET115) to elucidate, how this
additional interaction restricts the conformational freedom of
MET146.
We rotated δCβ‑Cγ‑S‑Cε in steps of 10° between −65° and
−175°. All dihedral angles beyond this span clearly led to
signiﬁcant clashes with the ligand or MET115. We simulta-
neously altered the distance dI···S from 295 to 405 pm in
increments of 10 pm, giving a total of 144 single points to be
evaluated. The results can be seen in Figure 5d. According to
the most reasonable geometry derived from the electron
density, the interaction energy amounts to approximately −28.6
kJ/mol. It should be noted that this interaction energy is only
the simple adduct formation energy of the complex, not
including desolvation eﬀects or entropy contributions. Thus,
the numbers cannot be interpreted as absolute, but only relative
values. If the dihedral angle is changed by more than 20°
toward the iodine atom (δCβ‑Cγ‑S‑Cε = −75°), the mismatch of
the sulfur electron density and the iodine σ-hole will be
dramatically increased and steric clashes start to arise from the
too close Cε···S contact, leading to an almost complete loss of
the attractive interaction. On the basis of steric repulsion with
MET115, dihedral angles of δCβ‑Cγ‑S‑Cε < −165° are not
possible. The interaction energy in the range −85° > δCβ‑Cγ‑S‑Cε
> −115° is quite similar at the given experimental distance of
dI···S = 315 pm (black line in Figure 5d). Moreover, at a larger
distance, the energy surface becomes even more shallow,
diﬀering between −75° and −145° by only up to 6 kJ/mol. The
chalcogen bond provides between a δCβ‑Cγ‑S‑Cε of −65° and
−145° an almost constant stabilization of the complex (−9.6 to
−10.8 kJ/mol on a TPSS-D2/TZVPP-level of theory), quite
independent of the dihedral angle.
The strength of the interaction could be further improved by
a larger distance of the iodine atom (∼345 pm instead of 315
pm). It is obvious from Figure 5d that the strength of the
halogen bond at 315 pm will be improved or maintained up to
a distance of more than 400 pm at these dihedral angles. Thus,
we conclude that the experimentally determined geometry
represents a still favorable, attractive interaction, however, fails
to utilize the potential of the stronger σ-hole of iodine. This is
due to the binding mode being clearly dominated by the tight
hydrogen-bonding network to the hinge and LYS93. In
addition, the too close iodine atom of 7d increases the
ﬂexibility of Cε of MET146, however, the rest of the residue
cannot adapt, because it accepts the chalcogen bond from
MET115.
We further evaluated the relative conformational strain of the
MET146 side chain, when it adopts diﬀerent dihedral angles.
We calculated the relative energy of our cMET146 model
system, when modifying δCβ‑Cγ‑S‑Cε. The identiﬁed torsional
minimum at approximately −75° causes an almost repulsive
interaction. The most plausible dihedral of −95° causes a
slightly increased conformational strain of +4.0 kJ/mol, which
appears to be less relevant in comparison to the gain of
interaction energy (in Figure 5d). Still, combining the trend
observed for the conformational strain of MET146 with the
trend in the interaction energies, it appears plausible that a
certain ﬂuctuation of the χ3 dihedral angle of MET146 of ±15°
with respect to the best angle might be possible. Interestingly,
in comparison to 4X21, the crystal structure of 7b (2P33)
appears to have a more well-deﬁned electron density for Cε,
probably also correlating with the larger halogen bond distance
and the smaller size of chlorine. Beside desolvation eﬀects, this
observation is one possible explanation for changes in enthalpy
and entropy between these ligands, while the overall ΔG is only
insigniﬁcantly diﬀerent. We have calculated solvation eﬀects
using COSMO-RS (see Supporting Information, Figure S2, and
Table S2) for the ligands 7a−d in complex with the capped
gatekeeper cMET146. The results show a good correlation
between the COSMO-RS corrected and the gas phase energies
(R2 = 0.96). The desolvation energy ranges between −18.0 kJ/
mol (4X21) and −19.8 kJ/mol (2P33).
■ CONCLUSION
We performed a matched molecular pair analysis of a series of
aminopyrimidine-based JNK3 inhibitors, designed to inves-
tigate halogen bonding eﬀects with the sulfur of MET146, the
gatekeeper residue of this kinase. With a signiﬁcant portion of
the human kinome sharing a methionine residue as the
gatekeeper, this case study is an interesting starting point for a
more systematic investigation of X···S halogen bonding eﬀects
on aﬃnity and selectivity tuning in kinase drug discovery. There
are important lessons learned from this case study, which may
help to guide future molecular design projects.
Despite the usual assumption that halogen bonding strength
increases from chlorine to bromine to iodine, in this ligand
series we encounter a plateau of aﬃnity, reached already for
chlorine (7b). Neither bromine (7c), nor iodine (7d) were
found to provide any statistically signiﬁcant advance in aﬃnity
in ﬂuorescence polarization-based measurements or isothermal
titration calorimetry. Thus, these two halogens clearly fail to
reach the full potential according to the size of their σ-hole,
which we have demonstrated by calculating their Vmax value and
by visualizing their electrostatic potentials. It should be
emphasized that the lack of a signiﬁcant improvement does
not imply that they do not have greater potential for gaining
aﬃnity; however, it means that in this system other factors did
not permit 7c or 7d to make use of this potential. On the basis
of the crystal structure of 7d in complex with JNK3 (4X21), its
comparison to the original structure of 7b in complex with
JNK3 (2P33), and exploiting a systematic QM-based evaluation
of parameters crucial for binding, we are able to identify these
factors and to rationalize, when halogen exchange toward
bromine and iodine might be a rewarding strategy and when it
may not provide any advantage. Such cases, where chlorine
already is the optimum can certainly be beneﬁcial, particularly
when being concerned about attrition caused by adverse eﬀects
that could be related to these heavier halogens.
From Figure 5, there is clear evidence that 7d is held so
tightly in place by the hydrogen bonding network involving the
hinge (MET149, GLU147) and LYS93 that a signiﬁcant
displacement of the scaﬀold is not expectable. Despite being
often considered rather ﬂexible, methionine seems not to be
able to adapt to the strongly ﬁxed ligand by increasing the
halogen bond distance from 315 pm (in the crystal structure)
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to roughly 335 to 365 pm, where the optimum is expected
according to our model calculations (shown in Figure 5d). We
have shown additionally that the conformational strain of such
adaptive processes should not be underestimated and can be a
real liability for ligand binding. Interestingly, in our JNK3
complex with 7d, MET146 is bivalently engaged by a halogen
bond from the ligand and a chalcogen bond from MET115.
This dual interaction strongly restricts the ﬂexibility of
MET146, except for the χ3 dihedral angle. The slightly too
close iodine atom in 7d enhances the ﬂexibility of Cε and causes
variations in χ3 within the boundaries of the bivalent halogen/
chalcogen bond, counterbalanced by the increasing conforma-
tional strain of MET146. In the context of the signiﬁcant shifts
between enthalpy (ΔΔH(7d−7b) = +3.0 kcal·mol−1) and
entropy (ΔΔS(7d−7b) = +11.1 cal·mol−1·K−1), this change in
ﬂexibility might be one relevant contribution. Of course,
changes in desolvation can likewise contribute to the observed
enthalpy−entropy compensation between 7b and 7d.44
As we have shown for JNK3 versus p38α, halogen bonding to
the gatekeeper residue methionine can modify the selectivity
proﬁle of kinase inhibitors. This eﬀect can, of course, depend
not only on the diﬀerence between the gatekeeper residues
(e.g., MET vs THR) and the discriminative way both can be
targeted by halogen bonding, but it also may depend on small
to subtle geometric variances in the binding site featuring the
same gatekeeper. As shown in this study, the diﬀerence
between an attractive and a repulsive interaction can be as small
as 20−30 pm. In addition, small changes in the spherical
orientation of the residue (e.g., the χ3 dihedral angle in
methionine) or deviations from a linear arrangement (σ-hole
angle of 180°) by 10−30° can be suﬃcient to cause a
substantial shift in selectivity. We prepared the gatekeeper
mutants M146A, M146L, and M146T of JNK3 to scrutinize the
role of the halogen bond in molecular recognition of 7b−d.
The strong loss of aﬃnity for M146A suggests that an
interaction with the gatekeeper residue is key to achieving high
aﬃnity for all ligands. The high similarity of the ligand binding
data between M146T and p38α implies that the exchange of
the gatekeeper into threonine is the major determinant of
p38α/JNK3-selectivity. Apparently, none of the interaction
patterns (halogen bond, hydrogen bond, dispersive/hydro-
phobic interaction) which threonine can form is able to
compensate for the loss of the halogen bond toward
methionine. In contrast, leucine as a gatekeeper of similar
size can compensate, based on dispersive/hydrophobic
interactions, for the loss of the methionine interaction. It
shows an interesting diﬀerentiation between the halogens: the
small chlorine is clearly preferred over the larger bromine and
even more over iodine. Thus, preference by leucine increases
with decreasing σ-hole size and decreasing volume of the
halogen. Hence, although failing to modify aﬃnity toward
JNK3-wt, the choice of halogen can have an important impact
on kinase selectivity.
A fascinating paradigm observed in this study is the
stabilization of MET146 by the proximal MET115. The quite
favorable chalcogen bond geometry restricts the motility of
MET146, preventing a more eﬃcient adaption to the too close
iodine atom. Thus, this combination of chalcogen bonding
partners in this position may give rise to some aﬃnity cliﬀs in
the structure−activity relationship (SAR) of ligand series. As
highlighted in Figure 5e, when the gatekeeper is a methionine
residue, the probability of a methionine as its proximal neighbor
in the αC-helix of the back pocket is only 24.6%. The overall
chance of two methionine residues occurring in these two
positions, is only 9.3% with respect to the human kinome.
Leucine has a much higher prevalence in this position of the
αC-helix, however, it only can interact by forming hydrophobic
contacts. Interestingly, analysis of the distribution of the 45
kinases featuring both methionine residues reveals an unequal
distribution among the kinase subfamilies. While JNK3 and
JNK1, both share this feature, neither JNK2, nor any other
kinase in the CMGC subtree (see Figure 5f) show this
combination of methionine residues. It seems to occur in small
clusters of two to four closely related kinases, however, is
spread rather equally across the diﬀerent subfamilies, except for
the Casein Kinase 1 family. Still, close proximity between two
methionine residues in these two positions will not by itself
guarantee formation of a chalcogen bond, as demonstrated in
2P33. However, the described paradigm may provide new
opportunities for selectivity proﬁling in the human kinome.
Clearly, more test cases and a more exhaustive comparison is
needed to highlight general trends.
In a nutshell, what did we learn from this model system?
Molecular design of halogen bonds in binding sites starting
from molecules of high complexity45 that comprise a substantial
number of highly preoptimized interactions is certainly not
trivial. Best results can be expected when the carbon···sulfur
distance between the aromatic scaﬀold and methionine is
approximately 540−560 pm and the σ-hole angle only deviates
by up to 20° from linearity. It is dangerous to rely on adaptive
behavior of the binding site, even with a side chain such as
methionine that is usually perceived to be more ﬂexible than
most other residues. An alternative, much better strategy for
such a situation is to select one of the most eﬃcient fragments
from a library such as HEFLibs (halogen-enriched frag-
ments),46,47 which shows an optimized halogen bond geometry
with this gatekeeper and then try to grow or merge the
fragment to introduce an optimized network of other
interactions. Still, molecular design is a most valuable method
for lead optimization. As a consequence, QM-based scoring
functions for docking approaches, accounting precisely for the
geometric restraints of halogen bonding17,48 can be valuable
tools complementary to the direct use of quantum chemistry or
integrated QM/SQM/MM-approaches.22,49,50
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